[
  {
    "id": 1,
    "question": "A patient is taking Tegretol (carbamazepine). What medication interaction should you be aware of?",
    "options": [
      "Acetaminophen",
      "Ibuprofen",
      "Cipro or Erythromycin",
      "Aspirin"
    ],
    "correctAnswer": 2,
    "rationale": "CYP3A4 INHIBITORS (Cipro, erythromycin, grapefruit) + carbamazepine = TOXICITY. PHARMACOKINETICS = body affects drug (metabolism). Inhibitors SLOW metabolism → drug ACCUMULATES → toxicity. Mnemonic inhibitors: 'SICK FACES' - SSRIs, Isoniazid, Cimetidine, Ketoconazole, Fluconazole, Amiodarone, Ciprofloxacin, Erythromycin, Sulfonamides.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 2,
    "question": "A patient started on an SSRI and tramadol two days ago now presents with agitation, diaphoresis, and muscle twitching. Which additional findings would confirm the PMHNP's suspected diagnosis?",
    "options": [
      "Bradycardia, hypothermia, and lethargy",
      "Tachycardia, hyperreflexia, and hyperthermia",
      "Lead-pipe rigidity, fever, and mutism",
      "Hypotension, respiratory depression, and pinpoint pupils"
    ],
    "correctAnswer": 1,
    "rationale": "Serotonin syndrome presents with tachycardia, hyperthermia, hyperreflexia, and muscle twitching. This is a medical emergency. Teach patient: Seek ER immediately if these symptoms occur when starting or increasing serotonergic meds.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 3,
    "question": "A 22-year-old college student is brought to the clinic by her roommate after exhibiting paranoid delusions and auditory hallucinations for the past 3 weeks. This is her first psychotic episode. Which antipsychotic is considered first-line treatment?",
    "options": [
      "Haloperidol (Haldol)",
      "Clozapine (Clozaril)",
      "Chlorpromazine (Thorazine)",
      "Paliperidone (Invega)"
    ],
    "correctAnswer": 3,
    "rationale": "Invega (paliperidone) is first-line for first-episode psychosis—better tolerated with lower EPS risk than older antipsychotics. Teach patient: Take consistently; improvement takes weeks.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 4,
    "question": "What medication is contraindicated in a patient with eating disorder (bulimia)?",
    "options": [
      "Prozac",
      "Zoloft",
      "Wellbutrin (Bupropion)",
      "Lexapro"
    ],
    "correctAnswer": 2,
    "rationale": "BUPROPION (Wellbutrin) CONTRAINDICATIONS: (1) Seizure disorder - lowers seizure threshold, (2) EATING DISORDERS (anorexia, bulimia) - electrolyte imbalances increase seizure risk, (3) Concurrent MAOIs, (4) Abrupt alcohol/benzo withdrawal. Seizure risk is dose-dependent (0.4% at 450mg). Also avoid in patients with history of head trauma, brain tumor. NOT associated with sexual dysfunction or weight gain - often used for these reasons. Good choice for depression with fatigue/low energy.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 5,
    "question": "A PMHNP is selecting an antipsychotic for a patient with schizophrenia who has a BMI of 32 and prediabetes. Which antipsychotic poses the HIGHEST risk for worsening this patient's metabolic status?",
    "options": [
      "Aripiprazole (Abilify)",
      "Ziprasidone (Geodon)",
      "Clozapine (Clozaril)",
      "Risperidone (Risperdal)"
    ],
    "correctAnswer": 2,
    "rationale": "Clozapine carries the highest metabolic risk: weight gain, diabetes, dyslipidemia. Teach patient: Monitor weight weekly, report increased thirst/urination. Labs: glucose and lipids at baseline, 3 months, then annually.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 6,
    "question": "A patient with bipolar I disorder has been stable on lithium for 2 years. The PMHNP is reviewing the patient's most recent lithium level. Which serum concentration indicates the patient is within the therapeutic range for maintenance therapy?",
    "options": [
      "0.3 mEq/L",
      "1.6 mEq/L",
      "2.2 mEq/L",
      "0.8 mEq/L"
    ],
    "correctAnswer": 3,
    "rationale": "LITHIUM THERAPEUTIC LEVEL for maintenance: 0.6-1.2 mEq/L (0.8 mEq/L is optimal). For acute mania: 0.8-1.2 mEq/L. Draw trough level 12 hours after last dose. Patient education: maintain consistent sodium and fluid intake, avoid NSAIDs and dehydration. Signs of toxicity (>1.5 mEq/L): tremor, ataxia, confusion, vomiting, diarrhea. Regular monitoring: every 3-6 months when stable.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 7,
    "question": "A patient on lithium is scheduled for routine monitoring. To obtain an accurate trough level, the PMHNP should instruct the patient to have blood drawn at which time?",
    "options": [
      "4 hours after the last dose",
      "8 hours after the last dose",
      "12 hours after the last dose",
      "24 hours after the last dose"
    ],
    "correctAnswer": 2,
    "rationale": "Draw lithium 12 hours after last dose for accurate trough level. Teach patient: Take evening dose, get blood drawn next morning before the AM dose.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 8,
    "question": "A patient on lithium develops elevated TSH. What does this indicate?",
    "options": [
      "Hypothyroidism",
      "Hyperthyroidism",
      "Normal finding",
      "Lithium toxicity"
    ],
    "correctAnswer": 0,
    "rationale": "Elevated TSH = hypothyroidism. Lithium blocks thyroid hormone release. Teach patient: Report fatigue, cold intolerance, weight gain. Check TSH every 6 months.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 9,
    "question": "What should you do if a patient on lithium develops hypothyroidism?",
    "options": [
      "Stop lithium immediately",
      "Reduce lithium dose",
      "Continue lithium and add levothyroxine",
      "Switch to Depakote"
    ],
    "correctAnswer": 2,
    "rationale": "Continue lithium (it works); add levothyroxine for the thyroid. Teach patient: Take thyroid medication separately, usually in the morning on empty stomach.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 10,
    "question": "A patient on lithium presents with tremor, ataxia, and confusion. The lithium level is 2.1 mEq/L. When reviewing potential causes, the PMHNP knows the MOST common cause of lithium toxicity is:",
    "options": [
      "Dehydration",
      "Intentional overdose",
      "Drug-drug interaction",
      "Acute renal failure"
    ],
    "correctAnswer": 0,
    "rationale": "Dehydration is the #1 cause of lithium toxicity—kidneys retain lithium when dry. Teach patient: Drink 8–10 glasses of water daily, avoid excessive sweating, report vomiting/diarrhea immediately.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 11,
    "question": "A PMHNP is initiating a mood stabilizer for a patient with bipolar II disorder. Which medication requires slow titration due to the risk of Stevens-Johnson Syndrome?",
    "options": [
      "Lamotrigine (Lamictal)",
      "Lithium carbonate",
      "Aripiprazole (Abilify)",
      "Fluoxetine (Prozac)"
    ],
    "correctAnswer": 0,
    "rationale": "Lamictal can cause Stevens-Johnson Syndrome—a life-threatening rash. Requires very slow titration. Teach patient: Stop immediately and call if any rash develops, especially with fever or mouth sores.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 12,
    "question": "A PMHNP is considering clozapine for a patient with treatment-resistant schizophrenia. When discussing the medication with the patient, which BLACK BOX WARNING must be emphasized?",
    "options": [
      "Hypothyroidism requiring thyroid monitoring",
      "Agranulocytosis requiring regular blood monitoring",
      "Hepatotoxicity requiring liver function tests",
      "Nephrotoxicity requiring renal function monitoring"
    ],
    "correctAnswer": 1,
    "rationale": "Clozapine black box: agranulocytosis (dangerously low WBCs). Requires weekly-to-monthly ANC monitoring via REMS. Teach patient: Report sore throat, fever, or flu-like symptoms immediately.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 13,
    "question": "A patient on clozapine has an ANC of 1200. What should you do?",
    "options": [
      "Continue clozapine as normal",
      "Stop clozapine permanently",
      "Interrupt treatment and monitor daily",
      "Reduce clozapine dose by 50%"
    ],
    "correctAnswer": 2,
    "rationale": "ANC 1000–1499 = moderate neutropenia. Hold clozapine, check ANC daily. Resume only when ANC ≥1500. Teach patient: Avoid crowds and sick contacts during this time.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 14,
    "question": "A patient on clozapine quits smoking. What should you do?",
    "options": [
      "Continue same dose",
      "Increase clozapine dose",
      "Reduce clozapine dose",
      "Stop clozapine"
    ],
    "correctAnswer": 2,
    "rationale": "CYP1A2: Smoking INDUCES (speeds up) metabolism of clozapine/olanzapine. Quit smoking → levels RISE 50% → toxicity risk. INDUCERS mnemonic: 'PC BRAS' - Phenytoin, Carbamazepine, Barbiturates, Rifampin, Alcohol (chronic), St. John's Wort, Smoking. REDUCE dose 25-50% when patient quits.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 15,
    "question": "Which SSRI is FDA-approved for bulimia nervosa?",
    "options": [
      "Zoloft 50 mg",
      "Paxil 40 mg",
      "Prozac 60 mg",
      "Lexapro 20 mg"
    ],
    "correctAnswer": 2,
    "rationale": "FLUOXETINE (Prozac) 60 mg/day is the ONLY FDA-approved medication for BULIMIA NERVOSA. Higher dose needed (60mg vs 20mg for depression) because bulimia requires more serotonin modulation. SSRIs reduce binge-purge frequency. Avoid bupropion in eating disorders (seizure risk due to electrolyte imbalances). CBT is first-line psychotherapy for bulimia.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 16,
    "question": "A 45-year-old patient presents with major depressive disorder and a 20-year smoking history. He expresses motivation to quit smoking. Which antidepressant would provide dual benefit for both conditions?",
    "options": [
      "Fluoxetine (Prozac)",
      "Sertraline (Zoloft)",
      "Bupropion (Wellbutrin)",
      "Duloxetine (Cymbalta)"
    ],
    "correctAnswer": 2,
    "rationale": "Wellbutrin treats depression AND helps with smoking cessation—dual benefit. Teach patient: Avoid alcohol; set a quit date 1–2 weeks after starting.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 17,
    "question": "What antidepressant is BEST for a patient with depression and insomnia?",
    "options": [
      "Wellbutrin",
      "Prozac",
      "Mirtazapine (Remeron) or Trazodone",
      "Lexapro"
    ],
    "correctAnswer": 2,
    "rationale": "DEPRESSION + INSOMNIA: Mirtazapine (Remeron) or trazodone—sedating. SLEEP NEUROANATOMY: PINEAL GLAND (epithalamus) secretes MELATONIN (darkness→production). Regulates CIRCADIAN RHYTHM via suprachiasmatic nucleus (SCN) in hypothalamus. Ramelteon=melatonin receptor agonist. Trazodone: 5HT2 antagonist + sedating H1 blockade.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 18,
    "question": "A 35-year-old man with depression reports that sexual dysfunction from his previous SSRI caused him to stop taking it. Which antidepressant has the LOWEST risk of sexual side effects?",
    "options": [
      "Fluoxetine (Prozac)",
      "Sertraline (Zoloft)",
      "Paroxetine (Paxil)",
      "Bupropion (Wellbutrin)"
    ],
    "correctAnswer": 3,
    "rationale": "BUPROPION (Wellbutrin) is preferred for patients with SSRI-induced sexual dysfunction. Mechanism: norepinephrine-dopamine reuptake inhibitor (NDRI) - NO serotonergic effects that cause sexual dysfunction. Also weight-neutral. Alternatives: mirtazapine (may cause sedation/weight gain), adding buspirone, dose reduction. Bupropion contraindicated in eating disorders and seizure history.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 19,
    "question": "A patient on phenelzine (Nardil) presents to the emergency department with severe occipital headache, hypertension (220/120), and diaphoresis after eating aged cheese. Which medication should be administered for this hypertensive crisis?",
    "options": [
      "Phentolamine",
      "Metoprolol",
      "Labetalol",
      "Lisinopril"
    ],
    "correctAnswer": 0,
    "rationale": "Phentolamine (alpha-blocker) treats MAOI hypertensive crisis from tyramine reaction. This is an emergency. Teach patient on MAOIs: Avoid aged cheese, cured meats, draft beer.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 20,
    "question": "A patient on sertraline requires surgery and will receive opioid pain management. The PMHNP should alert the surgical team that which opioid can precipitate serotonin syndrome when combined with SSRIs?",
    "options": [
      "Morphine",
      "Hydrocodone",
      "Meperidine (Demerol)",
      "Oxycodone"
    ],
    "correctAnswer": 2,
    "rationale": "Meperidine (Demerol) inhibits serotonin reuptake. Combined with MAOIs or SSRIs, it causes serotonin syndrome. Teach patient: Always list all psych meds before any procedure.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 21,
    "question": "A PMHNP is educating a nursing student about antidepressant mechanisms. When explaining how SSRIs work, which statement accurately describes their mechanism of action?",
    "options": [
      "They inhibit monoamine oxidase enzyme activity",
      "They block dopamine reuptake in the synapse",
      "They selectively inhibit serotonin reuptake, increasing synaptic serotonin",
      "They block NMDA glutamate receptors"
    ],
    "correctAnswer": 2,
    "rationale": "SSRIs block serotonin reuptake, increasing serotonin in the synapse. Teach patient: Takes 2–4 weeks to work; don't stop abruptly.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 22,
    "question": "A patient asks the PMHNP how bupropion (Wellbutrin) works differently from SSRIs. Which response accurately describes bupropion's mechanism of action?",
    "options": [
      "It is a selective serotonin reuptake inhibitor (SSRI)",
      "It is a serotonin-norepinephrine reuptake inhibitor (SNRI)",
      "It is a norepinephrine-dopamine reuptake inhibitor (NDRI)",
      "It is a monoamine oxidase inhibitor (MAOI)"
    ],
    "correctAnswer": 2,
    "rationale": "Wellbutrin is an NDRI—blocks norepinephrine and dopamine reuptake. Activating effect, no sexual side effects. Teach patient: May increase energy; take morning dose to avoid insomnia.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 23,
    "question": "A PMHNP is evaluating a patient who developed depression after starting a new medication for hypertension. Which medication classes are known to INDUCE depression?",
    "options": [
      "Beta-blockers, corticosteroids, interferon, and isotretinoin",
      "SSRIs and SNRIs",
      "Stimulants and wake-promoting agents",
      "Benzodiazepines only"
    ],
    "correctAnswer": 0,
    "rationale": "Beta-blockers, steroids, interferon, and Accutane can cause depression. Teach patient: Report mood changes when starting any new medication. Screen mood before and during treatment.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 24,
    "question": "A patient with bipolar I disorder is admitted to the hospital in a manic episode. The PMHNP reviews the medication history and notes the patient started a new medication two weeks ago. Which medications are known to INDUCE mania?",
    "options": [
      "Corticosteroids, antidepressants, isoniazid, and disulfiram",
      "Mood stabilizers",
      "Benzodiazepines",
      "Antipsychotics"
    ],
    "correctAnswer": 0,
    "rationale": "MANIA-INDUCING MEDICATIONS (SAID mnemonic): Steroids, Antidepressants, INH (isoniazid), Disulfiram. Always screen for bipolar history before starting antidepressants. Monitor for racing thoughts, decreased need for sleep, increased energy.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 25,
    "question": "A patient abruptly stopped paroxetine 3 days ago and presents with dizziness, electric shock sensations, irritability, and flu-like symptoms. Which condition is the MOST likely diagnosis?",
    "options": [
      "Serotonin syndrome",
      "Medication withdrawal seizure",
      "SSRI discontinuation syndrome",
      "Recurrence of depression"
    ],
    "correctAnswer": 2,
    "rationale": "SSRI DISCONTINUATION SYNDROME: Flu-like symptoms, dizziness, 'brain zaps' (electric shock sensations), irritability, insomnia. Most common with PAROXETINE (shortest half-life). Prevention: Always taper SSRIs gradually over 2-4 weeks. Fluoxetine rarely causes this due to long half-life.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 26,
    "question": "A PMHNP is reviewing antipsychotic options for a patient with a history of QTc prolongation. Which antipsychotic should be AVOIDED due to highest QTc risk?",
    "options": [
      "Aripiprazole (Abilify)",
      "Olanzapine (Zyprexa)",
      "Ziprasidone (Geodon)",
      "Risperidone (Risperdal)"
    ],
    "correctAnswer": 2,
    "rationale": "ZIPRASIDONE (Geodon) should be AVOIDED in patients with QTc prolongation - it has the HIGHEST QTc risk among atypical antipsychotics. Also avoid: thioridazine, IV haloperidol, droperidol. Safer alternatives for patients with QTc concerns: aripiprazole, lurasidone. Always get baseline ECG in patients with cardiac history. QTc >500ms or increase >60ms from baseline = discontinue medication.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 27,
    "question": "A patient with bipolar I disorder has had multiple breakthrough manic episodes despite adequate trials of lithium and valproate. Which mood stabilizer is MOST effective for rapid cycling bipolar disorder?",
    "options": [
      "Lithium",
      "Carbamazepine",
      "Valproate (Depakote)",
      "Lamotrigine"
    ],
    "correctAnswer": 2,
    "rationale": "VALPROATE (Depakote) is excellent for bipolar I with multiple breakthrough manic episodes. Advantages: rapid loading possible (20-30 mg/kg), effective for mixed states, less weight gain than olanzapine. Therapeutic level: 50-125 mcg/mL. Monitor: LFTs, CBC with platelets, ammonia. Contraindicated in pregnancy (neural tube defects). Consider if lithium has failed.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 28,
    "question": "Before initiating carbamazepine (Tegretol) in a patient of Asian descent, the PMHNP should order which genetic test?",
    "options": [
      "HLA-B*1502 allele",
      "CYP2D6 genotype",
      "MTHFR mutation",
      "COMT polymorphism"
    ],
    "correctAnswer": 0,
    "rationale": "HLA-B*1502 screening is REQUIRED before starting CARBAMAZEPINE in patients of ASIAN ancestry. This allele increases risk of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) by 100-fold. If positive, do NOT use carbamazepine. Also screen HLA-A*3101 for Northern European ancestry. Alternative mood stabilizers: valproate, lamotrigine, lithium.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 29,
    "question": "A patient presents to the emergency department in acute mania. The PMHNP decides to use valproate (Depakote) with a loading dose strategy. What is the appropriate loading dose?",
    "options": [
      "10 mg/kg/day",
      "40-50 mg/kg/day",
      "5 mg/kg/day",
      "20-30 mg/kg/day"
    ],
    "correctAnswer": 3,
    "rationale": "VALPROATE LOADING DOSE: 20-30 mg/kg/day for acute mania. Achieves therapeutic levels in 1-2 days vs 5-7 days with standard titration. Divide into 2-3 doses to reduce GI side effects. Can use oral or IV route. Target level: 85-125 mcg/mL for acute mania. Divalproex sodium ER formulation allows once-daily dosing. Check levels 12 hours after last dose.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 30,
    "question": "A patient on lithium is prescribed a new medication by their primary care provider. The PMHNP should warn that which TWO medication classes can approximately DOUBLE lithium levels?",
    "options": [
      "Acetaminophen and antihistamines",
      "ACE inhibitors and NSAIDs",
      "Proton pump inhibitors and statins",
      "Calcium channel blockers and antibiotics"
    ],
    "correctAnswer": 1,
    "rationale": "ACE INHIBITORS and NSAIDs can approximately DOUBLE lithium levels. NSAIDs reduce renal prostaglandins → decreased lithium clearance. ACEIs reduce GFR. Both increase lithium toxicity risk. Use acetaminophen instead of NSAIDs.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 31,
    "question": "A patient on lithium reports starting ibuprofen for knee pain. The PMHNP should advise that NSAIDs affect lithium levels by which mechanism?",
    "options": [
      "Increasing hepatic metabolism of lithium",
      "Increasing GI absorption of lithium",
      "Displacing lithium from protein binding",
      "Decreasing renal clearance of lithium, raising levels"
    ],
    "correctAnswer": 3,
    "rationale": "NSAIDs DECREASE RENAL CLEARANCE of lithium by inhibiting prostaglandin synthesis in kidneys. This reduces GFR and sodium excretion, leading to increased lithium reabsorption. Result: Higher lithium levels → toxicity risk. Monitor levels if NSAID use is necessary.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 32,
    "question": "A patient presents to the emergency department after a benzodiazepine overdose with respiratory depression. Which medication should be administered as the antidote?",
    "options": [
      "Naloxone (Narcan)",
      "Atropine",
      "Physostigmine",
      "Flumazenil (Romazicon)"
    ],
    "correctAnswer": 3,
    "rationale": "Flumazenil reverses benzodiazepine overdose by blocking GABA receptors. Caution: Can precipitate seizures in chronic benzo users.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 33,
    "question": "Emergency medical services brings in an unresponsive patient with pinpoint pupils and respiratory rate of 6. Track marks are visible on both arms. Which medication is the appropriate antidote?",
    "options": [
      "Flumazenil",
      "Activated charcoal",
      "N-acetylcysteine",
      "Naloxone (Narcan)"
    ],
    "correctAnswer": 3,
    "rationale": "NALOXONE (NARCAN) reverses opioid overdose. Signs: pinpoint pupils (miosis), respiratory depression, track marks indicate IV drug use. Give naloxone 0.4-2mg IV/IM/IN, repeat every 2-3 minutes. May precipitate withdrawal but saves life. Teach: Always call 911 even after naloxone—short half-life means overdose can return.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 34,
    "question": "A patient presents with tremors, diaphoresis, and tachycardia 24 hours after his last alcoholic drink. The CIWA-Ar score is 18. Which medication class is first-line for alcohol withdrawal?",
    "options": [
      "Antipsychotics",
      "Anticonvulsants",
      "Beta-blockers",
      "Benzodiazepines"
    ],
    "correctAnswer": 3,
    "rationale": "BENZODIAZEPINES are first-line for alcohol withdrawal—prevent seizures and DTs. CIWA-Ar guides dosing. ALSO give THIAMINE (B1) BEFORE glucose to prevent Wernicke's encephalopathy. Wernicke's triad: Confusion, Ataxia, Ophthalmoplegia. Untreated → Korsakoff's syndrome (permanent memory loss).",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 35,
    "question": "A patient with opioid use disorder presents in moderate withdrawal with COWS score of 16. Which medication is appropriate for treating opioid withdrawal and preventing relapse?",
    "options": [
      "Benzodiazepines",
      "Buprenorphine or methadone",
      "Naltrexone",
      "Clonidine only"
    ],
    "correctAnswer": 1,
    "rationale": "Buprenorphine or methadone treat opioid use disorder. Buprenorphine can be prescribed in office; methadone requires clinic. Both reduce cravings and prevent relapse.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 36,
    "question": "A patient on haloperidol develops high fever (104°F), severe muscle rigidity, altered mental status, and autonomic instability. Which condition should the PMHNP suspect?",
    "options": [
      "Serotonin syndrome",
      "Malignant hyperthermia",
      "Neuroleptic Malignant Syndrome (NMS)",
      "Anticholinergic toxicity"
    ],
    "correctAnswer": 2,
    "rationale": "NEUROLEPTIC MALIGNANT SYNDROME (NMS): Life-threatening reaction to dopamine antagonists (antipsychotics). Classic tetrad: (1) Fever (often >40°C), (2) LEAD-PIPE RIGIDITY, (3) Altered mental status, (4) Autonomic instability. Labs: elevated CK (often >1000), leukocytosis, metabolic acidosis. Key differentiator from serotonin syndrome: HYPOREFLEXIA and lead-pipe rigidity. Treatment: stop antipsychotic, supportive care, dantrolene, bromocriptine.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 37,
    "question": "A patient on multiple medications presents with fever, rigidity, and altered mental status. The PMHNP must differentiate between NMS and serotonin syndrome. Which finding is MORE characteristic of serotonin syndrome?",
    "options": [
      "Lead-pipe rigidity",
      "Bradyreflexia",
      "Hyperreflexia and clonus",
      "Elevated creatine kinase >10,000"
    ],
    "correctAnswer": 2,
    "rationale": "SEROTONIN SYNDROME triad: (1) Mental status changes (agitation, confusion), (2) Autonomic instability (hyperthermia, tachycardia, diaphoresis, BP changes), (3) Neuromuscular abnormalities (HYPERREFLEXIA, CLONUS, tremor, rigidity). Key differentiator from NMS: hyperreflexia and clonus (NMS has hyporeflexia and lead-pipe rigidity). Onset: rapid (within 24h of drug change). Treatment: stop offending agent, supportive care, cyproheptadine for severe cases.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 38,
    "question": "A PMHNP is comparing first-generation antipsychotics. Which typical antipsychotic has the HIGHEST risk of extrapyramidal symptoms (EPS)?",
    "options": [
      "Chlorpromazine (Thorazine)",
      "Thioridazine (Mellaril)",
      "Haloperidol (Haldol)",
      "Perphenazine (Trilafon)"
    ],
    "correctAnswer": 2,
    "rationale": "HALOPERIDOL (Haldol) = HIGHEST EPS risk among antipsychotics. First-generation (typical) antipsychotics block D2 receptors in nigrostriatal pathway causing EPS. Risk ranking: High-potency typicals (haloperidol, fluphenazine) > Low-potency typicals (chlorpromazine) > Second-generation atypicals. EPS includes: acute dystonia (hours-days), akathisia (days-weeks), parkinsonism (weeks), tardive dyskinesia (months-years). Treatment: Benztropine or diphenhydramine for acute dystonia; reduce dose or switch to atypical for other EPS.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 39,
    "question": "A patient with schizophrenia has significant weight gain and metabolic concerns. The PMHNP wants to switch to an atypical antipsychotic with the LOWEST metabolic risk. Which medication is most appropriate?",
    "options": [
      "Olanzapine (Zyprexa)",
      "Quetiapine (Seroquel)",
      "Ziprasidone (Geodon)",
      "Clozapine (Clozaril)"
    ],
    "correctAnswer": 2,
    "rationale": "ZIPRASIDONE and LURASIDONE have LOWEST metabolic risk among atypical antipsychotics. Minimal weight gain, low diabetes/lipid risk. Ziprasidone: Take with food (500 calories). Lurasidone: Take with 350+ calories. Good choices for patients with metabolic concerns. Monitor QTc with ziprasidone.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 40,
    "question": "A patient on clozapine is brought to the emergency department obtunded with a CK level of 15,000. The PMHNP suspects rhabdomyolysis. Which condition is this complication associated with?",
    "options": [
      "Serotonin syndrome",
      "Tardive dyskinesia",
      "Neuroleptic Malignant Syndrome",
      "Anticholinergic toxicity"
    ],
    "correctAnswer": 2,
    "rationale": "NEUROLEPTIC MALIGNANT SYNDROME (NMS) with RHABDOMYOLYSIS: CK >10,000 indicates severe muscle breakdown. This patient on clozapine shows classic NMS: obtunded (altered mental status), elevated CK (muscle rigidity/breakdown). Other NMS signs: fever >104°F, lead-pipe rigidity, autonomic instability. Treatment: stop antipsychotic, IV fluids, dantrolene, bromocriptine. ICU admission for monitoring.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 41,
    "question": "A PMHNP administers the PHQ-9 to a patient presenting with depressed mood. The patient scores 12. Based on this score, what severity level and treatment approach is indicated?",
    "options": [
      "Mild depression (5-9); watchful waiting appropriate",
      "Moderate depression (10-14); treatment indicated",
      "Moderately severe depression (15-19); aggressive treatment needed",
      "Severe depression (20-27); hospitalization may be needed"
    ],
    "correctAnswer": 1,
    "rationale": "PHQ-9 (0-27): Depression screening. 0-4=minimal, 5-9=mild, 10-14=moderate, 15-19=mod-severe, 20-27=severe. Treat ≥10. CO-OCCURRING: Always screen for SUD (AUDIT/CAGE/DAST)—substances worsen depression scores. Use separate tools for each condition.",
    "category": "Assessment Scales & Screening",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 42,
    "question": "A patient completes the PHQ-9 during a routine visit. At what score should the PMHNP consider this a positive screen indicating likely clinical depression?",
    "options": [
      "Score 5 or higher",
      "Score 10 or higher",
      "Score 15 or higher",
      "Score 20 or higher"
    ],
    "correctAnswer": 1,
    "rationale": "PHQ-9 scoring: 0-4 (minimal), 5-9 (mild), 10-14 (moderate), 15-19 (moderately severe), 20-27 (severe). Score of 10+ indicates moderate depression and is the clinical threshold for considering treatment intervention. Board pearl: PHQ-9 ≥10 = positive screen requiring further assessment and likely treatment. Always assess for suicidality (question 9) regardless of total score.",
    "category": "Assessment Scales & Screening",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 43,
    "question": "A PMHNP is evaluating a 72-year-old patient for cognitive impairment using the MMSE. Which score indicates the patient has cognitive impairment?",
    "options": [
      "<30",
      "<27",
      "<24",
      "<20"
    ],
    "correctAnswer": 2,
    "rationale": "GAD-7 (Generalized Anxiety Disorder 7-item scale): Score range 0-21. Cutoffs: 5-9 (mild), 10-14 (moderate), 15-21 (severe). Score ≥10 suggests clinically significant anxiety warranting treatment consideration. Questions assess: feeling nervous, unable to stop worrying, worrying too much, trouble relaxing, restless, irritable, afraid something awful will happen. Time frame: past 2 weeks. Used for screening and monitoring treatment response. Can also screen for panic disorder, social anxiety, PTSD.",
    "category": "Assessment Scales & Screening",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 44,
    "question": "An 80-year-old patient scores 26 on the MMSE. The family reports subtle memory changes at home. How should the PMHNP interpret this score?",
    "options": [
      "Score 20-24 indicates mild impairment",
      "Score 27-30 is the only normal range",
      "Only a perfect score of 30 is considered normal",
      "Score 24-30 is considered normal cognition"
    ],
    "correctAnswer": 3,
    "rationale": "PHQ-9 (Patient Health Questionnaire-9): Score range 0-27. Cutoffs: 5-9 (mild), 10-14 (moderate), 15-19 (moderately severe), 20-27 (severe). Score ≥10 is clinical threshold for treatment consideration. Questions map to DSM-5 MDD criteria: anhedonia, depressed mood, sleep, energy, appetite, guilt, concentration, psychomotor changes, suicidal ideation. Question 9 (suicidal thoughts) requires direct assessment regardless of total score. Time frame: past 2 weeks.",
    "category": "Assessment Scales & Screening",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 45,
    "question": "A patient with alcohol use disorder presents 18 hours after his last drink with tremors and anxiety. The CIWA-Ar score is 12. At what score should treatment be initiated?",
    "options": [
      "CIWA score greater than 8",
      "CIWA score greater than 5",
      "CIWA score greater than 10",
      "CIWA score greater than 15"
    ],
    "correctAnswer": 0,
    "rationale": "CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised) scoring: 0-9 (mild, may not need meds), 10-15 (moderate, consider PRN benzos), 16-20 (severe, scheduled benzos needed), >20 (very severe, high risk of seizures/DTs). Score >8-10 typically triggers pharmacologic intervention. Monitor q1-2h initially. Benzodiazepines are first-line treatment - commonly lorazepam, chlordiazepoxide, or diazepam.",
    "category": "Assessment Scales & Screening",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 46,
    "question": "A patient with opioid use disorder presents in withdrawal. The COWS score is 10. At what score is it appropriate to initiate buprenorphine treatment?",
    "options": [
      "COWS score greater than 8",
      "COWS score greater than 5",
      "COWS score greater than 10",
      "COWS score greater than 15"
    ],
    "correctAnswer": 0,
    "rationale": "COWS (Clinical Opiate Withdrawal Scale) scoring: 5-12 (mild), 13-24 (moderate), 25-36 (moderately severe), >36 (severe). For buprenorphine induction, patient should score ≥8-12 to avoid precipitated withdrawal. COWS assesses: resting pulse, sweating, restlessness, pupil size, bone/joint aches, runny nose, GI upset, tremor, yawning, anxiety, gooseflesh. Higher scores = safer to start buprenorphine.",
    "category": "Assessment Scales & Screening",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 47,
    "question": "A PMHNP is screening a patient for anxiety using the GAD-7. The patient scores 11. What does this score indicate?",
    "options": [
      "Minimal anxiety (0-4); no treatment needed",
      "Mild anxiety (5-9); monitoring appropriate",
      "Moderate anxiety (10-14); treatment indicated",
      "Severe anxiety (15-21); urgent intervention needed"
    ],
    "correctAnswer": 2,
    "rationale": "GAD-7 SCORING: 0-4=minimal, 5-9=mild, 10-14=moderate, 15-21=severe. Score of 11 = moderate anxiety = treatment indicated. Options: SSRIs/SNRIs first-line, buspirone, CBT. Avoid benzodiazepines for chronic anxiety. Always screen for co-occurring depression (PHQ-9) and substance use.",
    "category": "Assessment Scales & Screening",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 48,
    "question": "A patient completes the Beck Depression Inventory-II (BDI-II) and scores 24. How should the PMHNP classify this severity level?",
    "options": [
      "Minimal depression (0-13)",
      "Mild depression (14-19)",
      "Moderate depression (20-28)",
      "Severe depression (29-63)"
    ],
    "correctAnswer": 2,
    "rationale": "BDI-II (0-63): Self-report depression scale. 0-13=minimal, 14-19=mild, 20-28=moderate, 29-63=severe. SCALES BY DISORDER: Depression=PHQ-9/HAM-D/BDI. Anxiety=GAD-7/HAM-A. Alcohol=AUDIT/CAGE. Drugs=DAST. Cognition=MoCA/MMSE. Always screen co-occurring SUD.",
    "category": "Assessment Scales & Screening",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 49,
    "question": "A PMHNP is monitoring a patient's depression treatment response using the clinician-administered HAM-D. A score of 21 indicates what severity level?",
    "options": [
      "Mild depression (8-13)",
      "Moderate depression (14-18)",
      "Severe depression (≥19)",
      "Very severe depression (≥25 only)"
    ],
    "correctAnswer": 2,
    "rationale": "HAM-D 17-item (0-52): Clinician-rated depression scale. 0-7=remission, 8-13=mild, 14-18=moderate, 19-22=severe, ≥23=very severe. CO-OCCURRING: Screen for SUD separately—alcohol/drugs worsen HAM-D scores. Use AUDIT (alcohol) or DAST (drugs).",
    "category": "Assessment Scales & Screening",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 50,
    "question": "A PMHNP has administered the MMSE to a patient with suspected dementia. What is the correct approach to documenting the results?",
    "options": [
      "Document the total score AND describe specific domain deficits",
      "Document only the total numerical score",
      "Documentation is only required if the score is abnormal",
      "Document only a qualitative summary without the score"
    ],
    "correctAnswer": 0,
    "rationale": "MMSE documentation: Record total score (X/30) AND specific domain deficits (orientation, registration, attention, recall, language). Tracks progression over time.",
    "category": "Assessment Scales & Screening",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 51,
    "question": "While reviewing a patient's PHQ-9, the PMHNP notes the patient endorsed Question 9. What does this specific question assess?",
    "options": [
      "Sleep disturbance",
      "Appetite changes",
      "Thoughts of self-harm or suicide",
      "Difficulty concentrating"
    ],
    "correctAnswer": 2,
    "rationale": "PHQ-9 Question 9: 'Thoughts you would be better off dead or hurting yourself.' ANY positive response (score ≥1) requires immediate safety assessment. Do not skip.",
    "category": "Assessment Scales & Screening",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 52,
    "question": "A patient in alcohol withdrawal scores 18 on the CIWA-Ar. The PMHNP should order which treatment regimen?",
    "options": [
      "No pharmacological treatment needed at this level",
      "PRN benzodiazepines only",
      "Scheduled benzodiazepines with frequent monitoring",
      "Antipsychotic medication"
    ],
    "correctAnswer": 2,
    "rationale": "CIWA-Ar 18 = MODERATE-SEVERE WITHDRAWAL. Requires SCHEDULED benzodiazepines (not just PRN) to prevent seizures and DTs. Long-acting preferred (diazepam, chlordiazepoxide) unless liver disease (use lorazepam). Monitor q1-2 hours. Seizure risk highest 24-48 hours after last drink.",
    "category": "Assessment Scales & Screening",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 53,
    "question": "A patient in opioid withdrawal has a COWS score of 15. What treatment is indicated?",
    "options": [
      "No treatment; score too low",
      "Symptomatic treatment only with clonidine",
      "Initiation of buprenorphine or methadone",
      "Benzodiazepines for withdrawal"
    ],
    "correctAnswer": 2,
    "rationale": "COWS 15 = MODERATE OPIOID WITHDRAWAL - appropriate to start medication-assisted treatment. Options: Buprenorphine (can prescribe in office, start when COWS 8-12+) or Methadone (requires OTP clinic). Starting buprenorphine too early causes precipitated withdrawal.",
    "category": "Assessment Scales & Screening",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 54,
    "question": "A PMHNP is selecting a cognitive screening tool for a highly educated patient with subtle memory complaints. The SLUMS score range indicating dementia is:",
    "options": [
      "1-20 for patients with high school education or higher",
      "0-9 for all patients",
      "21-26 indicates dementia",
      "27-30 indicates dementia"
    ],
    "correctAnswer": 0,
    "rationale": "SLUMS (0-30): More sensitive than MMSE for MCI and executive dysfunction. MoCA also superior to MMSE. Use SLUMS or MoCA when: (1) suspecting early dementia, (2) educated patients, (3) need executive function assessment. SLUMS: 27-30=normal, 21-26=MCI, 1-20=dementia (≥HS education).",
    "category": "Assessment Scales & Screening",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 55,
    "question": "A PMHNP is using the clinician-administered Hamilton Anxiety Rating Scale (HAM-A) to monitor treatment response. A score of 20 indicates what severity level?",
    "options": [
      "Minimal anxiety (0-13)",
      "Mild anxiety (14-17)",
      "Moderate anxiety (18-24)",
      "Severe anxiety (≥25)"
    ],
    "correctAnswer": 2,
    "rationale": "HAM-A (0-56): Clinician-rated anxiety. <17=mild, 18-24=moderate, ≥25=severe. SCALE SELECTION: GAD-7=self-report screening. HAM-A=clinician-rated severity/monitoring. CO-OCCURRING: Rule out substance-induced anxiety with AUDIT/DAST.",
    "category": "Assessment Scales & Screening",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 56,
    "question": "A mother brings her 5-month-old infant for developmental assessment. She is concerned about head control. By what age should head lag be completely resolved?",
    "options": [
      "2 months",
      "6 months",
      "9 months",
      "4 months"
    ],
    "correctAnswer": 3,
    "rationale": "Head lag resolves by 4 months. Test by pulling infant to sit—head should come with body. Persistent lag suggests hypotonia or developmental delay.",
    "category": "Developmental Theory & Lifespan",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 57,
    "question": "A PMHNP is assessing primitive reflexes in a 7-month-old infant and notes the Moro reflex is still present. By what age should this reflex typically disappear?",
    "options": [
      "4-6 months",
      "2 months",
      "9 months",
      "12 months"
    ],
    "correctAnswer": 0,
    "rationale": "Moro reflex (startle response with arm extension) disappears by 4-6 months. Persistence beyond 6 months suggests cerebral palsy or neurological issue.",
    "category": "Developmental Theory & Lifespan",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 58,
    "question": "During a well-child exam, a PMHNP tests the Babinski reflex in a 15-month-old. The toes fan upward. By what age should this reflex disappear?",
    "options": [
      "6 months",
      "9 months",
      "12-24 months",
      "36 months"
    ],
    "correctAnswer": 2,
    "rationale": "Babinski reflex (toes fan up when sole stroked) is normal in infants but disappears by 12-24 months. Persistence or return in adults = upper motor neuron lesion. Teach parents: This is normal now but should go away by age 2.",
    "category": "Developmental Theory & Lifespan",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 59,
    "question": "A new mother asks the PMHNP about responding to her infant's cries. According to Erikson's psychosocial theory, what developmental task is the infant (0-1 year) working to resolve?",
    "options": [
      "Trust vs. Mistrust",
      "Autonomy vs. Shame and Doubt",
      "Initiative vs. Guilt",
      "Industry vs. Inferiority"
    ],
    "correctAnswer": 0,
    "rationale": "Erikson infancy (0-1): Trust vs. Mistrust. Consistent caregiver response builds trust—foundation for all future relationships. Teach parents: Respond to cries; you cannot spoil an infant.",
    "category": "Developmental Theory & Lifespan",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 60,
    "question": "A 2-year-old child is brought for evaluation because he says 'no' frequently and insists on dressing himself. According to Erikson, which developmental stage is this child navigating?",
    "options": [
      "Autonomy vs. Shame and Doubt",
      "Trust vs. Mistrust",
      "Initiative vs. Guilt",
      "Identity vs. Role Confusion"
    ],
    "correctAnswer": 0,
    "rationale": "Erikson early childhood (1-3): Autonomy vs. Shame/Doubt. Child develops independence through toilet training, self-feeding, saying 'no.' Teach parents: Allow safe exploration; avoid shaming for accidents.",
    "category": "Developmental Theory & Lifespan",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 61,
    "question": "A 16-year-old is experimenting with different peer groups, styles, and beliefs. According to Erikson's theory, which psychosocial stage is this adolescent (12-18 years) working through?",
    "options": [
      "Industry vs. Inferiority",
      "Intimacy vs. Isolation",
      "Generativity vs. Stagnation",
      "Identity vs. Role Confusion"
    ],
    "correctAnswer": 3,
    "rationale": "Erikson adolescence (12-18): Identity vs. Role Confusion. Teen forms personal identity through peer relationships and self-exploration. Teach parents: Some rebellion is normal; keep communication open.",
    "category": "Developmental Theory & Lifespan",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 62,
    "question": "A 50-year-old patient expresses feeling unfulfilled and questions whether his life has meaning. According to Erikson, which developmental stage (40-65 years) is this patient experiencing?",
    "options": [
      "Intimacy vs. Isolation",
      "Generativity vs. Stagnation",
      "Integrity vs. Despair",
      "Identity vs. Role Confusion"
    ],
    "correctAnswer": 1,
    "rationale": "Erikson middle adulthood (40-65): Generativity vs. Stagnation. Adults find meaning through parenting, mentoring, contributing to society. Stagnation leads to midlife crisis feelings.",
    "category": "Developmental Theory & Lifespan",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 63,
    "question": "A 4-year-old child believes the moon follows her car at night and that her stuffed animals have feelings. According to Piaget, which cognitive stage (ages 2-7) explains this thinking?",
    "options": [
      "Sensorimotor",
      "Preoperational",
      "Concrete Operational",
      "Formal Operational"
    ],
    "correctAnswer": 1,
    "rationale": "Piaget preoperational (2-7): Symbolic/magical thinking, egocentrism (can't see others' viewpoints), no conservation. Teach parents: 'Why' questions are normal; use concrete explanations.",
    "category": "Developmental Theory & Lifespan",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 64,
    "question": "An 8-year-old child can now understand that pouring water from a tall glass to a wide glass doesn't change the amount. According to Piaget, which stage (ages 7-11) has the child entered?",
    "options": [
      "Preoperational",
      "Formal Operational",
      "Concrete Operational",
      "Sensorimotor"
    ],
    "correctAnswer": 2,
    "rationale": "Piaget concrete operational (7-11): Logical thinking about real objects develops; conservation understood. Cannot think abstractly yet. Teach parents: Use hands-on learning, not hypotheticals.",
    "category": "Developmental Theory & Lifespan",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 65,
    "question": "A mother reports that her 10-month-old infant cries when she hides a toy under a blanket and now searches for it. This demonstrates which Piagetian concept?",
    "options": [
      "Present from birth",
      "Develops at 3-4 months",
      "Object permanence developing",
      "Not expected until 18-24 months"
    ],
    "correctAnswer": 2,
    "rationale": "Object permanence develops 8-12 months—infant understands objects exist even when hidden. This is why peek-a-boo becomes fun! Absence of this milestone suggests developmental delay.",
    "category": "Developmental Theory & Lifespan",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 66,
    "question": "A 5-year-old boy is very attached to his mother and views his father as competition. According to Freud, which psychosexual stage (ages 3-6 years) is this child in?",
    "options": [
      "Oral stage",
      "Anal stage",
      "Phallic stage (Oedipus complex)",
      "Latency stage"
    ],
    "correctAnswer": 2,
    "rationale": "Freud phallic stage (3-6): Oedipus/Electra complex—child identifies with same-sex parent. Superego (conscience) develops. Board tip: Know the stage ages.",
    "category": "Developmental Theory & Lifespan",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 67,
    "question": "A 9-year-old child focuses on academics and same-sex friendships with little interest in romantic relationships. According to Freud, which stage (ages 6-12) is this child experiencing?",
    "options": [
      "Phallic stage",
      "Latency stage",
      "Genital stage",
      "Anal stage"
    ],
    "correctAnswer": 1,
    "rationale": "Freud latency stage (6-12): Sexual impulses dormant. Child focuses on friendships, school, skills. This is the 'calm before the storm' of puberty.",
    "category": "Developmental Theory & Lifespan",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 68,
    "question": "A 75-year-old patient reflects on her life with satisfaction and acceptance. According to Erikson, she has successfully resolved which developmental stage?",
    "options": [
      "Generativity vs. Stagnation",
      "Intimacy vs. Isolation",
      "Integrity vs. Despair",
      "Identity vs. Role Confusion"
    ],
    "correctAnswer": 2,
    "rationale": "ERIKSON'S PSYCHOSOCIAL STAGES - Older adults (65+): INTEGRITY vs DESPAIR. Successful resolution: wisdom, acceptance of life lived, peace with mortality. Unsuccessful: despair, regret, fear of death. Other key stages for boards: Infancy (Trust vs Mistrust), Toddler (Autonomy vs Shame), Preschool (Initiative vs Guilt), School age (Industry vs Inferiority), Adolescence (Identity vs Role Confusion), Young adult (Intimacy vs Isolation), Middle adult (Generativity vs Stagnation).",
    "category": "Developmental Theory & Lifespan",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 69,
    "question": "A PMHNP is assessing developmental milestones. A typically developing 4-month-old infant should demonstrate which motor ability?",
    "options": [
      "Walking independently",
      "Sitting without support",
      "Rolling over and holding head steady",
      "Crawling on hands and knees"
    ],
    "correctAnswer": 2,
    "rationale": "4-MONTH MOTOR MILESTONES: Head control established (no head lag), rolls over (front to back first), brings hands together midline, reaches for objects. Sits with support. Red flags: persistent head lag, no reaching, no social smile by this age.",
    "category": "Developmental Theory & Lifespan",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 70,
    "question": "During a developmental assessment, a PMHNP notes a 12-month-old child says 'mama' and 'dada' specifically. What is the expected language milestone at this age?",
    "options": [
      "Cooing sounds only",
      "Babbling with no meaning",
      "1-3 words with meaning",
      "2-word phrases"
    ],
    "correctAnswer": 2,
    "rationale": "12-MONTH LANGUAGE MILESTONES: Says 'mama/dada' with meaning (not just babbling), 1-3 words total, understands 'no,' follows simple commands, points to objects. Red flags: No babbling by 9 months, no words by 12 months, no gestures. Consider hearing evaluation.",
    "category": "Developmental Theory & Lifespan",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 71,
    "question": "A patient with borderline personality disorder reports chronic feelings of emptiness, unstable relationships, and recurrent self-harm. Which therapeutic approach is considered the gold standard treatment?",
    "options": [
      "Cognitive Behavioral Therapy (CBT)",
      "Dialectical Behavior Therapy (DBT)",
      "Psychoanalysis",
      "Supportive therapy"
    ],
    "correctAnswer": 1,
    "rationale": "DIALECTICAL BEHAVIOR THERAPY (DBT) is the GOLD STANDARD for Borderline Personality Disorder. Four core modules: (1) Mindfulness, (2) Distress Tolerance, (3) Emotion Regulation, (4) Interpersonal Effectiveness. Evidence shows DBT reduces self-harm, suicidal behavior, and hospitalizations. Weekly individual therapy + skills group. Addresses chronic emptiness through validation and behavior change.",
    "category": "Psychotherapy & Treatment Modalities",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 72,
    "question": "A veteran presents with nightmares, hypervigilance, and avoidance behaviors following combat deployment. Which therapeutic approach is evidence-based first-line treatment for PTSD?",
    "options": [
      "Trauma-focused CBT with exposure therapy or EMDR",
      "Psychoanalysis",
      "Group therapy alone",
      "Supportive therapy only"
    ],
    "correctAnswer": 0,
    "rationale": "PTSD FIRST-LINE TREATMENTS: Psychotherapy: Prolonged Exposure (PE), Cognitive Processing Therapy (CPT), EMDR (Eye Movement Desensitization and Reprocessing). All are trauma-focused therapies. Medications: SSRIs (sertraline, paroxetine - FDA approved), SNRIs (venlafaxine). Second-line: prazosin for nightmares. NOT recommended: benzodiazepines (may worsen outcomes, interfere with extinction learning). Important: trauma-focused therapy is preferred over medication alone. Combination may be beneficial.",
    "category": "Psychotherapy & Treatment Modalities",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 73,
    "question": "A PMHNP is conducting family therapy for a family whose teenage son has been acting out. The family has identified the son as 'the problem.' In family systems terms, what is this family member called?",
    "options": [
      "The identified patient (symptom bearer)",
      "The patient who requested therapy",
      "The oldest family member",
      "The most cooperative family member"
    ],
    "correctAnswer": 0,
    "rationale": "Identified patient = the 'symptom bearer'—the person whose problems bring family to therapy. Key concept: The whole family system contributes; one person often carries the dysfunction.",
    "category": "Psychotherapy & Treatment Modalities",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 74,
    "question": "A PMHNP is using CBT with a depressed patient who states, 'If I fail this test, my life is ruined.' This represents which CBT concept?",
    "options": [
      "Memory impairment",
      "Cognitive distortion (catastrophizing)",
      "Hallucination",
      "Delusion"
    ],
    "correctAnswer": 1,
    "rationale": "Cognitive distortions are thinking errors that maintain depression/anxiety: catastrophizing, all-or-nothing thinking, mind reading, fortune telling. Teach patient: 'Catch it, check it, change it.'",
    "category": "Psychotherapy & Treatment Modalities",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 75,
    "question": "A PMHNP is explaining DBT components to a patient newly diagnosed with borderline personality disorder. Which skills are taught in DBT?",
    "options": [
      "Mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness",
      "Exposure and response prevention only",
      "Free association",
      "Dream analysis"
    ],
    "correctAnswer": 0,
    "rationale": "DBT four modules: Mindfulness (present moment), Distress Tolerance (crisis survival), Emotion Regulation (managing feelings), Interpersonal Effectiveness (relationships). Teach patient: Practice daily for best results.",
    "category": "Psychotherapy & Treatment Modalities",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 76,
    "question": "During supervision, a PMHNP notices she feels irritated by a patient who reminds her of her critical mother. The supervisor explains this is an example of which therapeutic phenomenon?",
    "options": [
      "Transference",
      "Countertransference",
      "They are the same",
      "Neither occurs in therapy"
    ],
    "correctAnswer": 1,
    "rationale": "Transference: patient projects feelings (often from past relationships) onto therapist. Countertransference: therapist's emotional reactions to patient. Both are therapeutic tools when recognized.",
    "category": "Psychotherapy & Treatment Modalities",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 77,
    "question": "A PMHNP is working with a patient with alcohol use disorder who is ambivalent about quitting. Which therapeutic approach is MOST appropriate to enhance motivation for change?",
    "options": [
      "Diagnostic assessment",
      "Intelligence testing",
      "Personality assessment",
      "Motivational interviewing"
    ],
    "correctAnswer": 3,
    "rationale": "Motivational interviewing (MI) increases motivation for change using non-confrontational techniques. Key elements: express empathy, develop discrepancy, roll with resistance, support self-efficacy. Teach patient: You're in control of your change process.",
    "category": "Psychotherapy & Treatment Modalities",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 78,
    "question": "A patient asks the PMHNP about a trauma therapy that uses eye movements to process traumatic memories. Which therapy uses this technique?",
    "options": [
      "Eye Movement Desensitization and Reprocessing (EMDR)",
      "Emotional Management and Depression Recovery",
      "Evidence-based Medical Decision Review",
      "Electroconvulsive therapy"
    ],
    "correctAnswer": 0,
    "rationale": "EMDR: Eye Movement Desensitization and Reprocessing. Uses bilateral stimulation (eye movements) to process traumatic memories. Evidence-based for PTSD. Teach patient: You control the pace; you can stop anytime.",
    "category": "Psychotherapy & Treatment Modalities",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 79,
    "question": "A patient with agoraphobia has been avoiding leaving home. The PMHNP recommends gradually accompanying the patient to increasingly anxiety-provoking situations. What is the primary goal of this exposure therapy?",
    "options": [
      "Complete avoidance of anxiety triggers",
      "Gradual habituation to reduce anxiety response",
      "Medication adjustment",
      "Dream interpretation"
    ],
    "correctAnswer": 1,
    "rationale": "Exposure therapy gradually exposes patients to feared stimuli until anxiety decreases (habituation). Gold standard for phobias. Teach patient: Anxiety peaks then falls—stay with it until it drops.",
    "category": "Psychotherapy & Treatment Modalities",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 80,
    "question": "A patient with OCD spends 4 hours daily washing her hands due to contamination fears. Which therapeutic approach is the gold standard for OCD?",
    "options": [
      "Psychoanalysis",
      "Supportive therapy only",
      "Hypnotherapy",
      "Exposure and Response Prevention (ERP)"
    ],
    "correctAnswer": 3,
    "rationale": "ERP (Exposure and Response Prevention) is gold standard for OCD: expose to triggers, prevent compulsions. Breaks the anxiety cycle. Teach patient: Resisting compulsions gets easier with practice.",
    "category": "Psychotherapy & Treatment Modalities",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 81,
    "question": "A PMHNP is implementing a recovery-oriented approach with a patient with schizophrenia. Which principle BEST describes the recovery model?",
    "options": [
      "Patient empowerment, hope, and person-centered care",
      "Cure-focused approach emphasizing symptom elimination",
      "Medication-only approach",
      "Institutional long-term care"
    ],
    "correctAnswer": 0,
    "rationale": "Recovery model: patient empowerment, hope, person-centered care. Focus on meaningful life, not just symptom reduction. Teach patient: Recovery is possible—you define what it means for you.",
    "category": "Psychotherapy & Treatment Modalities",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 82,
    "question": "A PMHNP is training staff on trauma-informed care principles. Which core principles should be emphasized?",
    "options": [
      "Safety, trustworthiness, peer support, collaboration, and empowerment",
      "Confrontation and challenging patient beliefs",
      "Requiring detailed trauma disclosure",
      "Punishment-based behavioral approaches"
    ],
    "correctAnswer": 0,
    "rationale": "Trauma-informed care: Safety, Trustworthiness, Peer support, Collaboration, Empowerment. Ask 'What happened to you?' not 'What's wrong with you?' Assumes trauma until proven otherwise.",
    "category": "Psychotherapy & Treatment Modalities",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 83,
    "question": "A PMHNP notices she tends to respond immediately after patients finish speaking. Her supervisor recommends implementing which therapeutic technique to allow for patient processing?",
    "options": [
      "Sessions limited to 10 seconds",
      "Taking 10-second breaks hourly",
      "Limiting each question to 10 seconds",
      "Waiting 10 seconds after patient speaks before responding"
    ],
    "correctAnswer": 3,
    "rationale": "10-second rule: wait 10 seconds after patient speaks before responding. Allows deeper processing and reflection. Therapeutic silence is powerful—don't rush to fill it.",
    "category": "Psychotherapy & Treatment Modalities",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 84,
    "question": "A PMHNP is working with a patient from an unfamiliar cultural background. Which approach demonstrates cultural humility?",
    "options": [
      "Assuming knowledge about the patient's culture from textbooks",
      "Avoiding cultural topics to prevent offense",
      "Applying the same approach used with all patients",
      "Engaging in lifelong self-reflection and learning FROM the patient about their culture"
    ],
    "correctAnswer": 3,
    "rationale": "Cultural humility: lifelong self-reflection and learning FROM patients about their culture. Different from competence—you can never fully 'know' another's culture. Ask: 'Help me understand your beliefs.'",
    "category": "Psychotherapy & Treatment Modalities",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 85,
    "question": "A 10-year-old child is diagnosed with moderate OCD causing significant impairment. What is the first-line treatment approach for pediatric OCD?",
    "options": [
      "Medication (SSRI) only",
      "Immediate hospitalization",
      "CBT with Exposure and Response Prevention (ERP), with SSRI added for moderate-severe cases",
      "Family therapy only"
    ],
    "correctAnswer": 2,
    "rationale": "TARASOFF DUTY: When patient makes credible threat against identifiable victim, clinician has DUTY TO PROTECT that victim. Options: (1) Warn intended victim directly, (2) Notify police, (3) Hospitalize patient. Varies by state - some require warning, others allow other protective actions. Does NOT apply to: vague threats, threats against self, threats without identifiable victim. Balance: maintain therapeutic alliance while fulfilling legal duty. Document assessment thoroughly.",
    "category": "Psychotherapy & Treatment Modalities",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 86,
    "question": "A PMHNP is teaching a student about neuroanatomy. Which brain structure is responsible for executive functions such as planning, decision-making, and impulse control?",
    "options": [
      "Amygdala",
      "Hippocampus",
      "Prefrontal cortex",
      "Cerebellum"
    ],
    "correctAnswer": 2,
    "rationale": "PREFRONTAL CORTEX (PFC) REGIONS: (1) DORSOLATERAL PFC=executive function, working memory, planning. (2) ORBITOFRONTAL=impulse control, social behavior. (3) VENTROMEDIAL=emotion regulation, decision-making. (4) ANTERIOR CINGULATE=error detection, motivation. PFC fully matures age 25. Damaged in TBI, atrophied in schizophrenia. ADHD=underactive PFC.",
    "category": "Neuroscience & Pathophysiology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 87,
    "question": "A patient with PTSD has exaggerated startle response and hypervigilance. Which brain structure is hyperactive in anxiety and fear-based disorders?",
    "options": [
      "Prefrontal cortex",
      "Amygdala",
      "Hippocampus",
      "Thalamus"
    ],
    "correctAnswer": 1,
    "rationale": "AMYGDALA: Emotional center in LIMBIC SYSTEM (primitive brain). Fear/threat detection, fight-or-flight. HYPERACTIVE in anxiety/PTSD/phobias. HYPOACTIVE in psychopathy. Connected to hippocampus (memory) and PFC (regulation). Exposure therapy 'retrains' amygdala response. Located in temporal lobe medially.",
    "category": "Neuroscience & Pathophysiology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 88,
    "question": "A PMHNP is explaining to a family why their loved one with Alzheimer's disease has progressive memory loss. Which brain structure is primarily responsible for memory formation?",
    "options": [
      "Amygdala",
      "Cerebellum",
      "Occipital lobe",
      "Hippocampus"
    ],
    "correctAnswer": 3,
    "rationale": "HIPPOCAMPUS: Memory formation in TEMPORAL LOBE. Part of LIMBIC SYSTEM. SHORT-TERM→LONG-TERM memory consolidation. SHRINKS with: chronic stress, cortisol, PTSD, Alzheimer's, chronic alcohol. BOARD TIP: 'Hippo'=memory. Connected to amygdala (emotional memories).",
    "category": "Neuroscience & Pathophysiology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 89,
    "question": "A patient had a stroke affecting the frontal lobe and now exhibits personality changes, disinhibition, and difficulty with planning. Which functions are localized to the frontal lobe?",
    "options": [
      "Vision",
      "Executive function, motor control, speech production (Broca's area), and personality",
      "Hearing",
      "Balance"
    ],
    "correctAnswer": 1,
    "rationale": "FRONTAL LOBE: BROCA'S AREA (inferior frontal gyrus)=speech PRODUCTION. Damage=BROCA'S APHASIA (non-fluent, telegraphic speech, preserved comprehension). 'Broca=Broken speech.' Motor cortex=voluntary movement. Personality/behavior regulation. Phineas Gage case=frontal damage→personality change.",
    "category": "Neuroscience & Pathophysiology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 90,
    "question": "A patient with a temporal lobe lesion has fluent but nonsensical speech and cannot comprehend spoken language. Which area is affected?",
    "options": [
      "Visual processing area",
      "Motor cortex",
      "Sensory cortex",
      "Wernicke's area"
    ],
    "correctAnswer": 3,
    "rationale": "TEMPORAL LOBE: WERNICKE'S AREA (posterior superior temporal)=speech COMPREHENSION. Damage=WERNICKE'S APHASIA (fluent but meaningless speech, 'word salad,' poor comprehension). 'Wernicke=Word comprehension.' Hippocampus=memory. Auditory cortex=hearing. Seizures cause déjà vu, olfactory hallucinations.",
    "category": "Neuroscience & Pathophysiology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 91,
    "question": "A patient with right parietal lobe damage ignores objects and people on his left side and cannot find his way around familiar places. Which functions are localized to the parietal lobe?",
    "options": [
      "Vision",
      "Hearing",
      "Sensory processing, spatial awareness, and proprioception",
      "Motor control"
    ],
    "correctAnswer": 2,
    "rationale": "PARIETAL LOBE: Sensory processing, spatial awareness, proprioception. RIGHT PARIETAL damage=HEMISPATIAL NEGLECT (ignores left side of body/world). Involved in clock drawing (visuospatial). GERSTMANN SYNDROME: finger agnosia, agraphia, acalculia, left-right confusion.",
    "category": "Neuroscience & Pathophysiology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 92,
    "question": "A patient with occipital lobe damage reports being unable to see despite intact eye function. Which function is localized to the occipital lobe?",
    "options": [
      "Visual processing",
      "Hearing",
      "Motor control",
      "Memory"
    ],
    "correctAnswer": 0,
    "rationale": "OCCIPITAL LOBE: Visual processing (primary visual cortex). Damage=CORTICAL BLINDNESS (eyes work but brain can't interpret). CHARLES BONNET SYNDROME=visual hallucinations in blind/low vision patients. Occipital seizures cause visual auras, flashing lights.",
    "category": "Neuroscience & Pathophysiology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 93,
    "question": "A patient with chronic alcohol use presents with ataxia, unsteady gait, and difficulty with coordination. Which brain structure is affected?",
    "options": [
      "Amygdala",
      "Hippocampus",
      "Cerebellum",
      "Frontal lobe"
    ],
    "correctAnswer": 2,
    "rationale": "CEREBELLUM + ALCOHOL: Acute intoxication affects cerebellum→ataxia, slurred speech. CHRONIC ALCOHOL EFFECTS: Cerebellar degeneration, Wernicke's encephalopathy (thiamine), Korsakoff's (memory), peripheral neuropathy. INTOXICATION=CNS depression. WITHDRAWAL=CNS hyperexcitability (seizures, DTs). Opposite presentations.",
    "category": "Neuroscience & Pathophysiology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 94,
    "question": "A patient presents with resting tremor, bradykinesia, and rigidity. The PMHNP knows these symptoms result from deficiency of which neurotransmitter?",
    "options": [
      "Serotonin",
      "Dopamine",
      "GABA",
      "Glutamate"
    ],
    "correctAnswer": 1,
    "rationale": "PARKINSON'S: SUBSTANTIA NIGRA (midbrain) dopamine neuron degeneration. Part of BASAL GANGLIA circuit. Triad: tremor, rigidity, bradykinesia. DOPAMINE PATHWAY: Substantia nigra→striatum (nigrostriatal). Antipsychotics worsen PD (block dopamine). Lewy bodies=protein aggregates.",
    "category": "Neuroscience & Pathophysiology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 95,
    "question": "A PMHNP is explaining the pathophysiology of Alzheimer's disease to a family. Deficiency of which neurotransmitter is primarily involved?",
    "options": [
      "Dopamine",
      "Serotonin",
      "Acetylcholine",
      "Norepinephrine"
    ],
    "correctAnswer": 2,
    "rationale": "ALZHEIMER'S: ACETYLCHOLINE deficiency from nucleus basalis of Meynert degeneration. HIPPOCAMPUS atrophies first (memory loss). Amyloid plaques + tau tangles. Treat: cholinesterase inhibitors (donepezil, rivastigmine). NMDA antagonist memantine for moderate-severe. Early PFC involvement=executive dysfunction.",
    "category": "Neuroscience & Pathophysiology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 96,
    "question": "A patient presents with 3 weeks of depressed mood, insomnia, and anhedonia. To meet DSM-5 criteria for Major Depressive Disorder, what is the minimum symptom duration required?",
    "options": [
      "1 week",
      "1 month",
      "6 months",
      "2 weeks"
    ],
    "correctAnswer": 3,
    "rationale": "MDD requires minimum 2 weeks of symptoms. Must have depressed mood OR anhedonia PLUS 4 additional criteria (SIGECAPS). Board tip: 2 weeks = MDD, 2 years = dysthymia.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 97,
    "question": "A patient has experienced persistent, excessive worry for the past 8 months, along with muscle tension, sleep disturbance, and irritability. To meet DSM-5 criteria for Generalized Anxiety Disorder, what is the minimum duration?",
    "options": [
      "1 month",
      "3 months",
      "6 months",
      "12 months"
    ],
    "correctAnswer": 2,
    "rationale": "GAD requires 6 MONTHS of excessive, difficult-to-control worry about multiple areas of life, plus 3+ physical symptoms: restlessness, fatigue, difficulty concentrating, irritability, muscle tension, sleep disturbance. First-line: SSRIs/SNRIs + CBT. Avoid benzodiazepines long-term.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 98,
    "question": "A veteran reports re-experiencing a traumatic event, avoidance behaviors, and hyperarousal for the past 6 weeks. To meet DSM-5 criteria for PTSD, what is the minimum symptom duration?",
    "options": [
      "1 week",
      "2 weeks",
      "1 month",
      "6 months"
    ],
    "correctAnswer": 2,
    "rationale": "PTSD requires minimum 1 month of symptoms (intrusion, avoidance, negative cognitions, hyperarousal). Under 1 month = Acute Stress Disorder. Teach patient: Symptoms under 1 month may resolve without treatment.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 99,
    "question": "A patient developed depressed mood and difficulty concentrating after losing his job 2 months ago. Symptoms began within 3 months of the stressor. According to DSM-5, adjustment disorder symptoms must develop within how long after a stressor?",
    "options": [
      "1 month",
      "6 months",
      "1 year",
      "3 months"
    ],
    "correctAnswer": 3,
    "rationale": "ADJUSTMENT DISORDER: Symptoms must develop within 3 MONTHS of identifiable stressor. Response is out of proportion to stressor OR causes significant impairment. Resolves within 6 months of stressor ending. Subtypes: with depressed mood, with anxiety, with mixed anxiety/depression.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 100,
    "question": "A patient reports 2 years of persistent, low-grade depressed mood. She has never been symptom-free for more than 2 months at a time. This presentation is consistent with which diagnosis?",
    "options": [
      "Persistent Depressive Disorder (Dysthymia)",
      "Major Depressive Disorder",
      "Bipolar II Disorder",
      "Adjustment Disorder"
    ],
    "correctAnswer": 0,
    "rationale": "PERSISTENT DEPRESSIVE DISORDER (Dysthymia): 2+ years of depressed mood more days than not, never symptom-free for >2 months. Plus 2+ of: appetite change, sleep change, low energy, low self-esteem, poor concentration, hopelessness. Can have 'double depression' (dysthymia + MDD episodes).",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 101,
    "question": "A patient reports depressed mood and difficulty sleeping after a job loss 6 weeks ago. The PMHNP must differentiate between adjustment disorder and major depression. What is the KEY distinguishing feature of adjustment disorder?",
    "options": [
      "More severe symptoms",
      "Identifiable stressor with symptom onset within 3 months",
      "Requires 2 weeks of symptoms",
      "No distinguishing features"
    ],
    "correctAnswer": 1,
    "rationale": "Key difference: Adjustment Disorder requires identifiable stressor and onset within 3 months. MDD has no required stressor and can arise without trigger. Both may have similar symptoms, but etiology differs.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 102,
    "question": "A 78-year-old patient is brought to the ED by family who report she was 'fine yesterday but confused today.' The PMHNP must differentiate delirium from dementia. Which description is accurate?",
    "options": [
      "Both have identical presentations",
      "Delirium is acute and fluctuating; dementia is gradual and progressive",
      "Delirium is chronic; dementia is acute",
      "Delirium is irreversible; dementia is reversible"
    ],
    "correctAnswer": 1,
    "rationale": "Delirium: ACUTE onset, fluctuating consciousness, often REVERSIBLE (find and treat cause). Dementia: GRADUAL onset, progressive, generally IRREVERSIBLE. Teach family: Sudden confusion = delirium = medical emergency.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 103,
    "question": "A patient in the ICU is disoriented, cannot maintain attention, and has waxing and waning consciousness. What is the hallmark feature of this condition?",
    "options": [
      "Inattention and fluctuating consciousness",
      "Memory loss alone",
      "Personality changes only",
      "Apathy without other symptoms"
    ],
    "correctAnswer": 0,
    "rationale": "Delirium hallmark: INATTENTION (can't focus) and FLUCTUATING consciousness (worse at night = 'sundowning'). Acute onset. Reversible if cause found. Common causes: infection, medications, dehydration.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 104,
    "question": "A family brings their father for evaluation of progressive forgetfulness over the past 2 years. He forgets recent events but remembers the distant past. What is the hallmark feature of dementia?",
    "options": [
      "Acute inattention",
      "Progressive memory impairment",
      "Hallucinations",
      "Sudden agitation"
    ],
    "correctAnswer": 1,
    "rationale": "Dementia hallmark: MEMORY IMPAIRMENT (especially recent memory first). Gradual, progressive. Multiple domains affected (language, executive function, visuospatial). Teach family: Patient often unaware of deficits.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 105,
    "question": "A patient presents with pervasive distrust of others, interpreting benign remarks as threatening. She has no close friends and bears grudges. Which personality disorder cluster includes this presentation?",
    "options": [
      "Cluster A",
      "Cluster B",
      "Cluster C",
      "None of the above"
    ],
    "correctAnswer": 0,
    "rationale": "CLUSTER A (Odd/Eccentric): Paranoid, Schizoid, Schizotypal. Mnemonic: 'MAD'—Mistrustful (Paranoid), Aloof (Schizoid), Disorganized thinking (Schizotypal). Genetic link to schizophrenia. Rarely seek treatment. Low-dose antipsychotics may help schizotypal perceptual disturbances.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 106,
    "question": "A patient presents with impulsive self-harm behaviors, chronic emptiness, and tumultuous relationships marked by idealization then devaluation. Which personality disorder cluster includes this presentation?",
    "options": [
      "Cluster B",
      "Cluster A",
      "Cluster C",
      "None of the above"
    ],
    "correctAnswer": 0,
    "rationale": "CLUSTER B (Dramatic/Emotional): Antisocial, Borderline, Histrionic, Narcissistic. Mnemonic: 'BAD'—Behavioral acting out, Attention-seeking, Dramatic. Most treatment-seeking cluster. DBT gold standard for BPD. High ER utilization. Set firm boundaries.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 107,
    "question": "A patient is extremely anxious about social situations, fears rejection, but desperately wants relationships. He also defers all decisions to others due to fear of being alone. Which cluster includes Avoidant, Dependent, and OCPD?",
    "options": [
      "Cluster A",
      "Cluster B",
      "Cluster C",
      "None of the above"
    ],
    "correctAnswer": 2,
    "rationale": "CLUSTER C (Anxious/Fearful): Avoidant, Dependent, OCPD. Mnemonic: 'SAD'—Scared (Avoidant), Attached (Dependent), Demanding perfection (OCPD). BEST PROGNOSIS of all clusters—respond well to CBT and SSRIs. Avoidant WANTS connection (unlike Schizoid). OCPD is ego-syntonic (patient sees no problem).",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 108,
    "question": "When evaluating a patient with borderline personality disorder who reports chaotic relationships and chronic emptiness, which historical factor is MOST important to assess?",
    "options": [
      "Family history of schizophrenia",
      "Recent substance use only",
      "Sleep patterns only",
      "History of childhood trauma or sexual abuse"
    ],
    "correctAnswer": 3,
    "rationale": "BORDERLINE PD and TRAUMA: 70-80% of BPD patients report childhood sexual/physical abuse or neglect. Trauma history is crucial for understanding BPD development and guiding trauma-informed treatment. DBT specifically addresses emotion dysregulation stemming from invalidating environments.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 109,
    "question": "A 30-year-old male with antisocial personality disorder reports heavy alcohol use. Research indicates which substance use disorder is MOST commonly comorbid with antisocial PD?",
    "options": [
      "Cannabis use disorder",
      "Opioid use disorder",
      "Alcohol use disorder",
      "Stimulant use disorder"
    ],
    "correctAnswer": 2,
    "rationale": "ANTISOCIAL PD + SUBSTANCE USE: Alcohol use disorder is MOST commonly comorbid (40-50% of ASPD). High rates of polysubstance abuse. Impulsivity drives both conditions. Poor treatment prognosis. Address SUD first for any chance at behavioral change. Naltrexone may help alcohol cravings.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 110,
    "question": "A patient presents to the ED with sudden onset chest tightness, palpitations, diaphoresis, and fear of dying. Symptoms peak in 10 minutes then gradually resolve. What is the MOST likely diagnosis?",
    "options": [
      "Acute myocardial infarction",
      "Panic attack",
      "Generalized anxiety disorder",
      "Agoraphobia"
    ],
    "correctAnswer": 1,
    "rationale": "PANIC ATTACK: Abrupt surge of intense fear peaking within MINUTES, with 4+ symptoms: palpitations, sweating, trembling, shortness of breath, chest pain, nausea, dizziness, chills/heat, numbness, derealization, fear of losing control, fear of dying. Rule out cardiac causes first. Treat: SSRIs + CBT.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 111,
    "question": "A patient avoids shopping malls, public transportation, and being in crowds because she fears being unable to escape if she has a panic attack. What is this condition called?",
    "options": [
      "Specific phobia",
      "Agoraphobia",
      "Social anxiety disorder",
      "Generalized anxiety"
    ],
    "correctAnswer": 1,
    "rationale": "Agoraphobia: fear/avoidance of situations where escape is difficult—crowds, public transport, open spaces, being outside home alone. Often develops after panic attacks. Treat with CBT exposure therapy.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 112,
    "question": "A patient avoids public speaking, eating in front of others, and meeting new people due to fear of embarrassment or negative judgment. What condition does this describe?",
    "options": [
      "Social anxiety disorder",
      "Agoraphobia",
      "Specific phobia",
      "Generalized worry"
    ],
    "correctAnswer": 0,
    "rationale": "Social anxiety disorder: fear of being judged/scrutinized in social situations leading to avoidance. Performance-only type exists. Teach patient: This is more than shyness; it's treatable with CBT and/or SSRIs.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 113,
    "question": "A patient with intrusive thoughts about contamination spends 4 hours daily washing hands to relieve anxiety. Another patient organizes everything perfectly because 'it's the right way to do things.' What distinguishes OCD from OCPD?",
    "options": [
      "OCD has ego-dystonic obsessions/compulsions; OCPD has ego-syntonic perfectionism",
      "No clinical difference",
      "OCPD is more severe",
      "OCD is a personality disorder"
    ],
    "correctAnswer": 0,
    "rationale": "OCD: obsessions/compulsions that are EGO-DYSTONIC (patient knows they're irrational). OCPD: perfectionism/control that is EGO-SYNTONIC (patient thinks it's fine). OCD is treatable; OCPD is harder to treat.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 114,
    "question": "A patient with schizophrenia has flat affect, rarely speaks, has no motivation, and no longer enjoys activities. Which symptom category do these represent?",
    "options": [
      "Positive symptoms",
      "Aggressive symptoms",
      "Paranoid symptoms",
      "Negative symptoms (deficits)"
    ],
    "correctAnswer": 3,
    "rationale": "Negative symptoms (the 5 A's): Affect flat, Avolition (no motivation), Alogia (poverty of speech), Anhedonia (no pleasure), Asociality. These are DEFICITS. Harder to treat than positive symptoms.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 115,
    "question": "A patient with schizophrenia reports auditory hallucinations, believes the FBI is monitoring him, and has disorganized speech. Which symptom category do these represent?",
    "options": [
      "Negative symptoms",
      "Positive symptoms",
      "Cognitive symptoms",
      "Mood symptoms"
    ],
    "correctAnswer": 1,
    "rationale": "POSITIVE SYMPTOMS of schizophrenia = ADDITIONS to normal: hallucinations (auditory most common), delusions (paranoid, referential, grandiose), disorganized speech (tangential, loose associations), disorganized behavior. Respond well to antipsychotics. Contrast with negative symptoms (deficits).",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 116,
    "question": "A patient has had auditory hallucinations, paranoid delusions, and social withdrawal for 8 months. For a diagnosis of schizophrenia, what is the minimum total duration of symptoms required?",
    "options": [
      "1 month",
      "3 months",
      "6 months",
      "1 year"
    ],
    "correctAnswer": 2,
    "rationale": "Schizophrenia requires 6 months total duration (including prodromal/residual). Active psychotic phase must be at least 1 month. Board tip: <1 month = brief psychotic, 1-6 months = schizophreniform, >6 months = schizophrenia.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 117,
    "question": "A patient developed paranoid delusions and auditory hallucinations 2 weeks ago following the sudden death of a family member. Symptoms are resolving. If duration is less than 1 month, what is the diagnosis?",
    "options": [
      "Brief psychotic disorder",
      "Schizophreniform disorder",
      "Schizophrenia",
      "Schizoaffective disorder"
    ],
    "correctAnswer": 0,
    "rationale": "Brief Psychotic Disorder: psychotic symptoms lasting 1 day to <1 month with full recovery. Often triggered by severe stress. Teach family: Good prognosis—most recover completely.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 118,
    "question": "A patient has had psychotic symptoms (delusions, hallucinations, disorganized speech) for 4 months. Symptoms have not resolved. What is the appropriate diagnosis?",
    "options": [
      "Brief psychotic disorder",
      "Schizophrenia",
      "Delusional disorder",
      "Schizophreniform disorder"
    ],
    "correctAnswer": 3,
    "rationale": "Schizophreniform: psychotic symptoms lasting 1-6 months. Same symptoms as schizophrenia, just shorter duration. Diagnosis changes to schizophrenia if symptoms persist beyond 6 months.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 119,
    "question": "A patient was hospitalized last year for a week-long episode of decreased need for sleep, grandiosity, pressured speech, and risky spending. She has also had depressive episodes. What is the diagnosis?",
    "options": [
      "Major depressive disorder",
      "Bipolar II disorder",
      "Cyclothymia",
      "Bipolar I disorder"
    ],
    "correctAnswer": 3,
    "rationale": "Bipolar I: at least ONE manic episode (7+ days OR hospitalization required). Depressive episodes common but NOT required for diagnosis. Teach patient: Mania can feel good but causes real harm.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 120,
    "question": "A patient reports several 4-5 day episodes of increased energy, decreased sleep, and elevated mood that did not require hospitalization. She also has recurrent depressive episodes. What is the diagnosis?",
    "options": [
      "Bipolar I disorder",
      "Major depressive disorder",
      "Bipolar II disorder",
      "Cyclothymia"
    ],
    "correctAnswer": 2,
    "rationale": "Bipolar II: hypomanic (4+ days, less severe) + depressive episodes. NO full mania. If patient ever has full mania, diagnosis changes to Bipolar I. Depression is often the presenting complaint.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 121,
    "question": "A patient tells his PMHNP that he plans to kill his ex-girlfriend next week and describes a specific plan. What is the PMHNP's legal obligation under Tarasoff?",
    "options": [
      "Warn the identified potential victim and notify authorities",
      "Maintain confidentiality",
      "Wait until harm occurs",
      "Only document the threat"
    ],
    "correctAnswer": 0,
    "rationale": "Tarasoff duty: If patient makes credible, specific threat against identifiable victim, you MUST warn potential victim AND notify authorities. Confidentiality yields to public safety. Document everything.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 122,
    "question": "A PMHNP is reviewing situations that require breaking patient confidentiality. Under what circumstances is disclosure legally permitted or required?",
    "options": [
      "Never break confidentiality",
      "Any time the clinician prefers",
      "Only with family permission",
      "Danger to self/others, child/elder abuse, valid court order, patient consent"
    ],
    "correctAnswer": 3,
    "rationale": "Break confidentiality for: danger to self/others, suspected child/elder abuse (mandatory reporting), valid court order, patient written consent. Safety always overrides confidentiality.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 123,
    "question": "A PMHNP is starting a patient on a new medication. What elements must be included for valid informed consent?",
    "options": [
      "Patient signature on a form only",
      "Patient understands risks, benefits, alternatives and voluntarily agrees",
      "Family agreement only",
      "Provider determines best option"
    ],
    "correctAnswer": 1,
    "rationale": "Informed consent requires: patient has capacity, understands risks/benefits/alternatives in their language, and voluntarily agrees without coercion. A signature alone is NOT informed consent.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 124,
    "question": "A 14-year-old presents alone requesting treatment for anxiety. The PMHNP reviews state law regarding minor consent for mental health treatment. At what age can minors typically consent (varies by state)?",
    "options": [
      "Ages 12-14 depending on state law",
      "Only at age 18",
      "Only at age 21",
      "Minors can never consent"
    ],
    "correctAnswer": 0,
    "rationale": "MINOR CONSENT for mental health: Typically ages 12-14 depending on state law. Know YOUR state's specific age. Many states also allow minor consent for: substance abuse treatment, STI treatment, pregnancy care, contraception. Document patient's understanding of consent.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 125,
    "question": "A family asks the PMHNP to determine if their elderly mother is 'competent' to manage her finances. The PMHNP clarifies the distinction between competence and capacity. Which statement is correct?",
    "options": [
      "They mean the same thing",
      "Capacity is legal; competence is clinical",
      "Both are determined by physicians",
      "Competence is a legal determination by court; capacity is a clinical assessment"
    ],
    "correctAnswer": 3,
    "rationale": "COMPETENCE: legal determination made by a JUDGE. CAPACITY: clinical assessment made by CLINICIAN. You assess capacity; only courts determine competence. Patients are presumed competent until proven otherwise.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 126,
    "question": "A patient involuntarily committed to a psychiatric unit requests to challenge his commitment. He has a constitutional right to what legal protection?",
    "options": [
      "Right to treatment",
      "Habeas corpus",
      "Right to refuse all medications",
      "Automatic release after 24 hours"
    ],
    "correctAnswer": 1,
    "rationale": "Habeas Corpus: Constitutional right to court hearing to challenge involuntary commitment. Patient can petition court to review if detention is legal. Protects against unlawful confinement.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 127,
    "question": "A PMHNP is consulted about involuntary commitment for a patient with schizophrenia who is refusing treatment. What criteria must be met for involuntary commitment?",
    "options": [
      "Mental illness AND danger to self/others or gravely disabled",
      "Mental illness alone is sufficient",
      "Family request is sufficient",
      "Homelessness alone"
    ],
    "correctAnswer": 0,
    "rationale": "Involuntary commitment requires BOTH: (1) mental illness AND (2) danger to self/others OR gravely disabled (can't meet basic needs). Mental illness alone is NOT sufficient. Know your state's specific laws.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 128,
    "question": "A PMHNP is comparing voluntary and involuntary psychiatric admission. Which statement correctly describes voluntary admission?",
    "options": [
      "Patient cannot leave once admitted",
      "Court order required",
      "Same as involuntary",
      "Patient requests admission and can request discharge"
    ],
    "correctAnswer": 3,
    "rationale": "Voluntary: patient consents, can request discharge (usually 72-hour notice). Involuntary: court-ordered for danger to self/others or gravely disabled, patient cannot leave. Always try voluntary first.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 129,
    "question": "A PMHNP is reviewing the ANA Code of Ethics before a presentation. What is the primary purpose of the Code of Ethics?",
    "options": [
      "Ethical framework guiding nursing practice",
      "Legal requirements only",
      "Hospital policies",
      "Insurance billing guidelines"
    ],
    "correctAnswer": 0,
    "rationale": "ANA CODE OF ETHICS: Professional framework guiding nursing practice. Key principles: Beneficence (do good), Non-maleficence (do no harm), Autonomy (patient self-determination), Justice (fair treatment), Fidelity (keep promises). Used to guide ethical decisions and as standard of care in legal cases.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 130,
    "question": "A new graduate NP asks about scope of practice. What defines the scope of practice for nurse practitioners?",
    "options": [
      "Federal law only",
      "Individual NP preference",
      "State Nurse Practice Act, board of nursing regulations, and collaborative agreements",
      "Hospital policy only"
    ],
    "correctAnswer": 2,
    "rationale": "NP SCOPE OF PRACTICE defined by: (1) State Nurse Practice Act (NPA), (2) Board of Nursing regulations, (3) Collaborative agreements (if required by state), (4) Institutional credentialing. Varies significantly by state. Always practice within your scope and maintain current knowledge of state requirements.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 131,
    "question": "A newly licensed PMHNP relocating from New York to Texas asks about scope of practice differences. The preceptor explains that NP scope of practice varies by state. Which statement BEST describes this variation?",
    "options": [
      "Ranges from full practice authority to restricted practice requiring supervision",
      "Same as physicians in all states",
      "Always requires physician supervision",
      "No prescriptive authority in any state"
    ],
    "correctAnswer": 0,
    "rationale": "NP scope varies by state: Full Practice (27 states—independent), Reduced Practice (requires collaboration), Restricted Practice (requires supervision). Know YOUR state before practicing.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 132,
    "question": "A PMHNP is establishing a new practice and needs to prescribe controlled substances for patients with ADHD and anxiety. What is required to prescribe controlled substances?",
    "options": [
      "Cannot prescribe any controlled substances",
      "DEA registration with state-specific schedule limitations",
      "Only non-controlled medications allowed",
      "Physician must be present for all prescriptions"
    ],
    "correctAnswer": 1,
    "rationale": "Yes—NPs can prescribe controlled substances with DEA registration. Schedules allowed vary by state (most allow II-V). Check state-specific regulations. Complete DEA training requirements.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 133,
    "question": "A PMHNP wants to provide telepsychiatry services to patients in rural areas of a neighboring state. What regulatory requirements must be met for telepsychiatry?",
    "options": [
      "No special requirements beyond standard licensure",
      "Can only treat patients in provider's home state",
      "Physician oversight required for all telehealth visits",
      "Licensure in patient's state, HIPAA-compliant platform, and informed consent"
    ],
    "correctAnswer": 3,
    "rationale": "Telepsychiatry requires: license in PATIENT'S state (not just yours), HIPAA-compliant video platform, informed consent documenting risks/limitations. Some states have interstate compacts.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 134,
    "question": "A PMHNP is developing a treatment protocol for treatment-resistant depression. When reviewing the literature for evidence-based recommendations, which represents the HIGHEST level of evidence?",
    "options": [
      "Expert opinion from leading psychiatrists",
      "Published case studies and case series",
      "Systematic reviews and meta-analyses of randomized controlled trials",
      "A single well-designed randomized controlled trial"
    ],
    "correctAnswer": 2,
    "rationale": "EVIDENCE HIERARCHY (highest to lowest): Level I = Systematic reviews/meta-analyses of RCTs. Level II = RCTs. Level III = Quasi-experimental/cohort studies. Level IV = Case-control/case series. Level V = Expert opinion/case reports. Use highest available evidence for clinical decisions.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 135,
    "question": "A nursing student asks the PMHNP preceptor to explain evidence-based practice. Which response BEST describes EBP?",
    "options": [
      "Following research findings exclusively",
      "Adhering strictly to institutional protocols",
      "Basing decisions on patient preferences alone",
      "Integrating best research evidence with clinical expertise and patient values"
    ],
    "correctAnswer": 3,
    "rationale": "EBP triad: Best research evidence + Clinical expertise + Patient values/preferences. All three must be considered—research alone doesn't dictate care. Patient autonomy matters.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 136,
    "question": "A PMHNP discovers she administered 20mg of escitalopram instead of the prescribed 10mg to a patient. The patient appears stable. What is the FIRST priority action?",
    "options": [
      "Document the error after the shift ends",
      "Assess the patient, report immediately, notify the provider, and document",
      "Wait to see if the patient develops symptoms",
      "Ignore since the patient appears unharmed"
    ],
    "correctAnswer": 1,
    "rationale": "Medication error steps: (1) Assess patient immediately, (2) Report to supervisor/provider, (3) Document factually (no blame language), (4) Complete incident report. Disclosure to patient often required.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 137,
    "question": "During a quality improvement meeting, the hospital reports that a psychiatric inpatient died by suicide on the unit. This event is classified as which type of occurrence?",
    "options": [
      "Minor medication error",
      "Near miss incident",
      "Routine patient complaint",
      "Sentinel event requiring root cause analysis"
    ],
    "correctAnswer": 3,
    "rationale": "Sentinel event: unexpected occurrence causing death or serious physical/psychological harm. Requires root cause analysis (RCA) and action plan. Joint Commission requires reporting. Examples: suicide, wrong-site surgery.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 138,
    "question": "A PMHNP receives feedback from a peer review committee regarding her documentation practices. She is upset about the criticism. What is the PRIMARY purpose of the peer review process?",
    "options": [
      "Disciplinary action against clinicians",
      "Quality improvement and professional development",
      "Comparison between providers for rankings",
      "Identifying clinicians for termination"
    ],
    "correctAnswer": 1,
    "rationale": "Peer review: quality improvement and professional development—NOT punishment. Protected process for evaluating clinical practice. Feedback should be constructive. Peer review records often legally protected.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 139,
    "question": "A patient with schizophrenia and diabetes is receiving care from a PMHNP, primary care physician, endocrinologist, and case manager. This care delivery model describes which approach?",
    "options": [
      "Independent practice model",
      "Nursing-only care coordination",
      "Collaborative/interprofessional practice for patient-centered care",
      "Physician-directed care without NP input"
    ],
    "correctAnswer": 2,
    "rationale": "Collaborative practice: interprofessional teamwork (nurses, physicians, social workers, pharmacists) for patient-centered care. Research shows it improves outcomes and reduces errors. Communication is key.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 140,
    "question": "A PMHNP is explaining the role of the psychiatric case manager to a patient being discharged after a psychiatric hospitalization. Which description BEST describes the case manager's role?",
    "options": [
      "Provides direct medication management",
      "Coordinates care, links to resources, and provides advocacy",
      "Prescribes psychiatric medications",
      "Completes insurance billing only"
    ],
    "correctAnswer": 1,
    "rationale": "Case management: care coordination, resource linkage, advocacy, discharge planning. Ensures continuity of care across settings. Critical for patients with complex needs. Reduces readmissions.",
    "category": "Ethics & Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 141,
    "question": "A Hispanic patient believes \"susto\" (fright) caused their illness. How should you respond?",
    "options": [
      "Respect cultural belief and incorporate into treatment plan",
      "Dismiss it as superstition",
      "Argue against it",
      "Ignore it"
    ],
    "correctAnswer": 0,
    "rationale": "Susto (soul loss from fright) is a valid cultural belief. Respect it, incorporate into treatment, involve curandero if patient wishes. Cultural humility: 'Tell me more about how this affects you.'",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 142,
    "question": "A Native American patient wants to use traditional healing. What should you do?",
    "options": [
      "Forbid it",
      "Require Western treatment only",
      "Refer out",
      "Respect and integrate with Western treatment if safe"
    ],
    "correctAnswer": 3,
    "rationale": "Integrate traditional healing with Western medicine if safe. Ask about herbs (check interactions), ceremonies, spiritual practices. Collaboration improves outcomes and trust. Never dismiss cultural practices.",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 143,
    "question": "A PMHNP is conducting a suicide risk assessment and considers demographic risk factors. Which population has the HIGHEST rate of suicide completion?",
    "options": [
      "Adolescent females aged 15-19",
      "Elderly females over age 75",
      "White males in midlife and older adults",
      "Young adult males aged 18-25"
    ],
    "correctAnswer": 2,
    "rationale": "SUICIDE COMPLETION RATES: White males have highest rate, especially ages 45+ and 75+. Firearms are #1 method (85% lethal). Key risk factors: prior attempt, depression, substance use, access to lethal means, isolation, chronic illness. ALWAYS ask about firearm access.",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 144,
    "question": "A 16-year-old patient who identifies as transgender presents with depression and social withdrawal. The PMHNP understands what about LGBTQ+ youth mental health?",
    "options": [
      "Higher rates of depression, anxiety, and suicide attempts; need affirming care",
      "Risk is equivalent to the general population",
      "Lower risk due to supportive peer communities",
      "No specific considerations needed"
    ],
    "correctAnswer": 0,
    "rationale": "LGBTQ+ youth: 4x higher suicide attempt rate. Family rejection = biggest risk factor; family acceptance = biggest protective factor. Use affirming care: correct pronouns, inclusive intake forms, no assumptions.",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 145,
    "question": "A PMHNP is implementing trauma-informed care principles in a community mental health center. Which statement BEST describes this approach?",
    "options": [
      "Recognizes trauma's widespread impact; emphasizes safety, trust, and empowerment",
      "Applies only to patients with PTSD diagnosis",
      "Requires patients to disclose all trauma details",
      "Focuses on avoiding all discussion of past experiences"
    ],
    "correctAnswer": 0,
    "rationale": "Trauma-informed care for ALL patients (not just PTSD): Safety, Trustworthiness, Choice, Collaboration, Empowerment. Ask 'What happened to you?' not 'What's wrong with you?' Never force disclosure.",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 146,
    "question": "What should you do first when a patient discloses rape?",
    "options": [
      "Call police",
      "Reassure safety, provide support",
      "Get detailed history",
      "Perform exam immediately"
    ],
    "correctAnswer": 1,
    "rationale": "First: ensure safety and provide emotional support ('I believe you. This wasn't your fault.'). Give patient control over next steps. Don't force police report—patient decides. Offer SANE exam/resources.",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 147,
    "question": "A PMHNP is prescribing sertraline 25mg for an 82-year-old patient with depression. The patient's daughter asks why the dose is lower than her own. Which principle guides geriatric psychopharmacology?",
    "options": [
      "Use standard adult doses for consistency",
      "Start low, go slow due to altered pharmacokinetics and increased sensitivity",
      "Avoid all psychiatric medications in elderly",
      "Always use maximum doses for faster efficacy"
    ],
    "correctAnswer": 1,
    "rationale": "'Start low, go slow' in elderly: decreased hepatic/renal function, increased fat stores, more drug interactions. Watch for anticholinergic effects (confusion), orthostatic hypotension (falls). Check Beers Criteria.",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 148,
    "question": "A 28-year-old woman with bipolar II disorder discovers she is pregnant at 8 weeks gestation. She is currently taking valproate and lamotrigine. What is the MOST important consideration?",
    "options": [
      "Immediately discontinue all psychiatric medications",
      "Continue all medications without changes",
      "Psychiatric medications are never safe during pregnancy",
      "Assess risks vs. benefits of each medication; consider safer alternatives"
    ],
    "correctAnswer": 3,
    "rationale": "Pregnancy: weigh untreated illness vs. medication risks. Untreated depression/psychosis also harms fetus. Get pregnancy test before starting ANY psych med in reproductive-age women. SSRIs generally safest.",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 149,
    "question": "A PMHNP is counseling a woman with bipolar disorder who is planning pregnancy. She asks about mood stabilizer risks. Which medication poses the HIGHEST risk for neural tube defects?",
    "options": [
      "Lithium",
      "Lamotrigine",
      "Carbamazepine",
      "Valproic acid"
    ],
    "correctAnswer": 1,
    "rationale": "LAMOTRIGINE (Lamictal) is the SAFEST mood stabilizer in pregnancy. Teratogenicity risk ranking: Valproate (HIGHEST - neural tube defects, contraindicated) > Carbamazepine > Lithium (Ebstein's anomaly) > Lamotrigine (LOWEST). Board pearl: If pregnant bipolar patient needs mood stabilizer, lamotrigine is first choice. Valproate is absolutely contraindicated in pregnancy and women of childbearing potential without reliable contraception.",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 150,
    "question": "A woman with bipolar II disorder becomes pregnant while on mood stabilizer therapy. The PMHNP considers medication changes. Which mood stabilizer is considered SAFEST during pregnancy?",
    "options": [
      "Lithium",
      "Valproic acid",
      "Lamotrigine",
      "Carbamazepine"
    ],
    "correctAnswer": 2,
    "rationale": "LAMOTRIGINE (Lamictal) = SAFEST mood stabilizer in pregnancy. Lower teratogenicity than lithium, valproate, carbamazepine. Preferred for bipolar during pregnancy. Important: Levels decrease during pregnancy due to increased metabolism - monitor and adjust dose. Still give folic acid supplementation.",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 151,
    "question": "An 8-year-old is diagnosed with ADHD and the PMHNP plans to start methylphenidate. Before initiating stimulant therapy, which assessment is ESSENTIAL?",
    "options": [
      "Cardiac history, family history of sudden death, baseline vital signs",
      "No specific assessments required",
      "Intelligence testing only",
      "Academic performance review only"
    ],
    "correctAnswer": 0,
    "rationale": "PSYCHIATRIC MEDICATIONS IN PREGNANCY - Risk categories: SAFEST: Lamotrigine (mood stabilizer), most SSRIs (sertraline preferred - most data). MODERATE RISK: Lithium (Ebstein's anomaly 1/1000 vs 1/20000 baseline). CONTRAINDICATED: Valproate (neural tube defects, lower IQ), Carbamazepine (facial abnormalities). Benzodiazepines: avoid first trimester (cleft palate), third trimester (floppy infant syndrome). General principle: untreated maternal mental illness also poses risks - weigh benefits vs risks individually.",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 152,
    "question": "A 7-year-old presents with hyperactivity, impulsivity, and difficulty focusing in school. After comprehensive evaluation confirms ADHD, what is the first-line pharmacological treatment?",
    "options": [
      "Stimulants",
      "Antipsychotics (risperidone)",
      "Antidepressants (fluoxetine)",
      "Anxiolytics (buspirone)"
    ],
    "correctAnswer": 0,
    "rationale": "Stimulants (methylphenidate, amphetamines) are first-line for pediatric ADHD—70-80% response rate. Monitor height, weight, BP/HR. Teach parents: Give morning dose; may affect sleep and appetite.",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 153,
    "question": "A 10-year-old child presents with excessive worry about school performance, physical symptoms including stomachaches, and difficulty sleeping for the past 8 months. After diagnosing generalized anxiety disorder, what is the first-line medication?",
    "options": [
      "Benzodiazepines (lorazepam)",
      "SSRIs",
      "Antipsychotics (quetiapine)",
      "Beta-blockers (propranolol)"
    ],
    "correctAnswer": 1,
    "rationale": "SSRIs first-line for pediatric anxiety (sertraline, fluoxetine FDA-approved). Also use CBT. Teach parents: Takes 4-6 weeks to work; watch for activation (increased anxiety, agitation) early on.",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 154,
    "question": "A 14-year-old presents with depressed mood, anhedonia, sleep disturbance, and declining grades for 3 months. After confirming major depressive disorder, what is the first-line medication?",
    "options": [
      "Tricyclic antidepressants",
      "MAOIs",
      "Benzodiazepines",
      "SSRIs"
    ],
    "correctAnswer": 3,
    "rationale": "SSRIs first-line for pediatric depression (fluoxetine, escitalopram FDA-approved). BLACK BOX WARNING: Monitor for suicidal ideation, especially first weeks. Weekly visits initially.",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 155,
    "question": "A patient is brought to the emergency department by police after being found wandering in traffic and making statements about 'ending it all.' What is the FIRST priority in crisis intervention?",
    "options": [
      "Medication administration",
      "Initiating psychotherapy",
      "Discharge planning",
      "Comprehensive safety assessment"
    ],
    "correctAnswer": 3,
    "rationale": "SAFETY FIRST in crisis—always assess suicide/homicide risk before anything else. Use Columbia Protocol or similar tool. Everything else (meds, therapy, planning) comes after safety is established.",
    "category": "Crisis & Emergency Management",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 156,
    "question": "A patient says \"I want to kill myself and I have a gun at home.\" What is your immediate action?",
    "options": [
      "Schedule follow-up",
      "Prescribe antidepressant",
      "Send home with family",
      "Safety assessment, remove access to means, possible hospitalization"
    ],
    "correctAnswer": 3,
    "rationale": "This is HIGH RISK: suicidal ideation + lethal means access. Immediate steps: (1) Safety assessment, (2) Lethal means counseling (remove gun TODAY), (3) Consider hospitalization. Never send home with access to means.",
    "category": "Crisis & Emergency Management",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 157,
    "question": "A patient tells the PMHNP, 'I've been thinking about death a lot lately.' Another patient states, 'I have a plan to overdose on my medications tonight.' The PMHNP must differentiate between these presentations. What is the KEY distinction?",
    "options": [
      "Both represent equal risk",
      "Ideation involves thoughts; intent involves a plan and determination to act",
      "Intent is less serious than ideation",
      "Both always require hospitalization"
    ],
    "correctAnswer": 1,
    "rationale": "Ideation: thoughts about suicide ('I wish I were dead'). Intent: plan + determination to act ('I'm going to take pills tonight'). Intent = higher acuity, usually needs hospitalization.",
    "category": "Crisis & Emergency Management",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 158,
    "question": "A PMHNP is assessing a patient who reports suicidal ideation. The patient states she cannot act on these thoughts because she has young children who need her. What does this represent?",
    "options": [
      "Protective factor",
      "Risk factor for suicide",
      "Indication for immediate hospitalization",
      "Evidence of psychosis"
    ],
    "correctAnswer": 0,
    "rationale": "Protective factors: strong social support, children at home, religious beliefs against suicide, future orientation, access to mental health care. Build these in treatment—ask about reasons for living.",
    "category": "Crisis & Emergency Management",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 159,
    "question": "A patient is being discharged from inpatient psychiatry after a suicide attempt. The treatment team schedules follow-up for 3 weeks later. The PMHNP expresses concern about this plan. What is the rationale?",
    "options": [
      "Suicide risk is eliminated after hospitalization",
      "Patients don't need follow-up after hospitalization",
      "First week post-discharge, especially first 24-48 hours, is highest risk period",
      "Risk is same as general population after discharge"
    ],
    "correctAnswer": 2,
    "rationale": "First week post-discharge = HIGHEST suicide risk period (especially first 24-48 hours). Schedule follow-up within 7 days. Call patient within 24-48 hours. Ensure medications filled before discharge.",
    "category": "Crisis & Emergency Management",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 160,
    "question": "A patient is agitated, threatening staff, and psychotic. What is the least restrictive intervention?",
    "options": [
      "Physical restraints immediately",
      "Verbal de-escalation first",
      "Seclusion",
      "Chemical restraint"
    ],
    "correctAnswer": 1,
    "rationale": "ALWAYS try verbal de-escalation FIRST (least restrictive): calm tone, offer choices, reduce stimulation, maintain safe distance. Escalate only if this fails. Order: verbal → PRN medication → restraints.",
    "category": "Crisis & Emergency Management",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 161,
    "question": "A patient in the psychiatric unit is agitated but calms down after verbal de-escalation and PRN medication. Later, a nurse asks when restraints would be appropriate. What is the correct indication?",
    "options": [
      "When staff are short-staffed",
      "Only when imminent danger exists AND less restrictive interventions have failed",
      "For patient punishment when rules are broken",
      "Whenever the patient is being difficult"
    ],
    "correctAnswer": 1,
    "rationale": "Restraints/seclusion ONLY when: (1) imminent danger to self/others, AND (2) less restrictive interventions failed. NEVER for punishment, convenience, or staffing issues. Document alternatives tried.",
    "category": "Crisis & Emergency Management",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 162,
    "question": "A patient has been placed in physical restraints due to violent behavior toward staff. What monitoring is REQUIRED while the patient is restrained?",
    "options": [
      "Hourly checks are sufficient",
      "No monitoring required if patient is calm",
      "Only monitor if patient requests it",
      "Q15 minute checks, offer hydration/toileting, MD evaluation within 1 hour"
    ],
    "correctAnswer": 3,
    "rationale": "Restraint monitoring: Q15 minute checks minimum, offer food/water/toileting, document circulation/behavior, MD must evaluate within 1 hour. Remove at earliest safe moment. Time limits apply.",
    "category": "Crisis & Emergency Management",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 163,
    "question": "A patient threatens to kill their neighbor. What is your legal obligation?",
    "options": [
      "Maintain confidentiality",
      "Tarasoff duty to warn - notify potential victim and authorities",
      "Do nothing",
      "Only document"
    ],
    "correctAnswer": 1,
    "rationale": "Tarasoff duty: credible threat against identifiable victim = MUST warn victim AND notify police. Confidentiality breaks for safety. Document the threat, your assessment, and actions taken.",
    "category": "Crisis & Emergency Management",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 164,
    "question": "A PMHNP is evaluating two patients for involuntary commitment. Patient A expresses passive suicidal ideation. Patient B has no suicidal thoughts but has not eaten in 5 days due to paranoid delusions that food is poisoned. The PMHNP considers the difference between danger to self and gravely disabled. Which statement is correct?",
    "options": [
      "Both terms mean the same thing",
      "Danger to self involves suicide/self-harm risk; gravely disabled means inability to meet basic needs",
      "Gravely disabled is less serious than danger to self",
      "Neither can justify involuntary commitment"
    ],
    "correctAnswer": 1,
    "rationale": "Danger to self: suicide/self-harm risk. Gravely disabled: cannot meet basic needs for survival (food, shelter, clothing) due to mental illness. Both are grounds for involuntary commitment.",
    "category": "Crisis & Emergency Management",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 165,
    "question": "A PMHNP works in a primary care clinic where she sees patients for depression and anxiety alongside their medical providers. This practice model is called:",
    "options": [
      "Specialty mental health care",
      "Stand-alone psychiatric practice",
      "Integrated/collaborative care",
      "Consultation-liaison psychiatry"
    ],
    "correctAnswer": 2,
    "rationale": "INTEGRATED/COLLABORATIVE CARE: Mental health services embedded in primary care settings. Same-day access, warm handoffs, team-based care. CoCM (Collaborative Care Model) is evidence-based: PCP + Care manager + Psychiatric consultant. Improves outcomes, reduces stigma, increases access.",
    "category": "Integrated Care",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 166,
    "question": "A 55-year-old woman presents with fatigue, weight gain, depressed mood, and difficulty concentrating. Before diagnosing major depressive disorder, the PMHNP should rule out which medical conditions?",
    "options": [
      "No medical workup needed",
      "Only diabetes",
      "Only cardiac disease",
      "Hypothyroidism, anemia, vitamin deficiencies, and chronic illness"
    ],
    "correctAnswer": 3,
    "rationale": "Medical depression mimics: hypothyroidism (fatigue, weight gain), anemia (fatigue), B12/folate deficiency, chronic illness (cancer, CHF). ALWAYS rule out medical before diagnosing psychiatric.",
    "category": "Integrated Care",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 167,
    "question": "A 45-year-old patient presents with palpitations, trembling, and feeling of impending doom. Physical exam reveals tachycardia and tremor. Before diagnosing anxiety disorder, which medical conditions should be ruled out?",
    "options": [
      "No medical evaluation needed",
      "Only pulmonary conditions",
      "Only neurological conditions",
      "Hyperthyroidism, cardiac arrhythmias, hypoglycemia, and stimulant use"
    ],
    "correctAnswer": 3,
    "rationale": "Medical anxiety mimics: hyperthyroidism (racing heart, tremor), arrhythmias (palpitations), hypoglycemia (shakiness), stimulant medications, caffeine, COPD (air hunger). Check TSH, EKG.",
    "category": "Integrated Care",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 168,
    "question": "A 42-year-old patient presents with depressed mood, anhedonia, and fatigue for 4 weeks. Before initiating antidepressant therapy, which laboratory tests should the PMHNP order?",
    "options": [
      "No labs needed for psychiatric diagnosis",
      "TSH, CBC, CMP, Vitamin D, and B12",
      "TSH only",
      "CBC only"
    ],
    "correctAnswer": 1,
    "rationale": "Depression workup labs: TSH (thyroid), CBC (anemia), CMP (electrolytes, glucose, kidney/liver), Vitamin D, B12. Rule out medical causes before treating as psychiatric. Add A1C if diabetic symptoms.",
    "category": "Integrated Care",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 169,
    "question": "A PMHNP is presenting a case conceptualization of a patient with depression to colleagues. She describes the patient's genetic vulnerability, cognitive distortions, and recent job loss. Which theoretical framework guides this comprehensive approach?",
    "options": [
      "Biopsychosocial model",
      "Biological model only",
      "Psychodynamic model only",
      "Social determinants model only"
    ],
    "correctAnswer": 0,
    "rationale": "Biopsychosocial model: Bio (genetics, neurotransmitters) + Psycho (cognitions, coping) + Social (relationships, stressors, culture). All three interact. Treatment should address all three domains.",
    "category": "Integrated Care",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 170,
    "question": "A PMHNP at a community health center provides naloxone kits and education to patients with opioid use disorder, even those not ready for treatment. This approach represents which philosophy?",
    "options": [
      "Harm reduction",
      "Abstinence-only treatment",
      "Enabling substance use",
      "Punitive intervention"
    ],
    "correctAnswer": 0,
    "rationale": "Harm reduction: meet patients where they are, reduce negative consequences (needle exchange, Narcan distribution, safe injection sites). NOT enabling—reduces deaths. Abstinence is ideal but not required.",
    "category": "Integrated Care",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 171,
    "question": "A 32-year-old patient with opioid use disorder asks about medication options for treatment. He has tried detox twice but relapsed each time. The PMHNP explains medication-assisted treatment (MAT). Which response is accurate?",
    "options": [
      "MAT just replaces one drug with another",
      "Only abstinence-based programs are effective",
      "Detox alone is the gold standard treatment",
      "MAT combines buprenorphine or methadone with counseling; reduces overdose deaths by 50%"
    ],
    "correctAnswer": 3,
    "rationale": "MAT = medication (buprenorphine, methadone, or naltrexone) + counseling. Gold standard for OUD—reduces overdose deaths by 50%. NOT 'replacing one drug with another.' Teach patient: This is treatment, like insulin for diabetes.",
    "category": "Integrated Care",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 172,
    "question": "A patient with alcohol use disorder tells the PMHNP, 'I know drinking is bad for me, but I'm not sure I'm ready to quit.' According to the Stages of Change model, which stage is this patient in?",
    "options": [
      "Precontemplation",
      "Preparation (planning change)",
      "Action",
      "Contemplation"
    ],
    "correctAnswer": 3,
    "rationale": "Stages of Change: Precontemplation (not thinking about it) → Contemplation (thinking about it) → Preparation (planning) → Action (doing it) → Maintenance (sustaining) → Relapse (normal part of process).",
    "category": "Integrated Care",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 173,
    "question": "A patient tells the PMHNP, 'I know I need to stop using cocaine, but I'm not sure if I can do it.' The patient is in the contemplation stage. Which intervention is MOST appropriate?",
    "options": [
      "Use motivational interviewing to explore ambivalence",
      "Provide a detailed action plan immediately",
      "Focus only on maintenance strategies",
      "No intervention until patient is ready for action"
    ],
    "correctAnswer": 0,
    "rationale": "Contemplation stage: patient is ambivalent about change. Use motivational interviewing—explore ambivalence, develop discrepancy, roll with resistance. Don't push action yet. Goal: tip the scales toward change.",
    "category": "Integrated Care",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 174,
    "question": "A patient with chronic pain and anxiety asks the PMHNP about medical marijuana. The PMHNP practices in a state where medical marijuana is legal. What should the PMHNP understand about recommending medical marijuana?",
    "options": [
      "NPs can never recommend medical marijuana",
      "State laws vary; NPs 'certify' or 'recommend' but don't 'prescribe' due to federal Schedule I status",
      "Federal law permits NP prescription in all states",
      "Physician approval is required in all cases"
    ],
    "correctAnswer": 1,
    "rationale": "Medical marijuana: state-by-state laws (some allow NPs, some don't). Federally still Schedule I (illegal). Know YOUR state. NPs 'certify' or 'recommend'—don't 'prescribe.' Document carefully.",
    "category": "Integrated Care",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 175,
    "question": "A nursing student asks the PMHNP to explain how SSRIs work differently from older antidepressants. Which statement accurately describes the mechanism of SSRIs?",
    "options": [
      "Block multiple neurotransmitter receptors like TCAs",
      "Inhibit the MAO enzyme that breaks down neurotransmitters",
      "Selectively inhibit serotonin reuptake, increasing synaptic serotonin",
      "Block dopamine and norepinephrine reuptake"
    ],
    "correctAnswer": 2,
    "rationale": "SSRIs: SELECTIVELY inhibit serotonin reuptake → more serotonin in synapse. Examples: fluoxetine, sertraline, escitalopram. First-line for depression/anxiety. Teach patient: Takes 2-4 weeks to work.",
    "category": "Antidepressants - Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 176,
    "question": "A PMHNP is explaining to a patient why amitriptyline causes more side effects than sertraline. What is the mechanism of action of tricyclic antidepressants?",
    "options": [
      "Selective serotonin reuptake inhibition only",
      "Inhibit monoamine oxidase enzyme",
      "Act as serotonin receptor agonists",
      "Block presynaptic reuptake of serotonin AND norepinephrine, plus histamine/alpha/muscarinic receptors"
    ],
    "correctAnswer": 3,
    "rationale": "TRICYCLIC ANTIDEPRESSANTS (TCAs): Block presynaptic reuptake of BOTH serotonin AND norepinephrine. ALSO block histamine (sedation, weight gain), alpha-1 (orthostatic hypotension), muscarinic (anticholinergic: dry mouth, constipation, urinary retention, confusion). Examples: amitriptyline, nortriptyline. Dangerous in overdose.",
    "category": "Antidepressants - Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 177,
    "question": "A patient taking phenelzine is admitted after eating aged cheese at a party. He presents with severe hypertensive crisis. The PMHNP explains to the medical team how MAOIs work. Which statement is correct?",
    "options": [
      "MAOIs inhibit reuptake of neurotransmitters",
      "MAOIs inhibit the enzyme that breaks down serotonin, norepinephrine, and dopamine",
      "MAOIs block postsynaptic receptors",
      "MAOIs increase neurotransmitter synthesis"
    ],
    "correctAnswer": 1,
    "rationale": "MAOIs inhibit MAO enzyme (which breaks down serotonin, norepinephrine, dopamine) → more neurotransmitters available. Tyramine restriction required—aged cheese, cured meats can cause hypertensive crisis.",
    "category": "Antidepressants - Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 178,
    "question": "A patient asks why duloxetine might help both her depression and chronic back pain. The PMHNP explains the mechanism of SNRIs. Which response is accurate?",
    "options": [
      "SNRIs only affect serotonin like SSRIs",
      "SNRIs inhibit MAO enzyme",
      "SNRIs inhibit reuptake of both serotonin AND norepinephrine",
      "SNRIs act primarily on dopamine receptors"
    ],
    "correctAnswer": 2,
    "rationale": "SNRIs inhibit BOTH serotonin AND norepinephrine reuptake selectively. Examples: venlafaxine, duloxetine, desvenlafaxine. Also treats chronic pain. Watch BP at higher doses (NE effect).",
    "category": "Antidepressants - Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 179,
    "question": "A patient reports that bupropion has not caused the sexual side effects she experienced with sertraline. The PMHNP explains why. What is bupropion's mechanism of action?",
    "options": [
      "Selective serotonin reuptake inhibition",
      "MAO inhibition",
      "Acetylcholine receptor blockade",
      "Norepinephrine and dopamine reuptake inhibition"
    ],
    "correctAnswer": 3,
    "rationale": "NDRIs (bupropion/Wellbutrin) block norepinephrine and dopamine reuptake. NO serotonin effect → no sexual side effects, no weight gain. Also used for smoking cessation. Contraindicated in seizure/eating disorders.",
    "category": "Antidepressants - Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 180,
    "question": "A patient is taking trazodone 50mg at bedtime for insomnia but is not experiencing antidepressant effects. The PMHNP explains that higher doses would be needed for depression. What is trazodone's mechanism of action?",
    "options": [
      "Dopamine receptor blockade and reuptake inhibition",
      "MAO inhibition and reuptake inhibition",
      "Histamine and serotonin blockade only",
      "5HT-2 receptor antagonism AND serotonin reuptake inhibition"
    ],
    "correctAnswer": 3,
    "rationale": "SARIs (trazodone): block 5HT-2 receptors AND inhibit serotonin reuptake. Very sedating (often used as sleep aid at low doses). Trazodone risk: priapism in men. Nefazodone: hepatotoxicity risk.",
    "category": "Antidepressants - Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 181,
    "question": "A patient stopped paroxetine abruptly 3 days ago and reports flu-like symptoms, dizziness, and 'electric shock' sensations. The PMHNP recognizes this as SSRI discontinuation syndrome. What causes these symptoms?",
    "options": [
      "Excessive dopamine activity",
      "Norepinephrine surge",
      "GABA receptor downregulation",
      "Sudden decrease in serotonin availability after brain adaptation to higher levels"
    ],
    "correctAnswer": 3,
    "rationale": "SSRI discontinuation = sudden serotonin depletion. Brain adapted to high serotonin levels. Symptoms: insomnia, flu-like feelings, brain zaps. Teach patient: NEVER stop SSRIs abruptly—always taper.",
    "category": "Antidepressants - Adverse Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 182,
    "question": "A patient who was non-compliant with sertraline presents with nausea, dizziness, and brain zaps. She admits she stopped taking her medication 4 days ago. Which additional symptom is characteristic of SSRI discontinuation?",
    "options": [
      "Hypertensive crisis",
      "Flu-like symptoms and sensory disturbances",
      "Generalized seizures",
      "Hyperthermia and muscle rigidity"
    ],
    "correctAnswer": 1,
    "rationale": "SSRI discontinuation symptoms (FINISH): Flu-like, Insomnia, Nausea, Imbalance, Sensory disturbances (brain zaps), Hyperarousal. Usually starts 2-4 days after stopping. Worst with paroxetine (short half-life).",
    "category": "Antidepressants - Adverse Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 183,
    "question": "A patient on SSRIs presents with myalgia, nausea/vomiting, impaired memory, paresthesias, shock-like sensations, irritability, anxiety, insomnia, and crying without provocation. What is the most likely diagnosis?",
    "options": [
      "Serotonin Syndrome",
      "SSRI Discontinuation Syndrome",
      "Neuroleptic Malignant Syndrome",
      "Anticholinergic toxicity"
    ],
    "correctAnswer": 1,
    "rationale": "SSRI DISCONTINUATION SYNDROME: Flu-like symptoms, brain zaps (electric shock sensations), nausea, dizziness, insomnia, irritability, crying spells. Starts 2-4 days after stopping. NOT serotonin syndrome (which has hyperthermia, hyperreflexia). Treatment: Restart SSRI and taper slowly over 2-4 weeks.",
    "category": "Antidepressants - Adverse Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 184,
    "question": "A PMHNP is educating a patient about the importance of tapering SSRIs rather than stopping abruptly. Which factors INCREASE the risk of discontinuation syndrome?",
    "options": [
      "Long half-life medications and gradual taper",
      "Short half-life medications, abrupt discontinuation, high dose, and long-term use",
      "Low doses and short duration of treatment",
      "Use of adjunctive therapy"
    ],
    "correctAnswer": 1,
    "rationale": "High-risk factors: SHORT half-life (paroxetine worst, fluoxetine safest), abrupt stop, high dose, long duration. Fluoxetine rarely causes discontinuation (long half-life, self-tapers). Taper over 2-4 weeks minimum.",
    "category": "Antidepressants - Adverse Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 185,
    "question": "A patient on antidepressants presents with confusion, delirium, agitation, irritability, ataxia, and incoordination. The mnemonic 'PACU PATIENTS' helps identify which syndrome?",
    "options": [
      "SSRI Discontinuation Syndrome",
      "Serotonin Syndrome",
      "Anticholinergic syndrome",
      "Lithium toxicity"
    ],
    "correctAnswer": 1,
    "rationale": "Serotonin Syndrome key features: agitation, confusion, hyperreflexia, tremor, hyperthermia, diaphoresis. Rapid onset (within 24 hours of med change). Medical emergency—stop all serotonergic meds, supportive care.",
    "category": "Serotonin Syndrome",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 186,
    "question": "A patient on fluoxetine and tramadol presents with fever of 104°F, muscle rigidity, autonomic instability, and altered mental status. Which finding indicates SEVERE serotonin syndrome?",
    "options": [
      "Bradycardia and hypothermia",
      "Seizures, respiratory depression, and hyperthermia >104°F",
      "Constipation and urinary retention",
      "Weight loss and fatigue"
    ],
    "correctAnswer": 1,
    "rationale": "Severe serotonin syndrome: high fever (>104°F), seizures, respiratory depression, coma. Can be fatal. ICU admission needed. Cyproheptadine (serotonin antagonist) may help. Prevention > treatment.",
    "category": "Serotonin Syndrome",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 187,
    "question": "A PMHNP is differentiating serotonin syndrome from neuroleptic malignant syndrome in a patient with fever and altered mental status. Which triad of findings is characteristic of serotonin syndrome?",
    "options": [
      "Hyperreflexia/clonus, autonomic instability, and mental status changes",
      "Hyporeflexia, bradycardia, and dry skin",
      "Lead-pipe rigidity, bradykinesia, and mutism",
      "Hypothermia, sedation, and hypotension"
    ],
    "correctAnswer": 0,
    "rationale": "Serotonin syndrome triad: (1) Mental status changes (agitation, confusion), (2) Autonomic instability (tachycardia, diaphoresis, hyperthermia), (3) Neuromuscular hyperactivity (hyperreflexia, clonus, tremor).",
    "category": "Serotonin Syndrome",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 188,
    "question": "A patient with depression asks about taking L-tryptophan supplements to boost her mood. She is currently taking sertraline. What should the PMHNP advise?",
    "options": [
      "L-tryptophan is safe with SSRIs",
      "L-tryptophan is a serotonin precursor and significantly increases serotonin syndrome risk",
      "L-tryptophan only interacts with MAOIs",
      "L-tryptophan has no serotonergic activity"
    ],
    "correctAnswer": 1,
    "rationale": "L-tryptophan is a serotonin precursor—high risk for serotonin syndrome when combined with SSRIs/MAOIs. Other high-risk combinations: SSRI + MAOI, SSRI + linezolid, SSRI + St. John's Wort.",
    "category": "Serotonin Syndrome",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 189,
    "question": "A PMHNP is reviewing a patient's medication list for serotonin syndrome risk. The patient takes sertraline, trazodone, and diphenhydramine. Which medication does NOT contribute to serotonin syndrome risk?",
    "options": [
      "Sertraline (SSRI)",
      "Trazodone (SARI)",
      "Diphenhydramine",
      "All three increase risk equally"
    ],
    "correctAnswer": 2,
    "rationale": "Diphenhydramine (Benadryl) is antihistamine/anticholinergic—NO serotonergic activity, so CANNOT cause serotonin syndrome. Trazodone, buspirone, and cocaine all have serotonergic effects.",
    "category": "Serotonin Syndrome",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 190,
    "question": "A patient on phenelzine (MAOI) requires surgery. The anesthesiologist asks the PMHNP which opioid should be AVOIDED. Which opioid is associated with serotonin syndrome when combined with serotonergic medications?",
    "options": [
      "Morphine",
      "Hydromorphone",
      "Fentanyl",
      "Meperidine (Demerol)"
    ],
    "correctAnswer": 3,
    "rationale": "Meperidine (Demerol) inhibits serotonin reuptake—can cause serotonin syndrome with MAOIs or SSRIs. CONTRAINDICATED with MAOIs. Use morphine or fentanyl instead in patients on serotonergic drugs.",
    "category": "Serotonin Syndrome",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 191,
    "question": "A patient on lithium presents with weight gain and impaired thyroid functioning. What is the most likely thyroid condition?",
    "options": [
      "Hyperthyroidism",
      "Thyroid storm",
      "Thyroiditis",
      "Hypothyroidism"
    ],
    "correctAnswer": 3,
    "rationale": "Lithium causes HYPOTHYROIDISM (up to 20% of patients)—inhibits thyroid hormone release. Monitor TSH every 6 months. Treat with levothyroxine; DON'T stop lithium if it's working. Weight gain is common.",
    "category": "Lithium - Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 192,
    "question": "A patient on lithium for 6 months reports a fine hand tremor that is interfering with her work as a graphic designer. What is the MOST appropriate response?",
    "options": [
      "Discontinue lithium immediately",
      "This indicates lithium toxicity requiring emergent evaluation",
      "Tremor is not associated with lithium therapy",
      "Recognize this as a common side effect; may improve with beta-blocker or dose adjustment"
    ],
    "correctAnswer": 3,
    "rationale": "Lithium CNS effects: fine hand tremor (most common—may improve with beta-blocker), cognitive dulling ('lithium fog'), fatigue, headache. Tremor worsens with higher levels. Dose-related side effects.",
    "category": "Lithium - Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 193,
    "question": "A patient on lithium therapy develops worsening acne and a new psoriasis flare. The dermatologist asks about the medication. What should the PMHNP explain?",
    "options": [
      "These are allergic reactions requiring immediate discontinuation",
      "Lithium does not affect the skin",
      "These indicate Stevens-Johnson syndrome",
      "Acne and psoriasis exacerbation are known dermatological side effects of lithium"
    ],
    "correctAnswer": 3,
    "rationale": "Lithium skin effects: acne, psoriasis exacerbation, maculopapular rash, hair loss. Can worsen existing psoriasis significantly. Dermatology referral if severe. Usually not reason to stop lithium.",
    "category": "Lithium - Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 194,
    "question": "A patient recently started on lithium reports persistent nausea and diarrhea. Her lithium level is 0.9 mEq/L. What is the MOST appropriate intervention?",
    "options": [
      "Discontinue lithium due to toxicity",
      "These symptoms are unrelated to lithium",
      "Increase the dose to achieve better efficacy",
      "Take with food; consider extended-release formulation; GI symptoms common early in treatment"
    ],
    "correctAnswer": 3,
    "rationale": "Lithium GI effects: nausea, diarrhea, stomach cramps, vomiting—especially early in treatment. Taking with food helps. Extended-release formulations reduce GI upset. Severe GI symptoms = check level (toxicity sign).",
    "category": "Lithium - Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 195,
    "question": "A patient on lithium for 3 years reports increased urination and thirst. Labs show lithium level of 0.8 mEq/L and creatinine of 1.0. The PMHNP recognizes these symptoms as:",
    "options": [
      "Nephrogenic diabetes insipidus from lithium-induced renal effects",
      "Signs of acute renal failure",
      "Normal findings requiring no action",
      "Indication for immediate lithium discontinuation"
    ],
    "correctAnswer": 0,
    "rationale": "Lithium renal effects: nephrogenic diabetes insipidus (polyuria/polydipsia—up to 40% of patients), chronic interstitial nephritis with long-term use. Monitor creatinine/BUN every 6 months. Adequate hydration essential.",
    "category": "Lithium - Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 196,
    "question": "A 52-year-old patient on lithium has an EKG showing T-wave flattening. She is asymptomatic. What should the PMHNP understand about this finding?",
    "options": [
      "Benign T-wave changes are common with lithium; usually not clinically significant",
      "This indicates serious cardiotoxicity requiring lithium discontinuation",
      "This is a medical emergency",
      "Lithium does not affect the heart"
    ],
    "correctAnswer": 0,
    "rationale": "Lithium cardiac effects: benign T-wave flattening/inversion (common, usually not clinically significant), rare arrhythmias. Get baseline EKG in patients >40 or with cardiac history. Usually safe for heart.",
    "category": "Lithium - Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 197,
    "question": "A patient on lithium has routine labs showing WBC of 12,000/μL. She is afebrile with no signs of infection. What does the PMHNP understand about this finding?",
    "options": [
      "This indicates serious infection requiring workup",
      "Lithium commonly causes benign leukocytosis",
      "This is a sign of lithium toxicity",
      "Lithium causes neutropenia, not leukocytosis"
    ],
    "correctAnswer": 1,
    "rationale": "Lithium causes LEUKOCYTOSIS (elevated WBC)—benign increase in neutrophils. NOT a sign of infection. Can actually be used therapeutically to raise WBC in clozapine-induced neutropenia.",
    "category": "Lithium - Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 198,
    "question": "A patient presents with depression that began 2 weeks after starting propranolol for hypertension. The PMHNP reviews medications that can cause depression. Which medication classes are known to induce depression?",
    "options": [
      "Beta-blockers, corticosteroids, isotretinoin, and interferon",
      "Antibiotics and antivirals",
      "Antipsychotics cause depression as primary effect",
      "SSRIs and SNRIs"
    ],
    "correctAnswer": 0,
    "rationale": "Medications causing depression (BABI RAPS): Beta-blockers, Accutane (isotretinoin), Benzodiazepines, Interferon, Reserpine, Antineoplastics, Progesterone, Steroids. Screen mood when starting these.",
    "category": "Medications - Psychiatric Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 199,
    "question": "A patient with hepatitis C is referred for psychiatric evaluation after developing depressive symptoms while on interferon therapy. What is the relationship between interferon and depression?",
    "options": [
      "No relationship exists",
      "Interferon only causes anxiety, not depression",
      "Depression only occurs with high-dose interferon",
      "Interferon commonly causes depression in up to 45% of patients"
    ],
    "correctAnswer": 3,
    "rationale": "Interferon commonly causes depression (up to 45% of patients). Consider prophylactic antidepressant before starting interferon. Screen mood regularly during treatment. May need to stop interferon if severe.",
    "category": "Medications - Psychiatric Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 200,
    "question": "A patient is taking interferon and excitalopram, and now complains of depression. As a PMHNP, which medication is the likely cause of her depression?",
    "options": [
      "Excitalopram",
      "Interferon",
      "Both medications equally",
      "Neither medication"
    ],
    "correctAnswer": 1,
    "rationale": "Interferon is the culprit—known to cause depression. Escitalopram treats depression (SSRI). If patient on antidepressant and still depressed, look for depression-causing medications like interferon.",
    "category": "Medications - Psychiatric Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 201,
    "question": "A patient with bipolar disorder presents to the ED in a manic episode. She was started on prednisone 2 weeks ago for asthma exacerbation. The PMHNP recognizes which medications can induce mania?",
    "options": [
      "Beta-blockers and benzodiazepines",
      "Antipsychotics and lithium",
      "Anticholinergics and antihistamines",
      "Steroids, antidepressants, isoniazid (INH), and disulfiram (SAID)"
    ],
    "correctAnswer": 3,
    "rationale": "SAID causes mania: Steroids, Antidepressants, INH (isoniazid), Disulfiram, and certain antibiotics. Antidepressants can flip bipolar patients into mania. Teach patient: Report sudden mood elevation, decreased sleep, racing thoughts. Board tip: Remember 'SAID it causes mania.'",
    "category": "Medications - Psychiatric Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 202,
    "question": "A patient with asthma and bipolar disorder asks if her Flonase nasal spray could affect her mood. What should the PMHNP explain about corticosteroids and mood?",
    "options": [
      "Only injectable steroids affect mood",
      "Corticosteroids",
      "Only testosterone affects mood",
      "Estrogen causes more mood effects than corticosteroids"
    ],
    "correctAnswer": 1,
    "rationale": "Corticosteroids (prednisone, dexamethasone, Flonase) can induce mania by increasing catecholamines. Even inhaled steroids rarely cause mood changes. Teach patient: Report unusual mood elevation or insomnia with steroid use. Taper steroids slowly.",
    "category": "Medications - Psychiatric Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 203,
    "question": "A patient on lithium for bipolar I disorder has blood drawn for routine monitoring. Which serum concentration indicates the patient is within the therapeutic range?",
    "options": [
      "0.6-1.2 mEq/L",
      "0.4-0.8 mEq/L",
      "1.5-2.0 mEq/L",
      "2.0-3.0 mEq/L"
    ],
    "correctAnswer": 0,
    "rationale": "LITHIUM THERAPEUTIC LEVEL: 0.6-1.2 mEq/L for maintenance. Key points: Draw trough level 12 hours post-dose. Acute mania target: 0.8-1.2 mEq/L. Maintenance target: 0.6-1.0 mEq/L (lower for elderly). Toxicity begins >1.5 mEq/L. Monitor every 3-6 months when stable. Factors that increase levels: dehydration, NSAIDs, ACE inhibitors, thiazides.",
    "category": "Mood Stabilizers - Therapeutic Levels",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 204,
    "question": "A patient starting lithium asks about common side effects to expect. Which side effects should the PMHNP discuss?",
    "options": [
      "Hypertension and tachycardia",
      "Nausea, fine hand tremor, increased urination and thirst, and weight gain",
      "Constipation and dry mouth",
      "Weight loss and insomnia"
    ],
    "correctAnswer": 1,
    "rationale": "Lithium common side effects: nausea, fine hand tremor, polyuria (increased urination), polydipsia (increased thirst), weight gain, hypothyroidism, cognitive dulling. Teach patient: Drink 8-10 glasses water daily, maintain consistent salt intake. Tremor may improve with beta-blockers.",
    "category": "Mood Stabilizers - Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 205,
    "question": "A patient on lithium presents with slurred speech, confusion, vomiting, and ataxia. Her lithium level is 2.3 mEq/L. Which symptoms indicate lithium TOXICITY rather than therapeutic side effects?",
    "options": [
      "Mild nausea and slight tremor",
      "Mild hand tremor only",
      "Polyuria and polydipsia",
      "Slurred speech, confusion, severe GI symptoms, and ataxia"
    ],
    "correctAnswer": 3,
    "rationale": "Lithium TOXICITY (>1.5 mEq/L): slurred speech, confusion, ataxia, coarse tremor, severe GI symptoms, cardiac arrhythmias, seizures. STOP lithium immediately. Dialysis for severe toxicity. Teach patient: Vomiting + confusion = ER immediately.",
    "category": "Mood Stabilizers - Toxicity",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 206,
    "question": "A woman with bipolar disorder on lithium discovers she is 6 weeks pregnant. She asks if she can continue lithium. What should the PMHNP explain?",
    "options": [
      "Lithium is safe throughout pregnancy",
      "Lithium poses risk of Ebstein anomaly, especially in first trimester; discuss risks/benefits",
      "Lithium has no fetal effects",
      "Lithium is only dangerous during delivery"
    ],
    "correctAnswer": 1,
    "rationale": "LITHIUM and pregnancy: Category D. First trimester exposure increases risk of EBSTEIN'S ANOMALY (tricuspid valve malformation) from 1/20,000 to 1/1,000. Risk is highest weeks 2-6 of gestation. Management: If possible, taper lithium before conception or during first trimester. If must continue, use lowest effective dose, check levels frequently (q2-4 weeks), obtain fetal echocardiogram at 16-20 weeks. NOT safe in early pregnancy - counsel patient on risks vs benefits of continuing.",
    "category": "Mood Stabilizers - Safety",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 207,
    "question": "A patient on lithium reports that her primary care provider started lisinopril for hypertension and she also takes ibuprofen for arthritis. What effect do NSAIDs and ACE inhibitors have on lithium levels?",
    "options": [
      "Decrease lithium levels significantly",
      "Have no effect on lithium levels",
      "Can approximately DOUBLE lithium levels, increasing toxicity risk",
      "Only affect lithium when taken together"
    ],
    "correctAnswer": 2,
    "rationale": "ACE INHIBITORS + LITHIUM = DANGEROUS interaction. ACE inhibitors decrease renal lithium clearance, can DOUBLE lithium levels causing toxicity. Same risk with ARBs. Other drugs that increase lithium: NSAIDs, thiazide diuretics (not loop diuretics), metronidazole. Drugs that decrease lithium: caffeine, theophylline, acetazolamide. When starting ACE inhibitor in patient on lithium: reduce lithium dose by 25-50%, check level in 5-7 days, monitor for toxicity (tremor, ataxia, confusion, GI symptoms).",
    "category": "Mood Stabilizers - Drug Interactions",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 208,
    "question": "A patient on carbamazepine for bipolar disorder has a level drawn. Which serum concentration indicates the patient is within the therapeutic range?",
    "options": [
      "2-6 mcg/mL",
      "12-20 mcg/mL (high)",
      "6-12 mcg/mL",
      "20-30 mcg/mL"
    ],
    "correctAnswer": 2,
    "rationale": "CARBAMAZEPINE THERAPEUTIC LEVEL: 6-12 mcg/mL. Important considerations: Auto-induction occurs (induces own metabolism) - levels may drop after 2-4 weeks. Check level 2-4 weeks after dose changes. Also monitor: CBC (agranulocytosis, aplastic anemia), LFTs (hepatotoxicity), sodium (SIADH). Drug interactions: potent CYP3A4 inducer reduces levels of many drugs including OCPs.",
    "category": "Mood Stabilizers - Therapeutic Levels",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 209,
    "question": "A patient recently started on carbamazepine reports feeling sedated and dizzy. Which side effects are COMMON with carbamazepine?",
    "options": [
      "Nausea, dizziness, sedation, headache, and ataxia",
      "Weight loss and hyperactivity",
      "Severe hypertension",
      "Constipation only"
    ],
    "correctAnswer": 0,
    "rationale": "CARBAMAZEPINE COMMON SIDE EFFECTS: sedation, dizziness, ataxia, diplopia (double vision), nausea, headache, and blurred vision. These are dose-related and often improve over time. Carbamazepine does NOT cause severe hypertension - it can actually cause SIADH leading to hyponatremia. Serious but rare: agranulocytosis, aplastic anemia, SJS/TEN. Weight loss and hyperactivity are not associated with carbamazepine.",
    "category": "Mood Stabilizers - Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 210,
    "question": "A PMHNP is counseling a patient starting carbamazepine about SERIOUS adverse effects that require immediate medical attention. Which effects should be emphasized?",
    "options": [
      "Mild sedation requiring activity adjustment",
      "Weight gain and appetite changes",
      "Agranulocytosis, aplastic anemia, and Stevens-Johnson syndrome",
      "Mild tremor"
    ],
    "correctAnswer": 2,
    "rationale": "Carbamazepine SERIOUS effects: Agranulocytosis (low WBC), aplastic anemia, Stevens-Johnson syndrome (severe skin reaction). Get baseline CBC, repeat at 2 weeks. Teach patient: Fever + sore throat + rash = stop med and call immediately.",
    "category": "Mood Stabilizers - Serious Adverse Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 211,
    "question": "A woman on carbamazepine for bipolar disorder asks about pregnancy risks. She also takes oral contraceptives. What is MOST important to discuss?",
    "options": [
      "Carbamazepine is safe during pregnancy",
      "Carbamazepine is a CYP inducer; reduces contraceptive efficacy and has teratogenic risk",
      "Carbamazepine has no drug interactions",
      "Carbamazepine enhances contraceptive efficacy"
    ],
    "correctAnswer": 2,
    "rationale": "Carbamazepine = potent CYP3A4 INDUCER. PHARMACOKINETICS: Inducers SPEED UP metabolism → LOWER drug levels → treatment failure. Affects: OCPs (pregnancy!), warfarin, anticonvulsants, antipsychotics. 'PC BRAS' = Phenytoin, Carbamazepine, Barbiturates, Rifampin, Alcohol, St. John's Wort.",
    "category": "Mood Stabilizers - Safety",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 212,
    "question": "A PMHNP is initiating carbamazepine in a patient of Korean descent. What screening is REQUIRED before starting this medication?",
    "options": [
      "CBC with differential only",
      "HLA-B*1502 allele screening",
      "Thyroid function tests only",
      "Liver function tests only"
    ],
    "correctAnswer": 1,
    "rationale": "HLA-B*1502 screening REQUIRED before carbamazepine in Asian patients (FDA Black Box Warning). This allele increases Stevens-Johnson syndrome risk 10-fold. Test once before any carbamazepine use. If positive, do NOT use carbamazepine or oxcarbazepine.",
    "category": "Mood Stabilizers - Screening",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 213,
    "question": "A PMHNP is selecting a mood stabilizer for a patient with rapid cycling bipolar disorder. Which statement about VALPROATE (Depakote) is TRUE?",
    "options": [
      "Valproate is MORE effective than lithium for rapid cycling",
      "Valproate is FDA-approved for schizophrenia",
      "Valproate is contraindicated in rapid cycling",
      "Valproate has no effect on mania"
    ],
    "correctAnswer": 0,
    "rationale": "VALPROATE (Depakote) is MORE effective than lithium for RAPID CYCLING bipolar (≥4 episodes/year). Also effective for mixed episodes. Lithium works best for classic euphoric mania. Therapeutic level: 50-125 mcg/mL. Monitor: LFTs, CBC, platelets. Teratogenic - avoid in pregnancy.",
    "category": "Mood Stabilizers - Indications",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 214,
    "question": "A patient on valproic acid for bipolar disorder has a level drawn. Which serum concentration indicates the patient is within the therapeutic range?",
    "options": [
      "25-75 mcg/mL",
      "50-125 mcg/mL",
      "100-200 mcg/mL (high)",
      "150-250 mcg/mL"
    ],
    "correctAnswer": 1,
    "rationale": "VALPROATE THERAPEUTIC LEVEL: 50-125 mcg/mL. Higher levels (85-125) for acute mania, lower (50-100) for maintenance. Draw trough level. Monitor: LFTs (hepatotoxicity - highest risk in children <2), CBC with platelets (thrombocytopenia), ammonia if confusion occurs. Black box warnings: hepatotoxicity, pancreatitis, teratogenicity. Common side effects: weight gain, tremor, hair loss.",
    "category": "Mood Stabilizers - Therapeutic Levels",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 215,
    "question": "A patient on valproic acid reports nausea, hair thinning, and has gained 15 pounds since starting the medication. Which side effects are COMMON with valproate?",
    "options": [
      "Nausea, weight gain, tremor, and alopecia (hair loss)",
      "Constipation and dry mouth",
      "Hypertension and tachycardia",
      "Weight loss and insomnia"
    ],
    "correctAnswer": 0,
    "rationale": "Valproate side effects: nausea, diarrhea, abdominal cramps, sedation, tremor, weight GAIN, alopecia (hair loss). Teach patient: Hair usually regrows. Take with food to reduce GI upset. Monitor weight.",
    "category": "Mood Stabilizers - Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 216,
    "question": "A PMHNP is counseling a patient starting valproic acid about SERIOUS adverse effects requiring immediate attention. Which effects should be emphasized?",
    "options": [
      "Mild sedation",
      "Mild tremor",
      "Appetite changes",
      "Hepatotoxicity, pancreatitis, thrombocytopenia, and Stevens-Johnson syndrome"
    ],
    "correctAnswer": 3,
    "rationale": "Valproate SERIOUS effects: hepatotoxicity (elevated LFTs), pancreatitis, Stevens-Johnson syndrome, thrombocytopenia. Highest liver risk in children <2 years and polypharmacy. Teach patient: Report abdominal pain, jaundice, unusual bleeding.",
    "category": "Mood Stabilizers - Serious Adverse Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 217,
    "question": "A patient presents in acute mania and the PMHNP decides to use valproic acid with a loading dose for rapid control. What is the appropriate loading dose?",
    "options": [
      "10 mg/kg",
      "20 mg/kg",
      "30 mg/kg",
      "40 mg/kg"
    ],
    "correctAnswer": 1,
    "rationale": "VALPROATE LOADING DOSE: 20 mg/kg for acute mania or status epilepticus. Allows rapid achievement of therapeutic levels within 24-48 hours. Can divide into 2-3 doses. Maximum daily dose generally 60 mg/kg/day. Alternative: 20-30 mg/kg/day divided. Check level after 2-3 days. GI side effects common with loading - consider IV route if severe.",
    "category": "Mood Stabilizers - Dosing",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 218,
    "question": "A PMHNP is using the SLUMS (St. Louis University Mental Status) exam to screen an educated patient for cognitive impairment. Which score range indicates dementia?",
    "options": [
      "27-30",
      "1-20",
      "Only scores below 10",
      "21-26 (MCI)"
    ],
    "correctAnswer": 3,
    "rationale": "SLUMS (St. Louis University Mental Status) scoring: 27-30 = normal, 21-26 = Mild Cognitive Impairment (MCI), <21 = dementia (for high school educated). For less than high school: 25-30 = normal, 20-24 = MCI, <20 = dementia. SLUMS is MORE SENSITIVE than MMSE for MCI detection. Tests visuospatial, memory, calculation, and executive function.",
    "category": "Mental Status Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 219,
    "question": "A 75-year-old patient is administered the MMSE as part of a dementia workup. She scores 21. What does this score indicate?",
    "options": [
      "Severe cognitive impairment (0-9)",
      "Moderate cognitive impairment (10-17)",
      "Mild cognitive impairment (18-23)",
      "Normal cognition (24-30)"
    ],
    "correctAnswer": 2,
    "rationale": "MMSE (0-30): 24-30=normal, 18-23=mild, 10-17=moderate, <10=severe. WHY MoCA OVER MMSE: (1) MoCA detects MCI missed by MMSE, (2) tests executive function better, (3) no ceiling effect in educated patients. MoCA cutoff: ≥26 normal, add 1 point if ≤12 years education.",
    "category": "Mental Status Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 220,
    "question": "A PMHNP administers the HAM-D to a patient being treated for depression. The score is 16. What severity level does this indicate?",
    "options": [
      "Normal/remission (0-7)",
      "Mild depression (8-13)",
      "Moderate depression (14-18)",
      "Severe depression (19+)"
    ],
    "correctAnswer": 2,
    "rationale": "HAM-D 17-item (0-52): 0-7=normal/remission, 8-13=mild, 14-18=moderate, 19-22=severe, ≥23=very severe. Treatment response: ≥50% score reduction. Remission: score ≤7.",
    "category": "Depression Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 221,
    "question": "A patient completes the PHQ-9 during a follow-up visit and scores 12. What severity level does this indicate?",
    "options": [
      "Minimal depression (0-4)",
      "Mild depression (5-9)",
      "Moderate depression (10-14)",
      "Moderately severe depression (15-19)"
    ],
    "correctAnswer": 2,
    "rationale": "PHQ-9 (0-27): 0-4=minimal, 5-9=mild, 10-14=moderate, 15-19=moderately severe, 20-27=severe. Screen at ≥10. Question 9=suicidal ideation. Self-report, 9 items.",
    "category": "Depression Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 222,
    "question": "A PMHNP uses the Beck Depression Inventory-II (BDI-II) to assess a patient. The score is 24. What severity level does this indicate?",
    "options": [
      "Minimal depression (0-13)",
      "Mild depression (14-19)",
      "Moderate depression (20-28)",
      "Severe depression (29-63)"
    ],
    "correctAnswer": 2,
    "rationale": "BDI-II (0-63): 0-13=minimal, 14-19=mild, 20-28=moderate, 29-63=severe. Self-report. Distinguish from HAM-D (clinician-administered). 21 items scored 0-3 each.",
    "category": "Depression Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 223,
    "question": "A PMHNP administers the HAM-A to monitor a patient's anxiety treatment response. The score is 20. What severity level does this indicate?",
    "options": [
      "Minimal anxiety (<14)",
      "Mild anxiety (14-17)",
      "Moderate anxiety (18-24)",
      "Severe anxiety (≥25)"
    ],
    "correctAnswer": 2,
    "rationale": "HAM-A (0-56): <17=mild, 18-24=moderate, ≥25=severe. Clinician-rated. 14 items (psychic + somatic). Used to monitor anxiety treatment response.",
    "category": "Anxiety Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 224,
    "question": "A patient completes the GAD-7 and scores 11. What severity level and clinical action does this indicate?",
    "options": [
      "Minimal anxiety (0-4); monitoring only",
      "Mild anxiety (5-9); watchful waiting",
      "Moderate anxiety (10-14); treatment indicated",
      "Severe anxiety (15-21); urgent intervention"
    ],
    "correctAnswer": 2,
    "rationale": "GAD-7 (0-21): 0-4=minimal, 5-9=mild, 10-14=moderate, 15-21=severe. Self-report. Treatment threshold: ≥10. High sensitivity/specificity for generalized anxiety disorder.",
    "category": "Anxiety Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 225,
    "question": "A patient with opioid use disorder presents to the ED requesting treatment. The COWS score is 15. What is the appropriate clinical action?",
    "options": [
      "Score too low; no treatment indicated (0-4)",
      "Mild withdrawal; symptomatic treatment only (5-12)",
      "Moderate withdrawal; buprenorphine or methadone initiation appropriate (≥13)",
      "Only treat when score exceeds 25"
    ],
    "correctAnswer": 2,
    "rationale": "COWS (0-48): INTOXICATION vs WITHDRAWAL SIGNS: OPIOIDS—Intox: MIOSIS (pinpoint pupils), bradycardia, respiratory depression, sedation. Withdrawal: MYDRIASIS (dilated pupils), tachycardia, diarrhea, yawning, piloerection. STIMULANTS—Intox: mydriasis, tachycardia, hypertension, hyperthermia, agitation. Withdrawal: fatigue, hypersomnia, depression, increased appetite.",
    "category": "Substance Use Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 226,
    "question": "A patient with alcohol use disorder is being monitored with the CIWA-Ar. The score is 18. What severity level and treatment is indicated?",
    "options": [
      "Minimal withdrawal (0-9); no pharmacological treatment",
      "Mild withdrawal (10-15); PRN benzodiazepines",
      "Moderate-severe withdrawal (16-20); scheduled benzodiazepines with close monitoring",
      "Only treat at scores above 25"
    ],
    "correctAnswer": 2,
    "rationale": "CIWA-Ar: ALCOHOL INTOX vs WITHDRAWAL: INTOXICATION: slurred speech, ataxia, sedation, disinhibition, nystagmus. WITHDRAWAL: tremor, anxiety, tachycardia, hypertension, diaphoresis, seizures (24-48hr), DTs (48-96hr with hallucinations). STIMULANT COMPARISON—Intox: euphoria, tachycardia, dilated pupils. Withdrawal: crash, depression, hypersomnia.",
    "category": "Substance Use Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 227,
    "question": "A 45-year-old patient presents with red-colored urine and muscle aches after starting aggressive workouts. He also has hematuria. What is the most concerning diagnosis?",
    "options": [
      "Urinary tract infection",
      "Rhabdomyolysis with muscle breakdown",
      "Bladder cancer",
      "Kidney stones"
    ],
    "correctAnswer": 1,
    "rationale": "Rhabdomyolysis: muscle breakdown → myoglobin in urine (dark red/cola-colored). Risk: intense exercise, statins, trauma, drugs. Labs: elevated CK, myoglobinuria. Teach patient: Stay hydrated during workouts. Can cause acute kidney injury.",
    "category": "Medical Complications",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 228,
    "question": "A patient with depression has failed to respond to three adequate trials of different SSRIs. The PMHNP considers treatment-resistant depression strategies. What is the appropriate next step?",
    "options": [
      "Try a fourth SSRI at higher doses",
      "Augment with lithium or atypical antipsychotic, or consider TMS/ECT/ketamine",
      "Continue the same SSRI indefinitely",
      "Discontinue all treatment"
    ],
    "correctAnswer": 0,
    "rationale": "Treatment-resistant depression: after 3 adequate SSRI trials fail, augment with lithium, atypical antipsychotic, or switch to different class. Consider TMS, ECT, or ketamine/esketamine. Avoid continuing same class that failed.",
    "category": "Treatment Guidelines",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 229,
    "question": "A PMHNP is assessing functional status in a 78-year-old patient with memory complaints. The family reports she can no longer manage her checkbook. What is the significance of this finding?",
    "options": [
      "Not clinically significant",
      "IADLs are most sensitive indicator of cognitive decline",
      "Only ADL impairment is clinically significant",
      "Financial management is not part of functional assessment"
    ],
    "correctAnswer": 1,
    "rationale": "IADL (Instrumental Activities of Daily Living) impairment is HIGHLY CLINICALLY SIGNIFICANT. Managing finances/checkbook is often the FIRST IADL affected in cognitive decline - it's the most sensitive indicator. IADLs (finances, medications, shopping, cooking, transportation) are affected BEFORE ADLs (bathing, dressing, toileting). A 78-year-old who can no longer manage her checkbook requires further cognitive evaluation. This is NOT normal aging.",
    "category": "Geriatric Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 230,
    "question": "A 5-year-old boy with autism spectrum disorder does not respond to verbal instructions from the PMHNP. How should this behavior be interpreted?",
    "options": [
      "The child is being oppositionally defiant",
      "Poor response to verbal commands is characteristic of autism, not defiance",
      "This indicates hearing impairment requiring audiology referral",
      "This suggests regression from previous abilities"
    ],
    "correctAnswer": 1,
    "rationale": "AUTISM SPECTRUM: Poor response to verbal commands is characteristic—not defiance. Core: social communication deficits, restricted/repetitive behaviors. GENETIC LINKS: Fragile X (most common inherited cause), 22q11.2 deletion, tuberous sclerosis. PMHNP role: Manage irritability (risperidone, aripiprazole FDA-approved), anxiety, sleep. Visual supports help.",
    "category": "Autism Spectrum Disorder",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 231,
    "question": "A PMHNP is asked to testify before the state legislature about barriers to mental health care access. What is the PRIMARY role of NPs in politics?",
    "options": [
      "Advocacy using evidence-based knowledge to influence health policy",
      "Fundraising for political candidates",
      "Campaign management",
      "Political party leadership"
    ],
    "correctAnswer": 0,
    "rationale": "NP in politics: primary role is ADVOCATE. Use evidence-based knowledge to influence health policy. Advocacy includes education, testifying, lobbying, coalition building. Professional obligation to advocate for patients and profession.",
    "category": "Professional Practice",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 232,
    "question": "An NP is working in a community health center and is also on the board of an organization that wants to put a clinic in the same area. What is the appropriate action?",
    "options": [
      "Abstain from voting, conflict of interest",
      "Continue in both roles",
      "Resign from the board",
      "Disclose but vote anyway"
    ],
    "correctAnswer": 0,
    "rationale": "Conflict of interest: abstain from voting when personal interests may influence decision. Disclose relationships, recuse from relevant decisions. Maintain objectivity and public trust. Board tip: Abstain + disclose = ethical response.",
    "category": "Professional Ethics",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 233,
    "question": "A patient on olanzapine has gained 25 pounds over 6 months. The PMHNP measures waist circumference as part of metabolic screening. What is the FIRST indicator of metabolic syndrome?",
    "options": [
      "Elevated blood pressure",
      "Elevated fasting glucose",
      "Abnormal lipid panel",
      "Increased waist circumference (central obesity)"
    ],
    "correctAnswer": 3,
    "rationale": "Metabolic syndrome: waist circumference is FIRST indicator (central obesity). Criteria: waist >40\" men/>35\" women, triglycerides ≥150, HDL <40 men/<50 women, BP ≥130/85, fasting glucose ≥100. Monitor with antipsychotics.",
    "category": "Metabolic Syndrome",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 234,
    "question": "A patient on carbamazepine is prescribed ciprofloxacin for a urinary tract infection. What effect will this interaction have?",
    "options": [
      "Decreased carbamazepine levels",
      "No interaction expected",
      "Only affects antibiotic levels",
      "Significantly INCREASED carbamazepine levels due to CYP3A4 inhibition"
    ],
    "correctAnswer": 3,
    "rationale": "CYP3A4 is MOST COMMON CYP—metabolizes ~50% of drugs. HIGH-YIELD INHIBITORS: azole antifungals, macrolide antibiotics (erythro, clarithro), grapefruit, HIV protease inhibitors. INDUCERS: carbamazepine, phenytoin, rifampin, St. John's Wort. 3A4 = 'the big one.'",
    "category": "Drug Interactions",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 235,
    "question": "A patient presents with fever, severe headache, and stiff neck. On exam, passive neck flexion is limited by involuntary muscle spasms. What condition does nuchal rigidity indicate?",
    "options": [
      "Tension headache",
      "Meningitis",
      "Migraine with aura",
      "Cervical strain"
    ],
    "correctAnswer": 1,
    "rationale": "Nuchal rigidity: meningitis sign—stiff neck, resistance to flexion. Other meningeal signs: Kernig (knee extension pain), Brudzinski (hip flexion with neck flexion). Medical emergency. Lumbar puncture to confirm. Teach: Fever + headache + stiff neck = ER.",
    "category": "Neurological Signs",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 236,
    "question": "A patient with heart failure is started on lisinopril. The PMHNP notes that ACE inhibitors can interact with lithium. What is the PRIMARY indication for ACE inhibitors?",
    "options": [
      "Diabetes management",
      "Hyperlipidemia",
      "Cardiac arrhythmias",
      "Heart failure and hypertension"
    ],
    "correctAnswer": 3,
    "rationale": "ACE inhibitors (lisinopril, enalapril): primary use = heart failure. Also hypertension, diabetic nephropathy. Block angiotensin II → reduce afterload. Side effects: dry cough, hyperkalemia, angioedema. Contraindicated in pregnancy.",
    "category": "Cardiovascular Medications",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 237,
    "question": "A PMHNP is teaching nursing students about serotonin syndrome. Which finding is NOT consistent with serotonin syndrome?",
    "options": [
      "Autonomic instability with tachycardia and hyperthermia",
      "Hyperreflexia, myoclonus, and agitation",
      "Bradycardia and hypothermia",
      "Occurs with SSRI + tramadol or SSRI + St. John's Wort combinations"
    ],
    "correctAnswer": 2,
    "rationale": "Serotonin syndrome does NOT cause bradycardia or hypothermia—causes TACHYcardia and HYPERthermia. Symptoms: agitation, hyperreflexia, tremor, diaphoresis, dilated pupils, diarrhea, clonus. Treatment: cyproheptadine, cooling, stop offending agents.",
    "category": "Serotonin Syndrome",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 238,
    "question": "A patient has a Grade II/V harsh systolic heart murmur. What is the most likely diagnosis?",
    "options": [
      "Mitral stenosis",
      "Tricuspid regurgitation",
      "Pulmonary stenosis",
      "Aortic stenosis (MR ASS, MS ARD)"
    ],
    "correctAnswer": 3,
    "rationale": "Harsh systolic murmur: aortic stenosis. Mnemonic 'MR ASS, MS ARD': Mitral Regurgitation/Aortic Stenosis = Systolic; Mitral Stenosis/Aortic Regurgitation = Diastolic. Grade II/VI = moderate. Crescendo-decrescendo pattern.",
    "category": "Cardiac Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 239,
    "question": "A woman with generalized anxiety disorder tells you she is pregnant and takes Buspar and Klonopin. What should you tell her?",
    "options": [
      "Continue both medications",
      "Stop both medications immediately",
      "Stop Klonopin and continue Buspar",
      "Increase Buspar dose"
    ],
    "correctAnswer": 2,
    "rationale": "Pregnancy + GAD: stop Klonopin (benzodiazepine = Category D, teratogenic), continue Buspar (buspirone = safer, Category B). Benzos cause fetal cleft palate, floppy infant syndrome. Teach patient: Taper benzos before conceiving.",
    "category": "Pregnancy and Medications",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 240,
    "question": "A patient on an inpatient unit is aggressive and has tried to hit staff. Despite seclusion and Ativan 2mg IM, there is no improvement. To shorten time in seclusion, what should be given?",
    "options": [
      "Another dose of Ativan",
      "Geodon IM",
      "Haldol PO",
      "Lithium"
    ],
    "correctAnswer": 1,
    "rationale": "Acute agitation not responding to benzodiazepine: add IM Geodon (ziprasidone) for rapid tranquilization. Also consider IM Zyprexa (olanzapine) or IM Haldol. Goal: minimize seclusion/restraint time. Monitor QTc with Geodon.",
    "category": "Acute Agitation Management",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 241,
    "question": "What is the most concerning diagnosis for an adolescent male with substance abuse history who has been working out and now presents with muscle ache and red-colored urine with hematuria?",
    "options": [
      "Urinary tract infection",
      "Dehydration",
      "Kidney infection",
      "Rhabdomyolysis - muscle breakdown"
    ],
    "correctAnswer": 3,
    "rationale": "Rhabdomyolysis in adolescent: suspect substance use (cocaine, amphetamines) plus intense exercise. Cola-colored urine = myoglobinuria. Check CK (often >10,000), creatinine, electrolytes. IV fluids critical to prevent kidney failure.",
    "category": "Medical Complications",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 242,
    "question": "What is the appropriate response when a patient confides in you that since she was born she saw herself as opposite sex?",
    "options": [
      "Refer to psychiatry immediately",
      "Tell the parents immediately",
      "Start hormone therapy",
      "Patient privacy and parents right to know"
    ],
    "correctAnswer": 3,
    "rationale": "Gender identity disclosure: balance patient privacy with parents' right to know. Assess safety—is patient at risk if parents know? Use developmentally appropriate approach. Support patient autonomy while maintaining therapeutic relationship.",
    "category": "Gender Identity and Ethics",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 243,
    "question": "A patient on lithium for 2 years has routine labs. The urinalysis shows protein in the urine. What does this finding indicate?",
    "options": [
      "Normal finding unrelated to lithium",
      "Lithium-induced nephropathy requiring close monitoring",
      "Sign of lithium toxicity",
      "Indication to increase lithium dose"
    ],
    "correctAnswer": 1,
    "rationale": "Lithium renal monitoring: proteinuria (protein in urine) indicates nephropathy. Monitor BUN, creatinine, urinalysis every 6 months. Lithium causes nephrogenic diabetes insipidus (polyuria) and chronic kidney disease with long-term use.",
    "category": "Lithium Monitoring",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 244,
    "question": "A PMHNP is selecting an antidepressant for an 80-year-old patient with depression. The patient asks why amitriptyline is not appropriate. What is the PRIMARY concern?",
    "options": [
      "Ineffective in elderly patients",
      "Strong anticholinergic effects causing constipation, urinary retention, confusion, and falls",
      "Causes diarrhea",
      "Leads to weight loss"
    ],
    "correctAnswer": 1,
    "rationale": "Amitriptyline (TCA) in elderly: AVOID per Beers Criteria. Strong anticholinergic effects: constipation, urinary retention, dry mouth, confusion, falls. Safer alternatives: SSRIs, SNRIs. Teach patient: Report constipation, confusion.",
    "category": "Geriatric Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 245,
    "question": "A patient on multiple medications asks about drug interactions with his ranitidine (Zantac). The PMHNP considers which H2 blocker has the MOST significant drug interactions?",
    "options": [
      "Ranitidine has the most interactions",
      "Cimetidine (Tagamet) is a potent CYP inhibitor with many drug interactions",
      "Famotidine has the most interactions",
      "All H2 blockers have equal interactions"
    ],
    "correctAnswer": 1,
    "rationale": "Cimetidine = potent CYP INHIBITOR (multiple CYPs: 3A4, 2D6, 1A2). Causes MANY drug interactions. Famotidine/ranitidine have FEWER interactions. Board tip: If asked 'which H2 blocker has most interactions?' = cimetidine. Inhibitor = levels go UP.",
    "category": "Gastrointestinal Medications",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 246,
    "question": "A patient with allergies asks the PMHNP about the difference between first-generation and second-generation antihistamines. Which statement is accurate?",
    "options": [
      "First-generation (diphenhydramine) are preferred due to fewer side effects",
      "Both generations are equally sedating",
      "Second-generation have more anticholinergic effects",
      "Second-generation antihistamines"
    ],
    "correctAnswer": 3,
    "rationale": "Antihistamines for allergies: H1 blockers. First-gen (diphenhydramine) = sedating, anticholinergic. Second-gen (loratadine, cetirizine) = less sedating, preferred. Don't confuse with H2 blockers (for stomach acid).",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 247,
    "question": "A patient with borderline personality disorder presents with chronic emptiness, unstable relationships, and recurrent self-harm. The PMHNP is selecting a primary treatment approach. What is the evidence-based first-line therapy for BPD?",
    "options": [
      "Dialectical Behavior Therapy (DBT)",
      "Cognitive Behavioral Therapy (CBT)",
      "Psychoanalysis",
      "Supportive therapy alone"
    ],
    "correctAnswer": 0,
    "rationale": "PERSONALITY DISORDER TREATMENT: NO FDA-approved medications for any PD. Meds target SYMPTOMS: SSRIs (depression, anxiety, impulsivity), mood stabilizers (impulsivity, aggression), low-dose antipsychotics (psychotic-like symptoms, dissociation). AVOID BENZOS in Cluster B (disinhibition). Therapy is primary treatment.",
    "category": "Psychotherapy",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 248,
    "question": "A 7-year-old with Oppositional Defiant Disorder is referred for treatment. The parents ask how to prevent progression to conduct disorder and antisocial personality disorder. What is the MOST effective intervention?",
    "options": [
      "Medication management alone",
      "Psychiatric hospitalization",
      "Parent management training combined with behavioral therapy",
      "School intervention only"
    ],
    "correctAnswer": 2,
    "rationale": "ODD→CONDUCT DISORDER PREVENTION: PARENT MANAGEMENT TRAINING (PMT) + BEHAVIOR THERAPY. Evidence-based. ODD vs DMDD: ODD=defiance/vindictiveness, DMDD=severe irritability. ODD vs CD: ODD=angry/defiant, CD=aggression/destruction/deceit/rule violations. 30% ODD progresses to CD without intervention. Early intervention CRITICAL.",
    "category": "Child Psychiatry",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 249,
    "question": "A patient with bipolar I disorder asks about the risk of her children developing bipolar disorder. What genetic risk information should the PMHNP provide?",
    "options": [
      "Children have 2 times the risk of general population",
      "No increased genetic risk",
      "Children have 4 times the risk of general population",
      "Children have 10 times the risk"
    ],
    "correctAnswer": 2,
    "rationale": "Bipolar genetic risk: children of bipolar parent have 4x higher risk. First-degree relatives: 10-15% risk vs 1-2% general population. Stronger genetic link in Bipolar I than Bipolar II. Monitor children for mood symptoms.",
    "category": "Genetics",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 250,
    "question": "A PMHNP is evaluating a 75-year-old patient presenting with fatigue and depressed mood. Before diagnosing a psychiatric disorder, which laboratory tests should be ordered?",
    "options": [
      "Complete blood count only",
      "Fasting glucose, thyroid panel, and calculated BMI",
      "Liver function tests only",
      "Lipid panel only"
    ],
    "correctAnswer": 1,
    "rationale": "Elderly metabolic workup: fasting glucose (diabetes screening), thyroid panel (hypothyroidism common), BMI calculation. Rule out medical causes of psychiatric symptoms. Also consider B12, folate, vitamin D.",
    "category": "Geriatric Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 251,
    "question": "A 55-year-old man with depression and erectile dysfunction is being evaluated. His primary care provider prescribed a PDE5 inhibitor. Which medication characteristic should the PMHNP understand?",
    "options": [
      "Tadalafil (Cialis) is slow-acting (36 hours); sildenafil (Viagra) is faster (4-6 hours)",
      "Testosterone supplementation",
      "Blood glucose effect",
      "Thyroid function interaction"
    ],
    "correctAnswer": 0,
    "rationale": "Erectile dysfunction workup: assess for Cialis (tadalafil) appropriateness. PDE5 inhibitors: Cialis = slow acting (36 hrs), Viagra = faster (4-6 hrs). Contraindicated with nitrates. Assess cardiovascular status before prescribing.",
    "category": "Sexual Dysfunction",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 252,
    "question": "During a neurological examination, a PMHNP asks the patient to smile and raise his eyebrows. Which cranial nerve is being assessed?",
    "options": [
      "Cranial nerve VII",
      "Cranial nerve V (Trigeminal)",
      "Cranial nerve IX",
      "Cranial nerve X (Vagus)"
    ],
    "correctAnswer": 0,
    "rationale": "CN VII (Facial nerve): controls facial expressions—frowning, smiling, eye closure. Test by asking patient to smile, raise eyebrows, puff cheeks. Bell's palsy = CN VII paralysis. Mnemonic: 'Seven makes you look like heaven' (facial expressions).",
    "category": "Neurological Examination",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 253,
    "question": "A PMHNP asks a patient to clench his jaw while palpating the temporal muscle. Which cranial nerve is being assessed?",
    "options": [
      "Cranial nerve III (Oculomotor)",
      "Cranial nerve VII",
      "Cranial nerve V (Trigeminal)",
      "Cranial nerve XI (Accessory)"
    ],
    "correctAnswer": 2,
    "rationale": "CN V (Trigeminal): motor function to muscles of mastication (temporal, masseter, pterygoids). Test by palpating temporal muscle during jaw clench. Also provides facial sensation. Board tip: V = chewing; VII = expressions.",
    "category": "Neurological Examination",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 254,
    "question": "A 17-year-old patient is taking isotretinoin (Accutane) for severe acne. The dermatologist refers to psychiatry. What psychiatric side effect is the PMHNP monitoring for?",
    "options": [
      "Depression",
      "Hypertension",
      "Diabetes",
      "Seizures"
    ],
    "correctAnswer": 0,
    "rationale": "Accutane (isotretinoin) causes DEPRESSION—FDA Black Box Warning. Must use iPLEDGE program. Also teratogenic (pregnancy test required). Teach patient: Report mood changes, suicidal thoughts. Monitor mood throughout treatment.",
    "category": "Medication Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 255,
    "question": "A PMHNP is assessing a 1-month-old infant for developmental milestones and primitive reflexes. Which reflex should be PRESENT at this age?",
    "options": [
      "Babinski reflex only",
      "Moro reflex",
      "Stepping reflex only",
      "No primitive reflexes expected"
    ],
    "correctAnswer": 1,
    "rationale": "MORO REFLEX: Present birth to 4-6 months. Persistence beyond 6 months = neurological concern. PMHNP should know: Primitive reflex retention seen in cerebral palsy, genetic syndromes. Refer for neurology workup. Early intervention referral if developmental delays noted.",
    "category": "Pediatric Development",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 256,
    "question": "During a developmental assessment of a 1-month-old infant, the PMHNP evaluates motor skills. Which motor ability is expected at this age?",
    "options": [
      "Palmar grasp and brief head lifting",
      "Rolling over",
      "Sitting unsupported",
      "Crawling"
    ],
    "correctAnswer": 0,
    "rationale": "1-MONTH MOTOR: Palmar grasp, follows to midline, lifts head briefly. SYNDROME RED FLAGS at any age: Hypotonia (Down, Prader-Willi), hypertonia (CP), absent reflexes. Down syndrome: hypotonia, flat facies, single palmar crease, cognitive impairment, high Alzheimer's risk by age 40.",
    "category": "Pediatric Development",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 257,
    "question": "A family has adopted a 2-year-old child diagnosed with fetal alcohol spectrum disorder (FASD). They ask about services and treatment. What should the PMHNP recommend?",
    "options": [
      "Regular pediatric follow-up only",
      "No special services needed",
      "Speech therapy only",
      "Early intervention services for developmental support"
    ],
    "correctAnswer": 3,
    "rationale": "FETAL ALCOHOL SYNDROME (FASD): Refer to Early Intervention (birth-3 yrs). PMHNP role: Manage ADHD (common), behavioral dysregulation, learning disabilities, impulsivity. Stimulants often needed. Parent training essential. No safe alcohol amount in pregnancy. Lifelong condition requiring ongoing support.",
    "category": "Fetal Alcohol Syndrome",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 258,
    "question": "A PMHNP is evaluating a child referred for developmental delays and behavioral problems. The chart notes prenatal alcohol exposure. Which facial features are characteristic of fetal alcohol syndrome?",
    "options": [
      "Microcephaly, thin upper lip, smooth philtrum, and short palpebral fissures",
      "Large head, thick upper lip, and wide-set eyes",
      "Macrocephaly and obesity",
      "Normal facial features with cognitive impairment only"
    ],
    "correctAnswer": 0,
    "rationale": "FAS FACIAL FEATURES: Microcephaly, thin upper lip, smooth philtrum, short palpebral fissures, flat midface. PMHNP considerations: High rates of ADHD (60-95%), mood disorders, anxiety. Executive function deficits persist into adulthood. Avoid blame—focus on support. Structured environment helps.",
    "category": "Fetal Alcohol Syndrome",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 259,
    "question": "A patient on haloperidol develops dystonia and akathisia. The PMHNP is concerned about long-term risks. Untreated extrapyramidal symptoms (EPS) can progress to which condition?",
    "options": [
      "Neuroleptic Malignant Syndrome",
      "Serotonin Syndrome",
      "Malignant hyperthermia",
      "Tardive dyskinesia"
    ],
    "correctAnswer": 3,
    "rationale": "TARDIVE DYSKINESIA (TD) is the concern after dystonia and akathisia with antipsychotic use. TD develops after months-years of D2 blockade (unlike acute dystonia/akathisia which occur early). Presents as involuntary choreoathetoid movements of face, tongue, jaw, trunk, extremities. Risk factors: older age, female, longer duration, higher doses, first-gen antipsychotics. May be irreversible - monitor with AIMS scale.",
    "category": "Antipsychotic Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 260,
    "question": "A PMHNP is educating a nursing student about extrapyramidal symptoms. Which finding is NOT classified as EPS?",
    "options": [
      "Akathisia",
      "Akinesia",
      "Hypothermia and bradycardia",
      "Dystonia and pseudoparkinsonism"
    ],
    "correctAnswer": 2,
    "rationale": "EXTRAPYRAMIDAL SYMPTOMS (EPS) do NOT include hypothermia and bradycardia. EPS include: (1) Acute dystonia (hours-days): muscle spasms, oculogyric crisis, (2) Akathisia (days-weeks): restlessness, (3) Parkinsonism (weeks): bradykinesia, rigidity, tremor, (4) Tardive dyskinesia (months-years): involuntary movements. Hypothermia/bradycardia suggest other conditions like NMS (which has HYPERthermia) or overdose.",
    "category": "Antipsychotic Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 261,
    "question": "A 45-year-old HIV-positive patient with a CD4 count of 150 presents with progressive memory problems and slowed thinking. What are the INITIAL symptoms of HIV-associated dementia?",
    "options": [
      "Seizures and focal deficits",
      "Visual hallucinations",
      "Poor concentration and memory loss",
      "Aggressive behavior"
    ],
    "correctAnswer": 2,
    "rationale": "HIV-associated dementia: first symptoms are cognitive—poor concentration, memory loss, slowed thinking. Subcortical dementia pattern. Screen when CD4 <200. Treat underlying HIV. Different from delirium.",
    "category": "HIV-Related Conditions",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 262,
    "question": "A PMHNP is prescribing an off-label medication to a 7-year-old patient for anxiety. Which documentation is MOST essential for this clinical encounter?",
    "options": [
      "The diagnosis and presenting symptoms only",
      "Informed consent from the parent/guardian including discussion of off-label use",
      "Standard prescription documentation without additional notation",
      "A referral to pediatrics for medication management"
    ],
    "correctAnswer": 1,
    "rationale": "OFF-LABEL PRESCRIBING IN MINORS: Must obtain and document INFORMED CONSENT from parent/legal guardian. Documentation must include: (1) discussion of off-label status, (2) risks and benefits, (3) alternative treatments, (4) lack of FDA pediatric approval, (5) parent's understanding and agreement. Required for medicolegal protection.",
    "category": "Documentation and Consent",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 263,
    "question": "A patient with a documented penicillin allergy develops a bacterial infection. Which antibiotic class should be avoided due to cross-reactivity?",
    "options": [
      "Cephalosporins",
      "Fluoroquinolones",
      "Macrolides",
      "Tetracyclines"
    ],
    "correctAnswer": 0,
    "rationale": "Penicillin allergy: avoid cephalosporins due to 2-10% cross-reactivity, especially first-generation (cephalexin). Later generations have lower cross-reactivity. Safe alternatives: azithromycin, fluoroquinolones. Get allergy details.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 264,
    "question": "A patient discloses confidential information about a family member who is also your patient. What is the MOST appropriate NP response?",
    "options": [
      "Discuss the family member information openly",
      "Maintain confidentiality and do not discuss other patients",
      "Share information with office staff",
      "Document in both patient charts"
    ],
    "correctAnswer": 1,
    "rationale": "Dual relationships: maintain confidentiality for EACH patient separately. Cannot discuss one patient's information with another, even family members. Document boundaries. Refer out if conflict unavoidable.",
    "category": "Professional Ethics",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 265,
    "question": "A patient with suspected obstructive sleep apnea presents with daytime sleepiness and reports that his wife says he snores loudly. What causes the snoring in sleep apnea?",
    "options": [
      "Nasal congestion only",
      "Upper airway obstruction during sleep",
      "Cardiac dysfunction",
      "Medication side effect"
    ],
    "correctAnswer": 1,
    "rationale": "SLEEP APNEA: Snoring from upper airway obstruction. SLEEP STAGES: Stage 1-2=light sleep. Stage 3=slow-wave/deep (restorative). REM=dreaming, memory consolidation, atonia. CIRCADIAN RHYTHM: PINEAL GLAND→melatonin (peaks 2-4am). SUPRACHIASMATIC NUCLEUS (hypothalamus)=master clock, responds to light. Sleep apnea disrupts architecture.",
    "category": "Sleep Disorders",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 266,
    "question": "A patient with specific phobia (fear of flying) asks about medication. Which medication approach should the PMHNP DISCOURAGE for long-term management?",
    "options": [
      "Long-term benzodiazepine use",
      "Cognitive behavioral therapy",
      "Exposure therapy",
      "SSRIs for severe cases"
    ],
    "correctAnswer": 0,
    "rationale": "Phobic anxiety: discourage benzodiazepine use long-term. First-line: CBT with exposure therapy, SSRIs. Benzos provide quick relief but prevent habituation and cause dependence. Use short-term if needed for specific events.",
    "category": "Anxiety Disorders",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 267,
    "question": "A patient with anorexia nervosa in the refeeding phase reports feeling bloated after meals. How should the PMHNP respond?",
    "options": [
      "This is concerning and requires immediate workup",
      "Bloating is normal due to gastroparesis; space meals and eat smaller portions",
      "Prescribe laxatives for relief",
      "Recommend fasting between meals"
    ],
    "correctAnswer": 1,
    "rationale": "Anorexia refeeding: bloating is NORMAL—gastroparesis from malnutrition. Advise spacing meals, smaller frequent portions. Avoid laxatives. Gradual refeeding prevents refeeding syndrome (watch phosphorus, potassium, magnesium).",
    "category": "Eating Disorders",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 268,
    "question": "A PMHNP is formulating a clinical research question for an evidence-based practice project. What does the PICOT framework represent?",
    "options": [
      "Protocol, Implementation, Control, Outcome, Testing",
      "Population, Intervention, Comparison, Outcome, Time",
      "Patient, Investigation, Comparison, Observation, Treatment",
      "Practice, Intervention, Control, Observation, Timeline"
    ],
    "correctAnswer": 1,
    "rationale": "PICOT framework: P=Population/Patient, I=Intervention, C=Comparison, O=Outcome, T=Time. Used to formulate clinical research questions. Example: In depressed adults (P), does CBT (I) vs medication (C) improve symptoms (O) at 8 weeks (T)?",
    "category": "Evidence-Based Practice",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 269,
    "question": "A patient on carbamazepine is started on a new medication by another provider. The PMHNP reviews drug interactions. As a potent CYP450 INDUCER, carbamazepine will cause which effect on other medications?",
    "options": [
      "Increase serum levels of other drugs",
      "No effect on other medications",
      "Only affect antibiotic metabolism",
      "Decrease serum levels of other drugs, potentially causing treatment failure"
    ],
    "correctAnswer": 3,
    "rationale": "Carbamazepine INDUCER: speeds metabolism of OTHER drugs (OCPs, warfarin). ITSELF is metabolized by CYP3A4. Adding inhibitor (erythromycin) → CBZ toxicity. Teratogen: neural tube defects. KINETICS mnemonic: 'Inducers make drugs go IN the toilet (subtherapeutic).'",
    "category": "Drug Interactions",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 270,
    "question": "A patient on carbamazepine develops ataxia and diplopia after starting erythromycin for bronchitis. Which mechanism explains this interaction?",
    "options": [
      "Erythromycin induces carbamazepine metabolism",
      "Carbamazepine inhibits erythromycin absorption",
      "No pharmacokinetic interaction expected",
      "Erythromycin INHIBITS CYP3A4, raising carbamazepine levels to toxic range"
    ],
    "correctAnswer": 3,
    "rationale": "CARBAMAZEPINE is a potent CYP3A4 INDUCER - decreases levels of many drugs including: OCPs (contraceptive failure), warfarin, valproate, lamotrigine, atypical antipsychotics. Also auto-induces own metabolism. CYP3A4 INHIBITORS increase carbamazepine levels causing toxicity: erythromycin, clarithromycin, ketoconazole, grapefruit juice, cimetidine. Carbamazepine toxicity: diplopia, ataxia, nystagmus, drowsiness. HLA-B*1502 screening required in Asian patients (risk of SJS/TEN).",
    "category": "Drug Interactions",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 271,
    "question": "A PMHNP is counseling a patient starting carbamazepine about serious adverse effects. Which effect is NOT associated with carbamazepine?",
    "options": [
      "Stevens-Johnson syndrome",
      "Toxic epidermal necrolysis",
      "Hypertensive crisis",
      "Aplastic anemia"
    ],
    "correctAnswer": 2,
    "rationale": "Carbamazepine does NOT cause hypertensive crisis (that's MAOIs). DOES cause: Stevens-Johnson syndrome, toxic epidermal necrolysis, agranulocytosis, aplastic anemia, hepatotoxicity. Screen HLA-B*1502 in Asians.",
    "category": "Serious Adverse Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 272,
    "question": "A pregnant woman discloses daily alcohol use. She asks about medication options for alcohol use disorder during pregnancy. What should the PMHNP explain?",
    "options": [
      "Naltrexone is NOT recommended in pregnancy; behavioral interventions are first-line",
      "Naltrexone is safe during pregnancy",
      "Disulfiram is preferred in pregnancy",
      "No treatment is needed during pregnancy"
    ],
    "correctAnswer": 0,
    "rationale": "Alcohol in pregnancy: FASD is leading preventable cause of intellectual disability. PMHNP managing pregnant woman with AUD: NO naltrexone (limited safety data), behavioral interventions first, benzos ONLY for acute withdrawal. Screen offspring for FASD features and developmental delays.",
    "category": "Substance Use in Pregnancy",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 273,
    "question": "A patient on Lexapro (escitalopram) and Wellbutrin (bupropion) is started on digoxin. Which drug interaction is of GREATEST concern?",
    "options": [
      "Lexapro causing bleeding",
      "Digoxin toxicity from Lexapro",
      "Bupropion lowers seizure threshold; monitor closely with this combination",
      "Wellbutrin causing hypertension"
    ],
    "correctAnswer": 2,
    "rationale": "Wellbutrin (bupropion) + Lexapro: lower Wellbutrin dose due to seizure risk. Bupropion lowers seizure threshold. Risk higher with doses >450mg/day or rapid dose increases. Digoxin interaction less concerning.",
    "category": "Drug Interactions",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 274,
    "question": "A PMHNP is obtaining informed consent for a research study involving psychiatric patients. What documentation is REQUIRED?",
    "options": [
      "Verbal consent is sufficient",
      "Witness signature only",
      "Signed written consent documenting understanding and voluntary participation",
      "No consent needed for minimal risk studies"
    ],
    "correctAnswer": 2,
    "rationale": "Research informed consent: MUST be signed (written consent required). Includes: purpose, procedures, risks, benefits, alternatives, voluntary participation, right to withdraw. IRB approval required. Document thoroughly.",
    "category": "Research Ethics",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 275,
    "question": "A PMHNP is working in an integrated care model that provides comprehensive, whole-person care in an ambulatory setting. This describes which healthcare delivery model?",
    "options": [
      "Emergency department psychiatry",
      "Patient-Centered Medical Home (PCMH) model",
      "Specialty psychiatric clinic",
      "Urgent care psychiatry"
    ],
    "correctAnswer": 1,
    "rationale": "Patient-Centered Medical Home (PCMH): provides comprehensive whole-person care in ambulatory setting. Integrates behavioral health, coordinates care, emphasizes prevention. Primary care model for chronic disease management.",
    "category": "Healthcare Delivery",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 276,
    "question": "Which part of these answer. Pt8 review third party payers. A kid does not want to participate in gym class, he says it hurts every time he turns. The family is worried about the family (Tredelenburg)?",
    "options": [
      "You might recommend to go to hip specialist. You will refer you to hip specialist",
      "Refer to physical therapy",
      "Prescribe pain medication",
      "Recommend rest only"
    ],
    "correctAnswer": 0,
    "rationale": "Child with hip/turning pain: refer to hip specialist for Trendelenburg sign assessment. May indicate hip pathology (Legg-Calve-Perthes, slipped capital femoral epiphysis). Don't assume behavioral—rule out organic causes first.",
    "category": "Pediatric Orthopedics",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 277,
    "question": "A patient with HIV presents with progressive cognitive decline. The CD4 count is 180. What is typically the FIRST symptom of HIV-associated dementia?",
    "options": [
      "Memory loss and concentration difficulties",
      "Psychosis with hallucinations",
      "Seizures",
      "Mood changes"
    ],
    "correctAnswer": 0,
    "rationale": "HIV-associated dementia: memory loss is FIRST symptom. Subcortical pattern (slowed processing, motor deficits). Occurs when CD4 <200. Rule out opportunistic CNS infections. ART may improve cognitive function.",
    "category": "HIV-Related Conditions",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 278,
    "question": "A kid does not want to participate in gym class because it hurts every time he turns. What should you assess for?",
    "options": [
      "Knee injury",
      "Assessment needs to be done. Ask family about previous hip injury. What do you tell the family (Trendelenburg)?",
      "Ankle sprain",
      "Growing pains"
    ],
    "correctAnswer": 1,
    "rationale": "Child gym pain with turning: assess for hip pathology. Trendelenburg gait = hip abductor weakness (positive when pelvis drops on non-stance side). May indicate developmental hip dysplasia, Perthes disease, or SCFE.",
    "category": "Pediatric Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 279,
    "question": "A 12-year-old patient who knows they have two conflicts involved. The patient has the right to know. A patient tells you she has had sex with her 6-year-old brother (Sodomy). Mother call and reported to you. What do you do?",
    "options": [
      "Maintain confidentiality",
      "Tell her, but keep secret away from each other, call child protective service and also notify the police. This is Sodomy",
      "Talk to parents first",
      "Refer to therapy only"
    ],
    "correctAnswer": 1,
    "rationale": "Mandatory reporting: child sexual abuse MUST be reported to CPS and police regardless of who discloses. This is NOT a confidentiality situation. Separate children for safety. Document objectively. Provide trauma-informed care.",
    "category": "Child Abuse Reporting",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 280,
    "question": "A mother brings her 14-year-old son for evaluation, concerned that his breast tissue appears larger than his 11-year-old sister's. What should the PMHNP explain?",
    "options": [
      "This requires immediate endocrinology referral",
      "Hormone therapy is needed",
      "Breast imaging is required",
      "Pubertal gynecomastia is NORMAL in adolescent males and usually resolves"
    ],
    "correctAnswer": 3,
    "rationale": "Pubertal gynecomastia: NORMAL in adolescent males (up to 65% experience it). Breast tissue growth from hormonal changes. Usually resolves within 2 years. Reassure patient. Only refer if persistent >2 years or painful.",
    "category": "Adolescent Development",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 281,
    "question": "A patient with asthma and depression is being evaluated. The PMHNP reviews her medication list including Qvar (inhaled beclomethasone). Which respiratory medication can cause depression?",
    "options": [
      "Albuterol",
      "Salmeterol",
      "Inhaled corticosteroids and montelukast",
      "Ipratropium"
    ],
    "correctAnswer": 2,
    "rationale": "Inhaled corticosteroids (Qvar, Flovent): can cause mood changes, depression with long-term use. Also: montelukast (Singulair) has FDA Black Box Warning for neuropsychiatric effects including suicidal ideation. Monitor mood with asthma meds.",
    "category": "Medication Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 282,
    "question": "A patient on quetiapine (Seroquel) is prescribed fluconazole (Diflucan) for a fungal infection. What drug interaction should the PMHNP anticipate?",
    "options": [
      "Fluconazole INHIBITS CYP3A4, INCREASING quetiapine levels and side effects",
      "No significant interaction",
      "Decreased quetiapine levels",
      "Only affects Diflucan metabolism"
    ],
    "correctAnswer": 0,
    "rationale": "Fluconazole INHIBITS CYP3A4 → quetiapine levels RISE → toxicity. KINETICS vs DYNAMICS: Pharmacokinetics = what BODY does to DRUG (ADME). Pharmacodynamics = what DRUG does to BODY (receptor effects). CYP interactions = pharmacoKINETIC. Reduce quetiapine dose.",
    "category": "Drug Interactions",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 283,
    "question": "A PMHNP is researching advocacy organizations. In addition to mental health advocacy, what other area does NAMI (National Alliance on Mental Illness) address?",
    "options": [
      "Housing issues only",
      "Research funding only",
      "Mental health public policy and legislation",
      "Insurance coverage only"
    ],
    "correctAnswer": 2,
    "rationale": "NAMI (National Alliance on Mental Illness): advocates for mental health AND public policy issues. Grassroots organization for education, support, advocacy. Fights stigma. Provides family support groups.",
    "category": "Mental Health Advocacy",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 284,
    "question": "In a study of education for prevention of delirium post cardiac surgery, why does the sample have bias?",
    "options": [
      "Sample size too small",
      "Wrong population studied",
      "Ethical intervention needs to be offered to all patients",
      "No control group"
    ],
    "correctAnswer": 2,
    "rationale": "Research ethics: if intervention is beneficial, it must be offered to ALL patients (equipoise principle). Withholding proven beneficial treatment is unethical. This creates selection bias but is ethically required.",
    "category": "Research Methodology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 285,
    "question": "A PMHNP is evaluating a patient with HIV and confusion. The team must differentiate HIV-associated dementia from delirium. HIV dementia is often confused with which condition?",
    "options": [
      "Delirium",
      "Alzheimer's disease",
      "Major depression",
      "Generalized anxiety"
    ],
    "correctAnswer": 0,
    "rationale": "HIV dementia vs delirium: often confused due to similar presentation (confusion, attention deficits). Key difference: dementia = chronic, gradual onset; delirium = acute, fluctuating. Check for reversible causes.",
    "category": "Differential Diagnosis",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 286,
    "question": "A PMHNP wants to open an outpatient psychiatric practice and needs to assess economic viability. Which financial document shows assets, liabilities, and equity?",
    "options": [
      "Income statement",
      "Balance sheet",
      "Cash flow statement",
      "Budget forecast"
    ],
    "correctAnswer": 1,
    "rationale": "Business viability: BALANCE SHEET shows assets, liabilities, equity at a point in time. Income statement shows revenue/expenses. Cash flow shows money movement. For new clinic, balance sheet assesses financial health.",
    "category": "Practice Management",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 287,
    "question": "A PMHNP is evaluating an 80-year-old patient for dementia. The family reports memory problems. What is the MOST important differential diagnosis to rule out?",
    "options": [
      "Medication side effects only",
      "Depression - treatable and reversible",
      "Normal aging",
      "Delirium only"
    ],
    "correctAnswer": 1,
    "rationale": "Dementia differential: must rule out depression (pseudodementia) and delirium. Depression is treatable and reversible. Use Geriatric Depression Scale. Also check thyroid, B12, medication effects.",
    "category": "Geriatric Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 288,
    "question": "A PMHNP is conducting qualitative research on nurse-patient therapeutic communication. Which method, associated with Hildegard Peplau, involves documenting interactions verbatim?",
    "options": [
      "Process recording",
      "Randomized controlled trial",
      "Meta-analysis",
      "Survey methodology"
    ],
    "correctAnswer": 0,
    "rationale": "Peplau's process recording: qualitative method documenting nurse-patient interactions verbatim. Analyzes therapeutic communication. Used for supervision and learning. Hildegard Peplau = mother of psychiatric nursing.",
    "category": "Research Methodology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 289,
    "question": "A patient with a frontal lobe brain tumor presents with personality changes, poor judgment, and difficulty planning. Which deficits are associated with frontal lobe dysfunction?",
    "options": [
      "Visual processing deficits",
      "Hearing impairment",
      "Memory deficits only",
      "Executive function, behavioral regulation, and personality changes"
    ],
    "correctAnswer": 3,
    "rationale": "Frontal lobe functions: executive function (planning, judgment, problem-solving), personality, behavior regulation, expressive language (Broca's area). Damage causes disinhibition, impulsivity, apathy, or aggression.",
    "category": "Neuropsychiatry",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 290,
    "question": "A PMHNP is preparing a patient with PTSD for mindfulness-based therapy. What is the recommended FIRST intervention before deeper meditation practices?",
    "options": [
      "Silent meditation immediately",
      "Prolonged exposure therapy",
      "Medication optimization first",
      "Guided imagery to establish safety and reduce hyperarousal"
    ],
    "correctAnswer": 3,
    "rationale": "PTSD mindfulness preparation: start with guided imagery before deeper meditation. Creates safety, reduces hyperarousal. Trauma-sensitive approach. Progress gradually to avoid triggering trauma responses.",
    "category": "PTSD Treatment",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 291,
    "question": "A pregnant woman with alcohol use disorder asks about pharmacological treatment options. What should the PMHNP explain about naltrexone in pregnancy?",
    "options": [
      "Naltrexone is NOT first-line in pregnancy; behavioral interventions are preferred",
      "Naltrexone is safe throughout pregnancy",
      "Naltrexone is only contraindicated in third trimester",
      "Naltrexone is the treatment of choice"
    ],
    "correctAnswer": 0,
    "rationale": "Naltrexone for alcohol: CONTRAINDICATED in pregnancy (Category C, limited data). Benzodiazepines used ONLY for acute alcohol withdrawal, not maintenance. First-line in pregnancy: behavioral interventions, support.",
    "category": "Pregnancy and Substance Use",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 292,
    "question": "A mother is anxious about giving her child a new psychiatric medication. She appears tearful and distracted during teaching. What should the PMHNP do FIRST?",
    "options": [
      "Complete the medication demonstration quickly",
      "Have another family member give the medication",
      "Provide written instructions and end the visit",
      "STOP and address her anxiety before continuing education"
    ],
    "correctAnswer": 3,
    "rationale": "Parent medication anxiety: STOP and address anxiety before teaching. Learning cannot occur when anxious. Use therapeutic communication, validate concerns, then demonstrate technique with return demonstration.",
    "category": "Patient Education",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 293,
    "question": "During a home visit to assess an overweight child, the PMHNP observes uncooked chicken left on the counter and the mother giving the child ice cream. What should be assessed?",
    "options": [
      "Understanding of nutrition and food safety practices",
      "Food preferences only",
      "Financial status only",
      "Cultural practices only"
    ],
    "correctAnswer": 0,
    "rationale": "Home visit assessment: uncooked chicken out = food safety concern; ice cream for overweight child = nutrition education need. Assess health literacy, provide culturally sensitive education about nutrition and food safety.",
    "category": "Health Education",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 294,
    "question": "A patient on a TCA complains of constipation. The PMHNP explains that anticholinergic medications affect GI motility. Which medication class SLOWS gastric motility?",
    "options": [
      "Metoclopramide",
      "Proton pump inhibitors",
      "H2 blockers",
      "Anticholinergics"
    ],
    "correctAnswer": 3,
    "rationale": "Anticholinergics slow gastric motility: block acetylcholine → decreased GI muscle contractions. Causes constipation. Opposite of metoclopramide (increases motility). Relevant for psychiatric med side effects (TCAs, antipsychotics).",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 295,
    "question": "A patient on olanzapine announces she is enrolling in a smoking cessation program. The PMHNP knows smoking affects olanzapine levels. What adjustment may be needed?",
    "options": [
      "Increase olanzapine dose when patient quits smoking",
      "DECREASE olanzapine dose by 25-50% when patient quits",
      "No dose adjustment needed",
      "Switch to different antipsychotic"
    ],
    "correctAnswer": 1,
    "rationale": "Olanzapine + smoking: CYP1A2 INDUCED by smoking → low olanzapine levels. QUIT SMOKING → levels RISE → reduce dose 25-50%. Same for clozapine. Board pearl: 'Smoking speeds CYP1A2' (olanzapine, clozapine, caffeine, theophylline).",
    "category": "Smoking Cessation",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 296,
    "question": "A PMHNP is prescribing sertraline to a 78-year-old patient. What electrolyte abnormality should be monitored, especially in elderly patients on SSRIs?",
    "options": [
      "Hyperkalemia",
      "Hyperglycemia",
      "Hyponatremia",
      "Hyperlipidemia"
    ],
    "correctAnswer": 2,
    "rationale": "SSRIs in elderly: HYPONATREMIA (SIADH) is major concern. Symptoms: confusion, falls, seizures. Check sodium at baseline and 2 weeks. Higher risk with: age >65, female, diuretics, low body weight.",
    "category": "Geriatric Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 297,
    "question": "A 16-year-old female is being treated with valproic acid for bipolar disorder. She has a boyfriend and is sexually active. What TEST is essential?",
    "options": [
      "Thyroid function tests",
      "Pregnancy test",
      "Vitamin D levels",
      "Lipid panel"
    ],
    "correctAnswer": 1,
    "rationale": "Teenage girl on Depakote: test HCG (pregnancy test). Valproate is HIGHLY teratogenic—neural tube defects, cognitive impairment in offspring. Must use contraception. If pregnant, discuss alternatives immediately.",
    "category": "Medication Monitoring",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 298,
    "question": "A PMHNP is opening a new outpatient psychiatric practice. What should be the PRIMARY focus?",
    "options": [
      "Marketing and advertising strategy",
      "Patient and family outcomes and quality of care",
      "Profit maximization",
      "Rapid expansion plans"
    ],
    "correctAnswer": 1,
    "rationale": "New NP clinic focus: patient and family outcomes FIRST. Quality of care, patient satisfaction, evidence-based practice. Business success follows quality care. Mission-driven practice builds sustainable referrals.",
    "category": "Professional Practice",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 299,
    "question": "When assessing a neonate in the nursery, the PMHNP prioritizes one assessment over others. What is MOST important to assess in a newborn?",
    "options": [
      "Primitive reflexes",
      "Family history of substance use",
      "Growth parameters only",
      "Hearing screening first"
    ],
    "correctAnswer": 1,
    "rationale": "Neonate assessment priority: family history of substance use—critical for identifying neonatal abstinence syndrome (NAS) risk. Symptoms: irritability, tremors, feeding difficulties, seizures. Early identification enables intervention.",
    "category": "Neonatal Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 300,
    "question": "A PMHNP is submitting a claim to Medicare for a patient visit. What coding system is required to identify services provided?",
    "options": [
      "CPT codes",
      "Social security number",
      "NPI number only",
      "Tax identification number"
    ],
    "correctAnswer": 0,
    "rationale": "Medicare billing: CPT codes (Current Procedural Terminology) required for services rendered. Also need NPI number and diagnosis codes (ICD-10). CPT describes what procedure/service was provided.",
    "category": "Billing and Coding",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 301,
    "question": "During a neurological exam, the PMHNP asks the patient to puff out his cheeks. Which cranial nerve is being tested?",
    "options": [
      "Trigeminal",
      "Facial",
      "Glossopharyngeal (CN IX)",
      "Hypoglossal (CN XII)"
    ],
    "correctAnswer": 1,
    "rationale": "CN VII (Facial nerve): puffing cheeks tests buccinator muscle (facial nerve). Also tests: smile, frown, eye closure, raise eyebrows. Bell's palsy = unilateral facial weakness. Board tip: VII = face expressions; V = chewing.",
    "category": "Neurological Examination",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 302,
    "question": "A PMHNP is reviewing epidemiological data on mood disorders among Hispanic populations. Research indicates which groups have higher rates of mood disorders?",
    "options": [
      "Mexican and Central American populations",
      "Puerto Rican and Dominican populations",
      "Cuban and Colombian populations",
      "All Hispanic groups have equal rates"
    ],
    "correctAnswer": 1,
    "rationale": "Cultural psychiatry: Puerto Rican and Dominican populations show higher rates of mood disorders (depression, anxiety) in epidemiological studies. Consider cultural expressions of distress (ataque de nervios). Cultural competence essential.",
    "category": "Cultural Psychiatry",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 303,
    "question": "A patient asks if gabapentin could help her depression. She is currently taking it for neuropathic pain. Which condition is gabapentin NOT indicated for?",
    "options": [
      "Epilepsy",
      "Neuropathic pain",
      "Hot flashes",
      "Depression"
    ],
    "correctAnswer": 3,
    "rationale": "Gabapentin (Neurontin) NOT used for depression. FDA-approved for: epilepsy, postherpetic neuralgia. Off-label: neuropathic pain, anxiety, hot flashes, alcohol withdrawal. Does not treat depression—different mechanism.",
    "category": "Anticonvulsants",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 304,
    "question": "A nursing student asks the PMHNP how gabapentin produces its calming effect. Which neurotransmitter system does gabapentin primarily affect?",
    "options": [
      "Serotonin",
      "GABA",
      "Dopamine",
      "Norepinephrine"
    ],
    "correctAnswer": 1,
    "rationale": "Gabapentin: enhances GABA activity (inhibitory neurotransmitter). Binds to alpha-2-delta subunit of voltage-gated calcium channels. Does NOT directly bind GABA receptors. Calming effect. Lower abuse potential than benzos.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 305,
    "question": "A patient with diabetes and depression is on sertraline. The PMHNP orders routine labs including a reticulocyte count. What is the rationale for checking reticulocytes?",
    "options": [
      "To assess for infection",
      "To evaluate for bone marrow suppression or aplastic anemia",
      "To monitor diabetes control",
      "To check liver function"
    ],
    "correctAnswer": 1,
    "rationale": "Reticulocyte count: assesses bone marrow function. Low reticulocytes with low RBCs suggests aplastic anemia or bone marrow failure. SSRIs rarely cause blood dyscrasias. Also check in diabetes for anemia of chronic disease.",
    "category": "Laboratory Monitoring",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 306,
    "question": "A patient on iron supplementation for anemia reports taking it with her morning coffee and antacid. What should the PMHNP advise?",
    "options": [
      "Continue current regimen",
      "Increase iron dose",
      "Switch to IV iron",
      "Caffeine and antacids DECREASE iron absorption; take separately"
    ],
    "correctAnswer": 3,
    "rationale": "Iron absorption DECREASED by: caffeine, tea, antacids (raise gastric pH), calcium, fiber, phytates. Iron absorption INCREASED by: vitamin C (ascorbic acid), meat. Teach patient: Take iron 1 hour before or 2 hours after other meds.",
    "category": "Drug Interactions",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 307,
    "question": "A patient is prescribed ciprofloxacin for a urinary tract infection. The PMHNP reviews the FDA Black Box warnings. Which serious adverse effect is associated with fluoroquinolones?",
    "options": [
      "Minor GI upset only",
      "Mild headache",
      "Temporary insomnia",
      "Tendon rupture"
    ],
    "correctAnswer": 3,
    "rationale": "Fluoroquinolones (Cipro, Levaquin): FDA Black Box Warning for TENDON RUPTURE, especially Achilles. Also: peripheral neuropathy, CNS effects, aortic aneurysm. Avoid in elderly, steroid users. Teach patient: Stop if tendon pain.",
    "category": "Antibiotic Side Effects",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 308,
    "question": "A mother asks if it's safe to give her 6-year-old child tetracycline for an infection. What adverse effect makes tetracyclines contraindicated in young children?",
    "options": [
      "Growth retardation",
      "Bone deformities",
      "Permanent teeth discoloration",
      "Liver damage"
    ],
    "correctAnswer": 2,
    "rationale": "Tetracyclines in children: cause permanent TEETH DISCOLORATION (yellow-gray-brown). Contraindicated <8 years old. Also affects bone development. Exception: doxycycline binds calcium less, may be safer in children.",
    "category": "Pediatric Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 309,
    "question": "A patient with fatigue, weight gain, and depression has a TSH of 8.5 mU/L. The PMHNP recognizes the need for treatment. What is Synthroid (levothyroxine) used for?",
    "options": [
      "Hyperthyroidism",
      "Osteoporosis",
      "Hypothyroidism",
      "Diabetes"
    ],
    "correctAnswer": 2,
    "rationale": "Synthroid (levothyroxine): thyroid hormone replacement for HYPOTHYROIDISM. Take on empty stomach, same time daily. Avoid with calcium, iron (separate by 4 hours). Monitor TSH every 6-8 weeks after dose changes.",
    "category": "Endocrine Medications",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 310,
    "question": "A PMHNP is evaluating a new depression screening tool. The test correctly identifies 95% of patients who actually have depression. This statistic describes which test characteristic?",
    "options": [
      "Specificity",
      "Positive predictive value",
      "Sensitivity",
      "Negative predictive value"
    ],
    "correctAnswer": 2,
    "rationale": "Sensitivity (true positive rate): proportion of people WITH disease who test POSITIVE. 'SnOUT' = Sensitive test, Negative result rules OUT disease. High sensitivity = few false negatives. Useful for screening.",
    "category": "Research and Statistics",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 311,
    "question": "A PMHNP is evaluating a female patient with short stature, webbed neck, and primary amenorrhea. Genetic testing reveals 45,XO. Which genetic syndrome is this?",
    "options": [
      "Down syndrome (trisomy 21)",
      "Klinefelter syndrome (47,XXY)",
      "Turner syndrome",
      "Triple X syndrome"
    ],
    "correctAnswer": 2,
    "rationale": "TURNER SYNDROME (45,XO): Females only. Features: short stature, webbed neck, shield chest, ovarian failure (infertility), coarctation of aorta. PMHNP considerations: Normal IQ but may have nonverbal learning disabilities, spatial deficits, social anxiety, ADHD. Hormone replacement needed. Support body image concerns.",
    "category": "Genetics",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 312,
    "question": "A patient on haloperidol develops fever of 104°F, severe muscle rigidity, altered mental status, and elevated CK. What syndrome should the PMHNP suspect?",
    "options": [
      "Neuroleptic Malignant Syndrome",
      "Hypotension syndrome",
      "Mild extrapyramidal symptoms",
      "Common medication side effects"
    ],
    "correctAnswer": 0,
    "rationale": "NEUROLEPTIC MALIGNANT SYNDROME (NMS): Classic tetrad - (1) Fever >104°F, (2) Severe muscle RIGIDITY (lead-pipe), (3) Altered mental status, (4) Autonomic instability. Labs: elevated CK (>1000, often >10,000), leukocytosis, metabolic acidosis. Caused by dopamine blockade. Treatment: STOP antipsychotic immediately, IV fluids, cooling, dantrolene, bromocriptine. Mortality 10-20% if untreated.",
    "category": "Antipsychotic Emergencies",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 313,
    "question": "A patient with NMS is transferred to the ICU. The antipsychotic has been discontinued. What pharmacological treatment is indicated for NMS?",
    "options": [
      "Resume antipsychotic at lower dose",
      "Increase antipsychotic dose",
      "SSRIs",
      "Dantrolene and/or bromocriptine"
    ],
    "correctAnswer": 3,
    "rationale": "NMS treatment: STOP antipsychotic, supportive care (cooling, hydration), dantrolene (muscle relaxant) or bromocriptine (dopamine agonist). Monitor CK, renal function. ICU admission often needed. Mortality 10-20% if untreated.",
    "category": "Emergency Treatment",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 314,
    "question": "A patient on sertraline and tramadol develops fever, agitation, tremor, hyperreflexia, and diaphoresis. What syndrome should the PMHNP suspect?",
    "options": [
      "Serotonin syndrome",
      "Hypothermia and bradycardia (not consistent)",
      "Lead-pipe rigidity and mutism",
      "Hypotension and sedation"
    ],
    "correctAnswer": 0,
    "rationale": "Serotonin syndrome: tachycardia, hyperthermia, agitation, hyperreflexia, clonus, diaphoresis, dilated pupils, diarrhea. Caused by excess serotonin. Treatment: stop serotonergic drugs, cyproheptadine, cooling, benzos for agitation.",
    "category": "Serotonin Syndrome",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 315,
    "question": "A patient scores 22 on the MMSE. The PMHNP interprets this score. What severity of cognitive impairment does a score of 18-23 indicate?",
    "options": [
      "Severe impairment (0-9)",
      "Moderate impairment (10-17)",
      "Mild impairment (18-23)",
      "Normal cognition (24-30)"
    ],
    "correctAnswer": 2,
    "rationale": "MMSE (0-30): 18-23=mild impairment. MMSE LIMITATIONS: misses MCI, poor executive function testing, ceiling effect. MoCA ADVANTAGES: ≥26=normal, more sensitive for early dementia, tests clock drawing/trails/abstraction. Board tip: Know when to use MoCA over MMSE.",
    "category": "Cognitive Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 316,
    "question": "A patient completes the Beck Depression Inventory-II and scores 25. What severity does this indicate using standard cutoffs?",
    "options": [
      "Minimal depression (0-13)",
      "Moderate depression (20-28)",
      "Severe depression (29-63)",
      "Mild depression (14-19)"
    ],
    "correctAnswer": 3,
    "rationale": "BDI-II scoring: 0-13=minimal, 14-19=mild, 20-28=moderate, 29-63=severe. Alternative cutoffs exist (0-9, 10-18, 19-29, 30-63). Know which version is tested.",
    "category": "Depression Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 317,
    "question": "A PMHNP administers the HAM-D to assess treatment response. The patient scores 20. What severity level does this clinician-administered scale indicate?",
    "options": [
      "Normal/remission (0-7)",
      "Moderate depression (14-18)",
      "Severe depression (19-22)",
      "Mild depression (8-13)"
    ],
    "correctAnswer": 3,
    "rationale": "HAM-D 17-item: 0-7=normal, 8-13=mild, 14-18=moderate, 19-22=severe, ≥23=very severe. Clinician-administered. Treatment response: 50% reduction. Remission: score ≤7.",
    "category": "Depression Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 318,
    "question": "A patient in therapy has met treatment goals, shows improved coping skills, and functions well independently. The PMHNP considers termination. What indicates readiness for termination?",
    "options": [
      "Patient becomes more dependent on therapist",
      "Patient shows no progress",
      "Patient demonstrates progress, goal achievement, and ability to function independently",
      "Patient requests more frequent sessions"
    ],
    "correctAnswer": 2,
    "rationale": "Termination readiness: patient shows symptom improvement, increased coping skills, met treatment goals, can function independently. Discuss termination early. Gradual spacing of sessions. Address termination feelings.",
    "category": "Psychotherapy",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 319,
    "question": "A school counselor calls about a student who made suicidal statements. The PMHNP consults on suicide risk assessment. What should a comprehensive school-based suicide assessment include?",
    "options": [
      "Asking only about suicidal thoughts",
      "Assessment of ideation, plan, means, intent, risk/protective factors, and behavioral changes",
      "Family history only",
      "Peer relationships only"
    ],
    "correctAnswer": 1,
    "rationale": "School suicide assessment: comprehensive evaluation includes: ideation, plan, means, intent, history of attempts, risk factors (substance use, family conflict, bullying), protective factors, academic decline, behavior changes.",
    "category": "Suicide Risk Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 320,
    "question": "During a psychiatric interview, the patient becomes silent and stops responding. What is the appropriate therapeutic response?",
    "options": [
      "End the interview immediately",
      "Fill the silence by talking more",
      "Immediately change topics",
      "Use therapeutic silence; allow space for processing before gently exploring"
    ],
    "correctAnswer": 3,
    "rationale": "Patient silence in interview: use therapeutic silence, give space for processing. Don't rush to fill silence. Silence can indicate deep reflection, emotion, or resistance. Observe nonverbal cues. Eventually gently explore.",
    "category": "Interviewing Techniques",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 321,
    "question": "A PMHNP is conducting couples therapy. One partner arrives alone and angrily complains about the absent partner. What should the PMHNP do?",
    "options": [
      "Continue therapy with the present partner",
      "Side with the present partner",
      "Terminate therapy",
      "Reschedule for when both partners can attend"
    ],
    "correctAnswer": 3,
    "rationale": "Couples therapy: if one partner absent and other is angry, reschedule for both to attend. Couples therapy requires both partners present. Don't conduct individual session disguised as couples work—maintain boundaries.",
    "category": "Couples Therapy",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 322,
    "question": "A patient with alcohol use disorder has presented to the ED three times this month. The PMHNP needs to coordinate care. Who should be consulted?",
    "options": [
      "Primary care physician only",
      "Case management and discharge planning team for care coordination",
      "Social work only",
      "Psychiatry consultation only"
    ],
    "correctAnswer": 1,
    "rationale": "Frequent ED visits (alcohol): consult case management/discharge planning team. Coordinate care, connect to treatment resources, reduce ED utilization. Multidisciplinary approach for complex patients. SBIRT may be helpful.",
    "category": "Case Management",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 323,
    "question": "As an NP, when a minor patient confides information in you about sexual orientation, what should you do?",
    "options": [
      "Tell parents immediately",
      "Increase intramural pressure",
      "Maintain confidentiality while assessing risk",
      "Discharge from care"
    ],
    "correctAnswer": 2,
    "rationale": "Minor sexual orientation disclosure: maintain confidentiality while assessing safety. Sexual orientation is protected health information. Assess: family acceptance, bullying, mental health, safety at home. Support the adolescent.",
    "category": "Adolescent Confidentiality",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 324,
    "question": "A baby is crying excessively. What should be assessed?",
    "options": [
      "Feeding schedule only",
      "Increase intramural pressure (ICP)",
      "Sleep patterns only",
      "Growth parameters only"
    ],
    "correctAnswer": 1,
    "rationale": "Crying infant—assess for increased intracranial pressure (ICP): bulging fontanelle, sunset eyes, irritability, poor feeding, vomiting, altered consciousness. ICP can indicate meningitis, hydrocephalus. Medical emergency if suspected.",
    "category": "Pediatric Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 325,
    "question": "As an NP, when you prescribe opioids for pain, what legal principle is of most concern regarding privacy and confidentiality?",
    "options": [
      "Tele-psychiatry: Okem both written and privacy",
      "FERPA",
      "ADA",
      "EMTALA"
    ],
    "correctAnswer": 0,
    "rationale": "Opioid prescribing and privacy: HIPAA protects all health information including substance use treatment. Prescription drug monitoring programs (PDMPs) have specific privacy rules. Document informed consent for treatment.",
    "category": "Legal Issues",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 326,
    "question": "A patient on carbamazepine is prescribed erythromycin for a respiratory infection. The PMHNP is concerned about a drug interaction. What effect will erythromycin have on carbamazepine levels?",
    "options": [
      "INCREASE carbamazepine levels causing toxicity",
      "Decrease carbamazepine levels",
      "No interaction expected",
      "Only affects erythromycin levels"
    ],
    "correctAnswer": 0,
    "rationale": "Erythromycin (inhibitor) + Tegretol (carbamazepine) = INCREASED Tegretol levels → TOXICITY. Inhibitor slows metabolism. KINETICS concept: Inhibitors block CYP enzymes → drug can't be broken down → accumulates. Signs: ataxia, diplopia, nystagmus, drowsiness.",
    "category": "Drug Interactions",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 327,
    "question": "A patient started on sertraline 3 weeks ago reports persistent nausea and headache. How should the PMHNP manage these side effects?",
    "options": [
      "Discontinue sertraline immediately",
      "Evaluate severity; early side effects often resolve; consider dose adjustment or switch if severe",
      "Double the dose",
      "Add an additional SSRI"
    ],
    "correctAnswer": 1,
    "rationale": "SSRI side effects at 3 weeks: evaluate type/severity. Common early side effects (nausea, headache) often resolve. Sexual dysfunction may require switch. Don't discontinue abruptly—taper if changing. Consider drug interactions affecting metabolism.",
    "category": "Medication Management",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 328,
    "question": "A 5-year-old child recently experienced parental divorce. He has decreased appetite without weight loss and seems less interested in activities. He can attend to tasks when engaged. What is the MOST likely diagnosis?",
    "options": [
      "Adjustment disorder with depressed mood",
      "Major Depressive Disorder",
      "ADHD",
      "Oppositional Defiant Disorder"
    ],
    "correctAnswer": 0,
    "rationale": "Adjustment disorder: emotional/behavioral symptoms in response to identifiable stressor, within 3 months. Symptoms resolve within 6 months of stressor ending. Less severe than MDD. Supportive therapy first-line; SSRIs if needed.",
    "category": "Child Psychiatry Diagnosis",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 329,
    "question": "A patient on risperidone develops NMS with fever, rigidity, and CK of 15,000. The antipsychotic has been stopped. What monitoring and treatment is indicated?",
    "options": [
      "Monitor CK and WBC; give dantrolene and/or bromocriptine; supportive care",
      "Resume antipsychotic at lower dose",
      "Add an SSRI",
      "Start lithium"
    ],
    "correctAnswer": 0,
    "rationale": "NMS treatment: STOP antipsychotic, monitor CK (for rhabdomyolysis) and WBC (leukocytosis common), give dantrolene (muscle relaxant) ± bromocriptine (dopamine agonist). Benzodiazepines for agitation. IV fluids. ICU admission.",
    "category": "Emergency Treatment",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 330,
    "question": "A PMHNP learns about a new regulation affecting prescriptive authority. This regulation was passed by the state legislature. What type of law is this?",
    "options": [
      "State statute",
      "Hospital policy",
      "Federal regulation",
      "Professional guideline"
    ],
    "correctAnswer": 0,
    "rationale": "State statute: law passed by state legislature. Different from: federal law (Congress), regulations (agency rules), policies (institutional guidelines). NPs must follow state-specific scope of practice laws.",
    "category": "Legal and Regulatory",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 331,
    "question": "A non-English speaking patient has been waiting for hours in the psychiatric ED. The PMHNP obtains an interpreter to communicate with him. This approach exemplifies which care principle?",
    "options": [
      "Cultural assessment completion",
      "Patient-centered care",
      "Efficiency optimization",
      "Standard documentation"
    ],
    "correctAnswer": 1,
    "rationale": "Patient-centered care: providing interpreter for non-English speaker is fundamental to patient-centered care. Ensures informed consent, accurate history, treatment adherence. Use professional interpreters, not family when possible.",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 332,
    "question": "A patient with heart failure and depression asks why she was started on lisinopril. What is the PRIMARY indication for ACE inhibitors?",
    "options": [
      "Diabetes management",
      "Hyperlipidemia",
      "Kidney disease only",
      "Heart failure"
    ],
    "correctAnswer": 3,
    "rationale": "ACE inhibitors: first-line for heart failure with reduced ejection fraction (HFrEF). Reduce mortality. Also: hypertension, diabetic nephropathy. Side effects: dry cough, hyperkalemia, angioedema. Contraindicated in pregnancy.",
    "category": "Cardiovascular Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 333,
    "question": "A PMHNP leads a quality improvement initiative and motivates staff through inspiration and modeling exemplary behavior. What leadership style does this describe?",
    "options": [
      "Authoritarian leadership",
      "Transformational leadership",
      "Transactional leadership",
      "Laissez-faire leadership"
    ],
    "correctAnswer": 1,
    "rationale": "Transformational leadership: motivates staff through inspiration, leading by example, innovation. Fosters change and growth. Different from transactional (rewards/punishments) or laissez-faire (hands-off) leadership styles.",
    "category": "Leadership",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 334,
    "question": "A PMHNP is explaining the recovery model to a patient's family. What is the PRIMARY focus of the recovery model in mental health?",
    "options": [
      "Patient empowerment, hope, and self-determination toward meaningful life",
      "Complete symptom elimination",
      "Hospitalization prevention",
      "Medication cure"
    ],
    "correctAnswer": 0,
    "rationale": "Recovery model: focuses on person's goals, hope, empowerment, self-determination. Beyond symptom reduction—aims for meaningful, satisfying life. Patient-centered. Addresses medication adherence through shared decision-making.",
    "category": "Recovery Model",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 335,
    "question": "A patient with frontotemporal dementia exhibits social disinhibition and personality changes but relatively preserved memory. What deficits are characteristic of frontal lobe involvement?",
    "options": [
      "Memory impairment as primary feature",
      "Social skills deficits and personality changes",
      "Visual processing deficits",
      "Motor function impairment only"
    ],
    "correctAnswer": 1,
    "rationale": "Frontotemporal dementia (FTD): early SOCIAL SKILLS and PERSONALITY changes (disinhibition, apathy). Memory relatively preserved early on. Different from Alzheimer's (memory first). Behavioral variant most common.",
    "category": "Dementia Types",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 336,
    "question": "A PMHNP is starting work at a new psychiatric clinic. The administrator asks about the practice focus. What should be the PRIMARY focus?",
    "options": [
      "Patient and family-centered care and outcomes",
      "Revenue generation",
      "Administrative efficiency",
      "Marketing strategies"
    ],
    "correctAnswer": 0,
    "rationale": "New NP practice focus: PATIENT and FAMILY oriented care first. Quality outcomes, patient safety, evidence-based practice. Strong patient relationships build sustainable practice. Business follows quality care.",
    "category": "Professional Practice",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 337,
    "question": "A PMHNP is reviewing evidence to develop a treatment protocol. What represents the HIGHEST level of evidence in the evidence hierarchy?",
    "options": [
      "Expert opinion (lowest level)",
      "Case studies",
      "Cohort studies",
      "Systematic reviews and meta-analyses of RCTs (highest level)"
    ],
    "correctAnswer": 3,
    "rationale": "Evidence hierarchy: highest = systematic reviews/meta-analyses of RCTs. Then: single RCTs, cohort studies, case-control, case series, expert opinion (lowest). NPs should advocate for access to current evidence.",
    "category": "Evidence-Based Practice",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 338,
    "question": "A PMHNP is assessing developmental milestones in a 2-year-old child. What social development skill is expected at this age?",
    "options": [
      "Writing letters",
      "Abstract thinking",
      "Formal logical reasoning",
      "Parallel play and beginning peer interactions"
    ],
    "correctAnswer": 3,
    "rationale": "Toddler development (1-3 years): parallel play, beginning peer interaction, imitation, developing routines/traditions. Not yet cooperative play. Erikson: autonomy vs shame/doubt. Language explosion occurs.",
    "category": "Child Development",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 339,
    "question": "A PMHNP is reviewing suicide risk factors across age groups. Which population has the HIGHEST suicide completion rate?",
    "options": [
      "Adolescents under 18 years old",
      "Young adults 25-35 years old",
      "Middle-aged adults 40-50 years old",
      "Elderly white males in assisted living facilities"
    ],
    "correctAnswer": 3,
    "rationale": "Highest suicide risk: elderly white males. Risk factors: living alone/assisted living, chronic illness, pain, depression, widowhood, access to firearms. Elderly make fewer attempts but higher lethality. Screen all elderly for depression.",
    "category": "Suicide Risk",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 340,
    "question": "A child with dyspraxia (developmental coordination disorder) is referred for evaluation. Which activity would this child have the MOST difficulty performing?",
    "options": [
      "Coordinating complex motor planning tasks",
      "Self-dressing with practice",
      "Self-feeding with adaptive utensils",
      "Walking independently"
    ],
    "correctAnswer": 0,
    "rationale": "Dyspraxia (developmental coordination disorder): difficulty with motor planning and coordination. Can often perform ADLs (dress, feed, walk) but with difficulty. Integrative care with OT helpful. Not primarily a behavioral issue.",
    "category": "Neurological Disorders",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 341,
    "question": "A patient on lithium has a TSH of 8.2 mU/L and complains of fatigue and cold intolerance. What thyroid condition does lithium commonly cause?",
    "options": [
      "Hypothyroidism with INCREASED TSH (most common)",
      "Hyperthyroidism with decreased TSH",
      "Normal thyroid function",
      "Variable thyroid effects"
    ],
    "correctAnswer": 0,
    "rationale": "Lithium causes HYPOTHYROIDISM: TSH is INCREASED (high TSH = hypothyroid). Lithium inhibits thyroid hormone synthesis and release. Monitor TSH every 6 months. May need levothyroxine supplementation.",
    "category": "Lithium Monitoring",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 342,
    "question": "A PMHNP works in a clinic where mental health and primary care providers share space and collaborate on patient care. This model is called:",
    "options": [
      "Consultation-liaison psychiatry",
      "Standard specialty referral",
      "Emergency psychiatry",
      "Integrated care"
    ],
    "correctAnswer": 3,
    "rationale": "Integrated care: mental health and primary care in same setting. Improves access, reduces stigma, better outcomes. Different from coordinated care (separate settings, shared information). Crisis intervention may be part of integrated model.",
    "category": "Crisis Intervention",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 343,
    "question": "A PMHNP is billing for services and must distinguish between time spent with the patient versus documentation time. What are these called?",
    "options": [
      "Direct care versus indirect care",
      "Beneficence vs. justice",
      "Clinical vs. administrative time",
      "Productive vs. nonproductive time"
    ],
    "correctAnswer": 0,
    "rationale": "Direct vs indirect care: Direct = face-to-face patient care time. Indirect = documentation, care coordination, phone calls. Both are billable but coded differently. Time spent with patient is direct care.",
    "category": "Professional Ethics",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 344,
    "question": "A PMHNP is asked to define standard of care during a deposition. What is the BEST definition?",
    "options": [
      "Personal preference of the provider",
      "What the insurance company approves",
      "Level of treatment a reasonably competent provider would deliver based on professional guidelines",
      "Local practice patterns only"
    ],
    "correctAnswer": 2,
    "rationale": "Standard of care: level of treatment that a reasonably competent provider would deliver. Based on clinical guidelines, research evidence, professional standards. Legal standard for malpractice determination.",
    "category": "Standards of Care",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 345,
    "question": "A researcher notes that bipolar treatment efficacy studies in children differ from adult studies. What accounts for this discrepancy?",
    "options": [
      "Different diagnostic criteria",
      "Children respond better to treatment",
      "No discrepancy exists",
      "Mood stabilizers less studied in pediatric populations; adult data extrapolated"
    ],
    "correctAnswer": 3,
    "rationale": "Bipolar treatment in children vs adults: mood stabilizers less studied in children. Efficacy data primarily from adult studies. Special considerations: growth, development, different side effect profiles. Careful risk-benefit analysis.",
    "category": "Bipolar Disorder Treatment",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 346,
    "question": "A 28-year-old woman with bipolar disorder on lithium is planning pregnancy. What is the FIRST laboratory test to order?",
    "options": [
      "Complete blood count",
      "Pregnancy test",
      "Liver function tests",
      "Thyroid function tests"
    ],
    "correctAnswer": 1,
    "rationale": "Women of childbearing age on LITHIUM: FIRST test before any medication changes is PREGNANCY TEST. Lithium is teratogenic (Category D) - causes Ebstein's anomaly. Must know pregnancy status before continuing, adjusting, or discontinuing. If pregnant: discuss risks, consider switching to lamotrigine, or if lithium essential, minimize dose and monitor closely with fetal echo at 16-20 weeks.",
    "category": "Lithium Monitoring",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 347,
    "question": "A teenage girl with bipolar disorder is on valproate (Depakote). She has a boyfriend. What laboratory test is MOST important?",
    "options": [
      "Complete blood count",
      "Kidney function tests",
      "Lipid panel",
      "Pregnancy test"
    ],
    "correctAnswer": 3,
    "rationale": "Depakote monitoring: pregnancy test (teratogenic), LFTs (hepatotoxicity), CBC with platelets (thrombocytopenia), and drug levels (50-125 mcg/mL). Pregnanediol is a pregnancy metabolite—pregnancy testing is the key concern.",
    "category": "Valproate Monitoring",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 348,
    "question": "A PMHNP is starting a stimulant for ADHD in a child. The mother reports a family history of sudden cardiac death. What cardiac workup is indicated?",
    "options": [
      "No cardiac workup needed",
      "Echocardiogram for all children",
      "Stress test before starting",
      "EKG screening for family history of cardiovascular disease or sudden death"
    ],
    "correctAnswer": 3,
    "rationale": "ADHD stimulant EKG: screen with EKG if family history of cardiovascular disease, sudden death, arrhythmias, or cardiomyopathy. Not routine for all children. Also ask about syncope, chest pain, palpitations.",
    "category": "ADHD Treatment",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 349,
    "question": "A PMHNP is reviewing evidence for bipolar medication adherence interventions. What represents the HIGHEST level of evidence?",
    "options": [
      "Expert opinion",
      "Single case study",
      "Systematic review and meta-analysis of adherence studies",
      "Descriptive survey"
    ],
    "correctAnswer": 2,
    "rationale": "Bipolar medication adherence: systematic reviews provide highest level evidence. Adherence critical—poor adherence leads to relapse. Strategies: psychoeducation, simplified regimens, side effect management, therapeutic alliance.",
    "category": "Bipolar Treatment",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 350,
    "question": "A 75-year-old patient presents with depression, fatigue, weight gain, and cold intolerance. Labs show elevated TSH. What condition is causing the depressive symptoms?",
    "options": [
      "Primary depression",
      "Medication side effect",
      "Hypothyroidism",
      "Normal aging"
    ],
    "correctAnswer": 2,
    "rationale": "Hypothyroidism causes depression: symptoms include fatigue, weight gain, cold intolerance, dry skin, constipation, cognitive slowing. TSH is INCREASED in hypothyroidism. Screen thyroid in all depressed patients. Treatable cause.",
    "category": "Geriatric Depression",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 351,
    "question": "A patient on long-term haloperidol develops involuntary lip-smacking, tongue protrusion, and finger movements. What condition is this?",
    "options": [
      "Parkinson's disease tremor",
      "Tardive dyskinesia",
      "Acute dystonia",
      "Essential tremor"
    ],
    "correctAnswer": 1,
    "rationale": "Tardive dyskinesia (TD): involuntary, repetitive movements—lip smacking, tongue protrusion, grimacing, finger movements. Caused by chronic dopamine blockade. May be irreversible. Monitor with AIMS scale every 6 months on antipsychotics.",
    "category": "Movement Disorders",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 352,
    "question": "A PMHNP is prescribing ziprasidone (Geodon) to a patient. What monitoring is REQUIRED due to cardiac risk?",
    "options": [
      "No cardiac monitoring needed",
      "EKG monitoring for QTc prolongation",
      "Blood pressure only",
      "Weight monitoring only"
    ],
    "correctAnswer": 1,
    "rationale": "Ziprasidone (Geodon): REQUIRES EKG monitoring due to QTc prolongation risk. Contraindicated if QTc >500ms or history of arrhythmia. Also monitor electrolytes (hypokalemia increases risk). Take with food (500+ calories) for absorption.",
    "category": "Antipsychotic Monitoring",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 353,
    "question": "A patient develops depression after starting prednisone for an autoimmune condition. Which medications are known to cause depression?",
    "options": [
      "Antibiotics only",
      "Antipsychotics only",
      "Vitamins and supplements",
      "Steroids, isotretinoin (Accutane), interferon, beta-blockers"
    ],
    "correctAnswer": 3,
    "rationale": "Medications causing depression: steroids, Accutane (isotretinoin), interferon, beta-blockers, benzodiazepines, oral contraceptives, reserpine. Mnemonic: 'Sad BRIC'—Steroids, Accutane, Beta-blockers, Reserpine, Interferon, Contraceptives.",
    "category": "Medication-Induced Depression",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 354,
    "question": "A patient with type 2 diabetes and depression asks about first-line diabetes medication. What is first-line pharmacotherapy for type 2 diabetes?",
    "options": [
      "Insulin",
      "Sulfonylureas",
      "DPP-4 inhibitors",
      "Metformin"
    ],
    "correctAnswer": 3,
    "rationale": "Type 2 diabetes first-line: METFORMIN. Benefits: weight neutral, low hypoglycemia risk, cardiovascular protection, inexpensive. Contraindicated: eGFR <30, hepatic failure. Common side effect: GI upset (start low, go slow).",
    "category": "Diabetes Management",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 355,
    "question": "A patient with bipolar disorder becomes manic after starting prednisone. Which medications are known to INDUCE mania?",
    "options": [
      "Steroids, antidepressants, isoniazid (INH), disulfiram (SAID mnemonic)",
      "Lithium and antipsychotics",
      "Benzodiazepines",
      "Mood stabilizers"
    ],
    "correctAnswer": 0,
    "rationale": "Mania-inducing medications: SAID mnemonic—Steroids, Antidepressants, INH (isoniazid), Disulfiram. Antidepressants can 'flip' bipolar patients to mania. Use mood stabilizer before or with antidepressant in bipolar.",
    "category": "Medication-Induced Mania",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 356,
    "question": "A PMHNP is evaluating a patient who is suspicious, mistrustful, and socially isolated. She interprets benign remarks as threatening. Which personality disorder CLUSTER does this describe?",
    "options": [
      "Cluster B",
      "Cluster A",
      "Cluster C",
      "Not a personality disorder"
    ],
    "correctAnswer": 1,
    "rationale": "CLUSTER A (Odd/Eccentric): Paranoid, Schizoid, Schizotypal. Mnemonic: 'MAD'—Mistrustful, Aloof, Disorganized thinking. PMHNP role: Rule out prodromal schizophrenia (especially schizotypal). Low-dose antipsychotics for perceptual disturbances. These patients rarely seek help—family often brings them.",
    "category": "Personality Disorders",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 357,
    "question": "A patient presents with grandiosity, need for admiration, and lack of empathy. Which personality disorder CLUSTER includes narcissistic personality disorder?",
    "options": [
      "Cluster A",
      "Cluster B",
      "Cluster C",
      "Not classified in clusters"
    ],
    "correctAnswer": 1,
    "rationale": "CLUSTER B includes NARCISSISTIC PD: Grandiosity, need for admiration, lack of empathy. Fragile self-esteem under surface. May decompensate with perceived failures ('narcissistic injury'). PMHNP: Treat comorbid depression (common when narcissistic supply fails). Therapy difficult—they don't see a problem.",
    "category": "Personality Disorders",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 358,
    "question": "A patient is extremely fearful of rejection, desires social connection but avoids it, and is easily hurt by criticism. Which personality disorder CLUSTER does this describe?",
    "options": [
      "Cluster A",
      "Cluster B",
      "Cluster C",
      "Not a personality disorder"
    ],
    "correctAnswer": 1,
    "rationale": "CLUSTER C includes AVOIDANT PD: Wants social connection but fears rejection/criticism. Different from Schizoid (doesn't want connection). PMHNP: Responds well to SSRIs + CBT/exposure. May have comorbid social anxiety disorder. Gradual exposure therapy helpful. Better prognosis than Cluster A/B.",
    "category": "Personality Disorders",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 359,
    "question": "A patient on clozapine has an ANC of 900/mm³. What is the appropriate action?",
    "options": [
      "Continue clozapine at same dose",
      "No monitoring needed",
      "Increase clozapine dose",
      "DISCONTINUE clozapine"
    ],
    "correctAnswer": 3,
    "rationale": "Clozapine ANC monitoring: if ANC <1500, hold clozapine. If ANC <1000, discontinue. Weekly monitoring first 6 months, then biweekly for 6 months, then monthly. REMS program required. Risk of agranulocytosis (~1%).",
    "category": "Clozapine Monitoring",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 360,
    "question": "What brings a daughter and mother to therapy?",
    "options": [
      "Daughter brings mother in - Subclavicular firm",
      "Medication management",
      "Crisis intervention",
      "Family conflict"
    ],
    "correctAnswer": 0,
    "rationale": "Subclavicular mass: firm mass in subclavicular area requires medical workup. May indicate malignancy, lymphadenopathy, or other pathology. Refer for imaging and possible biopsy. Not primarily psychiatric presentation.",
    "category": "Medical Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 361,
    "question": "An 80-year-old white male living alone expresses hopelessness. He has access to firearms. What suicide prevention intervention is MOST critical?",
    "options": [
      "Lethal means restriction, safety planning, frequent follow-up",
      "Prescribe antidepressants only",
      "Hospitalize all elderly with depression",
      "Weekly therapy only"
    ],
    "correctAnswer": 0,
    "rationale": "Elderly suicide prevention: reduce access to means (firearms, medications), treat depression, address isolation, regular follow-up. School-based clinics relevant for youth suicide prevention, not elderly—focus on community resources for elderly.",
    "category": "Suicide Prevention",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 362,
    "question": "A PMHNP is working to reduce mental health stigma in the community. What intervention is effective for stigma reduction?",
    "options": [
      "Support groups and community education programs",
      "Avoiding discussion of mental illness",
      "Isolating patients from community",
      "Medication-only approach"
    ],
    "correctAnswer": 0,
    "rationale": "Support groups: reduce mental health stigma, provide peer support, education, advocacy. NAMI offers support groups. Evidence-based adjunct to treatment. Normalize mental health discussions. Improve treatment adherence.",
    "category": "Mental Health Advocacy",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 363,
    "question": "A patient on an SSRI asks about osteoporosis prevention. What lifestyle modifications should the PMHNP recommend?",
    "options": [
      "Bed rest to prevent falls",
      "Weight-bearing exercise and limiting caffeine",
      "High-protein diet only",
      "Calcium supplements without exercise"
    ],
    "correctAnswer": 1,
    "rationale": "Osteoporosis management: weight-bearing EXERCISE, decrease caffeine (increases calcium excretion), adequate calcium/vitamin D, bisphosphonates if indicated. Relevant for patients on SSRIs (bone density concerns) or antipsychotics.",
    "category": "Osteoporosis Management",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 364,
    "question": "A PMHNP is educating an elderly patient starting sertraline. Besides medication education, what lifestyle advice is important?",
    "options": [
      "Regular exercise benefits mood; limit caffeine; do not stop medication abruptly",
      "Limit all activity",
      "Increase caffeine intake",
      "No lifestyle changes needed"
    ],
    "correctAnswer": 0,
    "rationale": "Elderly + SSRI education: exercise benefits mood and bone health. Reduce caffeine (can worsen anxiety, affects bone density). Monitor for hyponatremia, falls. Different from discontinuation syndrome (which needs taper education).",
    "category": "Geriatric Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 365,
    "question": "A parent asks when adolescents should be screened for ADHD. What screening recommendation should the PMHNP provide?",
    "options": [
      "Screen all adolescents routinely",
      "Screen adolescents at risk; educate parents",
      "No screening needed in adolescence",
      "Only screen if failing all classes"
    ],
    "correctAnswer": 1,
    "rationale": "ADHD screening in adolescents: screen those at risk (academic problems, behavioral issues, family history). Educate parents about symptoms across settings. Use validated tools: Vanderbilt, Conners. Get collateral from teachers.",
    "category": "ADHD Screening",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 366,
    "question": "A patient involved in social justice, religion campaigns, legal rights, gay right activism demonstrates which ethical principle?",
    "options": [
      "A. Social justice",
      "B. Autonomy",
      "C. Beneficence",
      "D. Non-maleficence"
    ],
    "correctAnswer": 0,
    "rationale": "Social justice: ethical principle ensuring fair distribution of resources, equal treatment, advocating for marginalized groups. NPs have obligation to advocate for healthcare access. Foundation of health equity work.",
    "category": "Ethics",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 367,
    "question": "Is it possible to get a random sample if you are doing research on a preoperative patient where you have a treatment group and no treatment group?",
    "options": [
      "A. Yes, it is possible",
      "B. No, it is impossible to get a random sample",
      "C. Only with consent",
      "D. Only with IRB approval"
    ],
    "correctAnswer": 1,
    "rationale": "Research randomization: sometimes impossible to randomize (ethical constraints, practical limitations). Preoperative patients may require treatment—can't withhold for control group. Use quasi-experimental designs instead.",
    "category": "Research",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 368,
    "question": "What is the highest level of evidence in research?",
    "options": [
      "A. Case studies",
      "B. Cohort studies",
      "C. Systematic reviews of RCTs",
      "D. Expert opinion"
    ],
    "correctAnswer": 2,
    "rationale": "Evidence hierarchy (highest to lowest): 1) Systematic reviews/meta-analyses, 2) RCTs, 3) Cohort studies, 4) Case-control, 5) Case series/reports, 6) Expert opinion. EBP integrates best evidence + clinical expertise + patient values.",
    "category": "Research",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 369,
    "question": "A PMHNP opening a private practice must calculate time for patient care versus administrative tasks. What are these time categories called?",
    "options": [
      "Direct (patient care) versus indirect (administrative) processes",
      "Revenue vs expense time",
      "Clinical vs billing time",
      "Productive vs nonproductive hours"
    ],
    "correctAnswer": 0,
    "rationale": "Direct vs indirect care time: Direct = face-to-face patient contact. Indirect = documentation, care coordination, phone calls, supervision. Both important for practice management. Calculate for productivity and billing.",
    "category": "Professional Practice",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 370,
    "question": "A PMHNP is planning community mental health education. What is the MOST effective way to disseminate information to a diverse community?",
    "options": [
      "Community meetings with representatives from various cultural groups",
      "Medical journal publication",
      "Social media only",
      "Professional conferences"
    ],
    "correctAnswer": 0,
    "rationale": "Community health reform dissemination: community meetings with diverse cultural representation ensure buy-in, cultural appropriateness, and reach. More effective than journal publication for community-level change.",
    "category": "Professional Practice",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 371,
    "question": "A PMHNP is testifying under oath. The patient's attorney advises withholding information about missed appointments. Which ethical principle guides the PMHNP's response?",
    "options": [
      "Personal and professional integrity",
      "Confidentiality only",
      "Patient advocacy",
      "Legal immunity"
    ],
    "correctAnswer": 0,
    "rationale": "Testifying under oath: personal/professional INTEGRITY requires truthfulness. Cannot withhold information at attorney's request—perjury is illegal. Document accurately, testify honestly. Integrity supersedes advocacy.",
    "category": "Ethics",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 372,
    "question": "A patient asks about using kava kava supplements for anxiety. What is the PRIMARY safety concern the PMHNP should discuss?",
    "options": [
      "Addiction potential",
      "Hepatotoxicity requiring LFT monitoring",
      "Serotonin syndrome risk",
      "Cardiovascular effects"
    ],
    "correctAnswer": 1,
    "rationale": "Kava kava: PRIMARY concern is HEPATOTOXICITY (liver damage). FDA warning issued. Requires LFT monitoring. Avoid with alcohol, other hepatotoxic drugs, liver disease. Some countries have banned kava supplements.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 373,
    "question": "A PMHNP works in a rural area where minority populations have limited access to mental health care. What is the NP's ethical responsibility?",
    "options": [
      "Accept the status quo",
      "Focus only on current patients",
      "Advocate through lobbying, media awareness, and community education",
      "Refer elsewhere"
    ],
    "correctAnswer": 2,
    "rationale": "Healthcare disparities: NPs have ethical obligation to ADVOCATE. Methods include lobbying, media awareness, policy involvement, community education. Social justice principle. Address barriers to care for minorities.",
    "category": "Professional Practice",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 374,
    "question": "A 9-year-old is brought in for severe irritability, temper outbursts occurring daily, and persistent anger between outbursts for over a year. This began at age 7. What is the MOST likely diagnosis?",
    "options": [
      "Oppositional Defiant Disorder",
      "Disruptive Mood Dysregulation Disorder",
      "Bipolar disorder",
      "Intermittent Explosive Disorder"
    ],
    "correctAnswer": 1,
    "rationale": "DMDD vs ODD vs CD COMPARISON: DMDD=severe CHRONIC irritability + temper outbursts ≥3x/week × 12 months, onset <10 yrs, irritable BETWEEN outbursts. ODD=angry/irritable mood + defiant behavior + vindictiveness × 6 months, developmentally inappropriate. CD=aggression, destruction, deceitfulness, rule violation. PROGRESSION: ODD(30%)→CD(40%)→Antisocial PD. DMDD prevents bipolar over-diagnosis in children.",
    "category": "Child Psychiatry",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 375,
    "question": "A PMHNP is evaluating economic viability for starting a consulting practice. Which financial analysis shows revenue versus expenses?",
    "options": [
      "Business plan narrative",
      "Income statement/profit and loss analysis",
      "Market research survey",
      "SWOT analysis"
    ],
    "correctAnswer": 1,
    "rationale": "Economic viability: REVENUE AND EXPENSES ANALYSIS (income statement/P&L) shows profitability. Business plan is broader strategy. SWOT analyzes strengths/weaknesses. Market survey assesses demand. For viability, focus on financials.",
    "category": "Professional Practice",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 376,
    "question": "A patient with severe persistent mental illness needs intensive community-based support including housing, employment, and 24/7 crisis services. What treatment model provides this?",
    "options": [
      "Assertive Community Treatment (ACT)",
      "Standard outpatient care",
      "Group therapy only",
      "Inpatient treatment"
    ],
    "correctAnswer": 0,
    "rationale": "ACT (Assertive Community Treatment): intensive, community-based team approach for severe mental illness. Multidisciplinary team provides 24/7 support, medication management, case management, housing, employment. Reduces hospitalizations.",
    "category": "Treatment Modalities",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 377,
    "question": "A PMHNP is using an organizational change approach that focuses on identifying what works well rather than problems. What approach is this?",
    "options": [
      "Problem-focused analysis",
      "Appreciative inquiry",
      "Root cause analysis",
      "Deficit-based assessment"
    ],
    "correctAnswer": 1,
    "rationale": "Appreciative inquiry: focuses on STRENGTHS and COMPETENCIES, not problems. Positive change methodology. 4-D cycle: Discover (what works), Dream (vision), Design (plan), Destiny (implement). Opposite of deficit-based approach.",
    "category": "Therapy Approaches",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 378,
    "question": "A hospital implements a system where medical errors are analyzed for learning rather than punishment. This distinguishes human error from reckless behavior. What culture is this?",
    "options": [
      "Punitive culture",
      "Just culture",
      "Blame culture",
      "Hierarchical culture"
    ],
    "correctAnswer": 1,
    "rationale": "Just culture: learning from errors rather than punishing. Distinguishes human error (system), at-risk behavior (coaching), and reckless behavior (discipline). Promotes safety reporting. Not blame-free but fair.",
    "category": "Professional Practice",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 379,
    "question": "A patient complained they didn't add her to a clinical trial because they think she can't afford the medication. Which ethical principle is violated?",
    "options": [
      "A. Autonomy",
      "B. Beneficence",
      "C. Justice",
      "D. Non-maleficence"
    ],
    "correctAnswer": 2,
    "rationale": "Justice principle: FAIR distribution of resources, equal treatment. Excluding patient from trial based on assumed inability to pay violates justice. All patients deserve equal access to healthcare/research opportunities.",
    "category": "Ethics",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 380,
    "question": "Child tells you he is gay and tells you not to tell parents. What applies?",
    "options": [
      "B. Don't tell - Parents right to know VS patient's privacy",
      "A. Break confidentiality",
      "C. Tell parents immediately",
      "D. Ignore the disclosure"
    ],
    "correctAnswer": 0,
    "rationale": "MINOR CONFIDENTIALITY - Sexual orientation: Maintain confidentiality unless there is a safety concern. Sexual orientation is protected health information. The minor's right to privacy must be balanced against any duty to inform parents. Assess: Is the family environment safe? Is there abuse risk if disclosed? In most states, sexual orientation alone is NOT a reason to break confidentiality with a minor.",
    "category": "Ethics",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 381,
    "question": "A PMHNP's electronic health record documentation is subpoenaed for court. How is the validity of EHR documentation proven?",
    "options": [
      "Verbal testimony from provider",
      "Electronic/authorization signature with time-stamp",
      "Witness confirmation only",
      "Printed copies only"
    ],
    "correctAnswer": 1,
    "rationale": "EHR validity in court: electronic/authorization SIGNATURE proves validity and accountability. Documentation must be authenticated, time-stamped, unaltered. Metadata tracked. E-signatures legally valid under ESIGN Act.",
    "category": "Legal/Documentation",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 382,
    "question": "A patient tells the PMHNP he plans to kill his ex-girlfriend. The PMHNP must act based on which legal precedent?",
    "options": [
      "HIPAA regulations",
      "Right to treatment laws",
      "Tarasoff duty to warn",
      "Informed consent requirements"
    ],
    "correctAnswer": 2,
    "rationale": "Tarasoff v. Regents (1976): established DUTY TO WARN. Must warn identifiable potential victim when patient makes credible threat. Confidentiality is breached for safety. Know state-specific laws. Document warning given.",
    "category": "Legal/Ethics",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 383,
    "question": "A PMHNP discusses medication risks and benefits with a patient, then sends the prescription to pharmacy without obtaining signature. What did the PMHNP omit?",
    "options": [
      "Nothing - discussion is sufficient",
      "Documentation only",
      "Signed informed consent form",
      "Second provider consultation"
    ],
    "correctAnswer": 2,
    "rationale": "Informed consent: patient must SIGN consent form before treatment. Discussion alone insufficient—must document patient agreement. Exception: emergencies. Consent includes: diagnosis, treatment options, risks, benefits, alternatives.",
    "category": "Legal/Ethics",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 384,
    "question": "A patient brings internet printouts about symptoms and medications to the visit. How should the PMHNP respond?",
    "options": [
      "Discourage internet research entirely",
      "Recommend only .gov websites",
      "Review information together and verify accuracy with clinical judgment",
      "Dismiss the patient's concerns"
    ],
    "correctAnswer": 2,
    "rationale": "Internet health information: advise patient that information should be DISCUSSED AND VERIFIED with provider. Validate information-seeking. Recommend reputable sources (.gov, .edu). Don't dismiss concerns.",
    "category": "Patient Education",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 385,
    "question": "A patient on risperidone needs metabolic monitoring. What parameters should the PMHNP assess?",
    "options": [
      "Blood sugar only",
      "Weight only",
      "Liver function only",
      "Waist circumference, BMI, lipids, glucose, and blood pressure"
    ],
    "correctAnswer": 3,
    "rationale": "Risperdal (risperidone) monitoring: metabolic panel—waist circumference, BMI, weight, hip-to-waist ratio, fasting glucose, lipid panel. Atypical antipsychotics cause metabolic syndrome. Also monitor for EPS.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 386,
    "question": "A patient previously diagnosed with Alzheimer's 3 years ago had an MMSE of 29. Today's MMSE is 26. How should the PMHNP interpret this?",
    "options": [
      "Expected progression",
      "Score 18-23 indicates mild impairment",
      "Score 10-17 indicates moderate impairment",
      "Slow decline suggests reconsidering diagnosis or using MoCA for better sensitivity"
    ],
    "correctAnswer": 1,
    "rationale": "MMSE 18-23=mild impairment. CRITICAL: If patient scores 24-30 on MMSE but you suspect cognitive decline, USE MoCA. MoCA (0-30): ≥26=normal, <26=impaired. More sensitive for Parkinson's dementia, vascular dementia, frontotemporal dementia.",
    "category": "Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 387,
    "question": "An 80-year-old patient with memory complaints has MMSE scores of 29 initially and 26 after 3 years. This slow decline is unusual for Alzheimer's. What should the PMHNP consider?",
    "options": [
      "Continue current treatment unchanged",
      "Increase cholinesterase inhibitor dose",
      "Reconsider the diagnosis; use MoCA for better sensitivity to early changes",
      "Refer immediately to neurology"
    ],
    "correctAnswer": 2,
    "rationale": "Slow MMSE decline (29→26 over 3 years): too slow for Alzheimer's. Consider MoCA—more sensitive for MCI and early changes. MoCA tests executive function (trails, clock) that MMSE misses. Reconsider diagnosis or use MoCA for better sensitivity.",
    "category": "Diagnosis",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 388,
    "question": "A PMHNP is reviewing medications for a patient with comorbid depression and congestive heart failure (CHF). Which medication class is considered first-line for CHF management?",
    "options": [
      "ACE inhibitors",
      "Beta-blockers only",
      "Calcium channel blockers",
      "Thiazide diuretics only"
    ],
    "correctAnswer": 0,
    "rationale": "ACE inhibitors treat CHF: TRUE. First-line for heart failure with reduced EF. Reduce mortality. Also: hypertension, post-MI, diabetic nephropathy. Mechanism: block angiotensin II → reduce afterload.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 389,
    "question": "A patient in the psychiatric ED remains agitated after receiving lorazepam. To prevent prolonged restraint use, what is the next pharmacological intervention?",
    "options": [
      "Repeat same benzodiazepine dose",
      "Oral medication only",
      "Physical restraint indefinitely",
      "Add IM antipsychotic"
    ],
    "correctAnswer": 3,
    "rationale": "Acute agitation unresponsive to benzo: add IM antipsychotic (Geodon/ziprasidone, Haldol, or Zyprexa). Reduces restraint time. Geodon preferred—IM has lower QTc risk than PO. Monitor vitals.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 390,
    "question": "A 22-year-old woman on valproate (Depakote) for bipolar disorder is sexually active. What laboratory monitoring is ESSENTIAL?",
    "options": [
      "Pregnancy test only",
      "Liver function tests only",
      "CBC with platelets only",
      "ALL: pregnancy test, LFTs, CBC, and drug levels"
    ],
    "correctAnswer": 3,
    "rationale": "Young female on Depakote—order ALL: pregnancy test (teratogenic), LFTs (hepatotoxicity), CBC (thrombocytopenia), AND drug level. Valproate causes neural tube defects, PCOS. Must use contraception.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 391,
    "question": "A patient on risperidone for 10 months is prescribed metoclopramide (Reglan) for nausea. What should the PMHNP teach about this combination?",
    "options": [
      "Safe combination with no concerns",
      "Only monitor for weight gain",
      "Monitor for cardiac effects only",
      "BOTH are dopamine antagonists - increased risk of EPS, TD, and akathisia"
    ],
    "correctAnswer": 3,
    "rationale": "Risperdal + Reglan (metoclopramide): BOTH block dopamine → additive EPS risk, TD, akathisia. Metoclopramide is a dopamine antagonist. Combination increases movement disorder risk. Use alternative antiemetic.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 392,
    "question": "A patient on citalopram is started on omeprazole for GERD. What pharmacokinetic interaction should the PMHNP anticipate?",
    "options": [
      "INCREASED SSRI levels",
      "Decreased SSRI levels",
      "No interaction expected",
      "Increased risk of serotonin syndrome"
    ],
    "correctAnswer": 0,
    "rationale": "SSRI + PPI (omeprazole): PPIs inhibit CYP2C19 → can increase SSRI levels (citalopram, escitalopram). PHARMACOKINETIC interaction. Monitor for increased side effects. CYP2C19 poor metabolizers (~3% Caucasians, 15-20% Asians) already have higher levels.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 393,
    "question": "A patient on long-term lithium has urinalysis showing 4+ proteinuria. What does this finding indicate?",
    "options": [
      "Normal finding",
      "Lithium-induced nephropathy requiring nephrology referral",
      "Dehydration only",
      "Medication non-compliance"
    ],
    "correctAnswer": 1,
    "rationale": "Lithium nephrotoxicity: 4+ proteinuria indicates renal damage. Lithium causes nephrogenic diabetes insipidus, chronic kidney disease. Monitor BUN, creatinine, urinalysis. May need nephrology referral.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 394,
    "question": "A pregnant woman is taking sertraline and isotretinoin (Accutane). Which medication MUST be discontinued immediately?",
    "options": [
      "Sertraline",
      "Both medications",
      "Neither medication",
      "Isotretinoin"
    ],
    "correctAnswer": 3,
    "rationale": "ISOTRETINOIN (Accutane) is absolutely CONTRAINDICATED in pregnancy - Category X, highly teratogenic. Causes severe birth defects including craniofacial, cardiac, and CNS abnormalities. Requires iPLEDGE program with two forms of contraception. Sertraline is relatively safe in pregnancy (preferred SSRI). If patient becomes pregnant on isotretinoin, discontinue IMMEDIATELY and refer to high-risk OB.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 395,
    "question": "A patient on multiple serotonergic medications presents with hyperthermia, altered mental status, and neuromuscular abnormalities. Which finding helps differentiate serotonin syndrome from NMS?",
    "options": [
      "CLONUS and HYPERREFLEXIA",
      "Elevated CK levels",
      "Lead-pipe rigidity",
      "Leukocytosis"
    ],
    "correctAnswer": 0,
    "rationale": "SEROTONIN SYNDROME distinguishing features: CLONUS and HYPERREFLEXIA (especially lower extremity). Triad: (1) Mental status changes, (2) Autonomic instability (hyperthermia, diaphoresis, tachycardia), (3) Neuromuscular hyperactivity (HYPERREFLEXIA, clonus, tremor, rigidity). Key differentiator from NMS: Serotonin syndrome has hyperreflexia/clonus; NMS has lead-pipe rigidity and HYPOreflexia.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 396,
    "question": "A child with enuresis is prescribed desmopressin (DDAVP). What is the medication's mechanism of action?",
    "options": [
      "Increases urine production",
      "Relaxes bladder muscle",
      "Promotes deeper sleep",
      "DECREASES urine production (synthetic ADH)"
    ],
    "correctAnswer": 3,
    "rationale": "DDAVP (desmopressin): synthetic ADH → REDUCES urine output. Used for: enuresis (bedwetting), diabetes insipidus, bleeding disorders. Risk: hyponatremia from water retention. Monitor sodium.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 397,
    "question": "A teenager with diabetes presents to the ED with DKA and attempts to leave without psychiatric evaluation. What should the PMHNP do?",
    "options": [
      "Allow the patient to leave",
      "Call security immediately",
      "Collaborate with ED staff to ensure medical and psychiatric evaluation",
      "Document only"
    ],
    "correctAnswer": 2,
    "rationale": "Teenager with DKA leaving without psych eval: COLLABORATE with ER staff. DKA can indicate medication non-adherence, eating disorder, substance use. Provide relevant psychiatric history. Patient safety first.",
    "category": "Professional Practice",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 398,
    "question": "A PMHNP is prescribing an off-label medication to a 10-year-old. What documentation is REQUIRED?",
    "options": [
      "No special documentation needed",
      "Written consent from the child",
      "FULL DISCLOSURE to guardian about off-label use, risks, benefits, and alternatives",
      "Second opinion mandatory"
    ],
    "correctAnswer": 2,
    "rationale": "Off-label prescribing in children: FULL DISCLOSURE to guardian required. Explain: lack of FDA pediatric approval, evidence supporting use, risks, alternatives. Document informed consent. Common practice in child psychiatry.",
    "category": "Ethics/Legal",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 399,
    "question": "A patient presents with fever, altered mental status, and neuromuscular symptoms after starting an antipsychotic. Labs show significantly elevated CK. What syndrome is this?",
    "options": [
      "Serotonin syndrome",
      "Malignant hyperthermia",
      "Anticholinergic toxicity",
      "NEUROLEPTIC MALIGNANT SYNDROME"
    ],
    "correctAnswer": 3,
    "rationale": "NMS vs Serotonin Syndrome: NMS = lead-pipe rigidity, fever, autonomic instability, elevated CK/WBC. Labs distinguish: NMS has elevated CK (rhabdomyolysis). Both emergencies. Stop offending agent.",
    "category": "Medical Emergencies",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 400,
    "question": "A patient with extrapyramidal symptoms from antipsychotic use is at risk for developing which chronic condition?",
    "options": [
      "Weight loss",
      "Improved motor function",
      "Resolution of all symptoms",
      "TARDIVE DYSKINESIA"
    ],
    "correctAnswer": 3,
    "rationale": "EPS progression to TD: chronic dopamine blockade → receptor upregulation → tardive dyskinesia. Early EPS (acute dystonia, akathisia) may precede TD. Monitor with AIMS. TD may be irreversible.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 401,
    "question": "A Native American patient is in restraints after refusing to give up his healing stick, which staff considered dangerous. What should the PMHNP do?",
    "options": [
      "Support staff decision",
      "Remove restraints only",
      "TEACH STAFF about cultural competency and significance of healing traditions",
      "Transfer patient"
    ],
    "correctAnswer": 2,
    "rationale": "Cultural competency: teach staff about healing traditions. Native American healing stick has spiritual significance. Restraints were inappropriate cultural conflict, not medical necessity. Advocate for culturally sensitive care.",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 402,
    "question": "A Hispanic patient who recently lost a parent presents with depression and somatic complaints (stomach ache) that medical workup cannot explain. How should the PMHNP approach this?",
    "options": [
      "Refer to gastroenterology",
      "Order more tests",
      "VALIDATE experience and provide culturally sensitive care recognizing somatic expression of grief",
      "Prescribe antacids"
    ],
    "correctAnswer": 2,
    "rationale": "Somatization in Hispanic culture: 'nervios' (nerves) manifests as GI symptoms. Grief + depression presents somatically. Validate experience, recognize cultural expression of distress. Don't over-medicalize. Culturally specific care essential.",
    "category": "Cultural Competence",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 403,
    "question": "A PMHNP is explaining the neurobiological basis of ADHD to a parent. Which brain region is primarily associated with the executive dysfunction and impulsivity seen in ADHD?",
    "options": [
      "Hippocampus",
      "Amygdala",
      "Cerebellum",
      "Prefrontal cortex/Orbitofrontal region"
    ],
    "correctAnswer": 3,
    "rationale": "ADHD + BRAIN: DORSOLATERAL PFC=executive dysfunction (planning, working memory). ORBITOFRONTAL=poor impulse control. ANTERIOR CINGULATE=motivation/attention deficits. Prefrontal-striatal circuits underactive. Stimulants INCREASE dopamine/NE in PFC. Fully matures age 25—explains why some 'outgrow' ADHD symptoms.",
    "category": "Neurobiology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 404,
    "question": "A patient with anorexia nervosa has a BMI of 16 and heart rate of 45. What determines need for hospitalization in eating disorders?",
    "options": [
      "BMI below 15 only",
      "BMI below 17.5 only",
      "BMI below 18.5 only",
      "ANY weight with medical instability"
    ],
    "correctAnswer": 3,
    "rationale": "Eating disorder hospitalization: any weight with MEDICAL INSTABILITY (not just BMI). Criteria: HR <50, BP <80/50, temp <97°F, electrolyte abnormalities, arrhythmias, acute weight refusal, syncope. Medical stability determines level of care.",
    "category": "Eating Disorders",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 405,
    "question": "A 6-year-old with autism spectrum disorder has difficulty imitating others and understanding social cues. Which brain system dysfunction is theorized to contribute to these deficits?",
    "options": [
      "Frontal lobe motor cortex",
      "Mirror neuron system",
      "Temporal lobe auditory cortex",
      "Occipital lobe visual cortex"
    ],
    "correctAnswer": 1,
    "rationale": "AUTISM BRAIN: MIRROR NEURON SYSTEM dysfunction (frontal-parietal)—affects imitation, social learning. AMYGDALA abnormalities=emotion processing. LARGER brain volume early life, then normalizes. BASAL GANGLIA involved in repetitive behaviors. Social brain network (STS, fusiform) affected.",
    "category": "Neurobiology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 406,
    "question": "A postmenopausal patient on sertraline is concerned about bone health. What intervention is MOST effective for osteoporosis prevention?",
    "options": [
      "Calcium supplements alone",
      "Medication only",
      "Vitamin D alone",
      "WEIGHT-BEARING EXERCISE and smoking cessation"
    ],
    "correctAnswer": 3,
    "rationale": "Osteoporosis prevention: WEIGHT-BEARING EXERCISE + lifestyle changes (stop smoking, limit alcohol/caffeine). Also: calcium 1200mg + vitamin D 800-1000 IU daily. Relevant for patients on SSRIs, steroids, antipsychotics.",
    "category": "Health Promotion",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 407,
    "question": "The clock drawing test assesses function of which brain regions?",
    "options": [
      "Right hemisphere and dorsolateral prefrontal cortex",
      "Left hemisphere language areas only",
      "Frontal motor cortex only",
      "Parietal sensory cortex only"
    ],
    "correctAnswer": 0,
    "rationale": "CLOCK DRAWING: Tests (1) RIGHT HEMISPHERE=visuospatial skills, (2) DORSOLATERAL PFC=executive function, planning, sequencing. Abnormal in dementia, stroke, frontal lesions. Numbers crowded on one side=hemispatial neglect. Poor planning/sequencing=PFC damage.",
    "category": "Neurobiology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 408,
    "question": "A PMHNP completes a quality improvement project. What method of sharing findings provides the HIGHEST credibility?",
    "options": [
      "Social media",
      "Newspaper article",
      "Conference poster only",
      "PEER-REVIEWED JOURNAL publication"
    ],
    "correctAnswer": 3,
    "rationale": "Research dissemination: PEER-REVIEWED JOURNALS provide highest credibility. Ensures quality control, expert review. Conferences, newspapers for broader reach but less rigorous. EBP relies on peer-reviewed evidence.",
    "category": "Research",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 409,
    "question": "When developing treatment guidelines, what represents the HIGHEST level of evidence?",
    "options": [
      "Case reports",
      "META-ANALYSES and SYSTEMATIC REVIEWS of RCTs",
      "Single RCT",
      "Expert opinion"
    ],
    "correctAnswer": 1,
    "rationale": "Evidence hierarchy: META-ANALYSES and SYSTEMATIC REVIEWS of RCTs are highest level. Synthesize multiple studies, reduce bias. Then: RCTs > cohort > case-control > case series > expert opinion (lowest).",
    "category": "Research",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 410,
    "question": "A newly pregnant patient is on multiple medications. Which medication is Category X and MUST be discontinued?",
    "options": [
      "Acetaminophen",
      "Isotretinoin",
      "Prenatal vitamins",
      "Folic acid"
    ],
    "correctAnswer": 1,
    "rationale": "Accutane (isotretinoin): HIGHLY TERATOGENIC (Category X). Causes severe birth defects: craniofacial, cardiac, CNS abnormalities. iPLEDGE program mandates contraception + pregnancy tests. Absolute contraindication in pregnancy.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 411,
    "question": "A child on amphetamine stimulant develops tics. Which medication should the PMHNP switch to?",
    "options": [
      "Different amphetamine formulation",
      "Add antipsychotic",
      "Discontinue all ADHD medications",
      "Switch to GUANFACINE"
    ],
    "correctAnswer": 3,
    "rationale": "Stimulant-induced tics: switch to GUANFACINE or clonidine (alpha-2 agonists). Non-stimulant options don't worsen tics. Guanfacine preferred (once daily, longer acting). Atomoxetine also an option.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 412,
    "question": "A patient with depression and marital conflicts wants 3-6 months of therapy. Which therapy approach is MOST appropriate?",
    "options": [
      "Long-term psychoanalysis",
      "Medication only",
      "INTERPERSONAL THERAPY (IPT) - focuses on relationships, time-limited",
      "Exposure therapy"
    ],
    "correctAnswer": 2,
    "rationale": "Depression with marital conflicts (3-6 months): INTERPERSONAL THERAPY (IPT) ideal—focuses on relationship issues, role transitions. Time-limited (12-16 sessions). Psychodynamic for deeper exploration. Exposure for PTSD, not depression.",
    "category": "Therapy Approaches",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 413,
    "question": "An 8-year-old with ADHD on methylphenidate develops motor tics. What medication change should the PMHNP make?",
    "options": [
      "Increase stimulant dose",
      "Switch to different stimulant",
      "Continue same medication",
      "Switch to GUANFACINE"
    ],
    "correctAnswer": 3,
    "rationale": "ADHD with tics—switch to GUANFACINE: alpha-2 agonist that DOESN'T worsen tics (may help them). Stimulants can exacerbate tics. Guanfacine also treats ADHD. Once-daily dosing. Fewer cardiovascular effects than clonidine.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 414,
    "question": "A young woman with bipolar disorder expresses strong concerns about weight gain from medications. Which mood stabilizer is WEIGHT-NEUTRAL?",
    "options": [
      "Oxcarbazepine (Trileptal)",
      "Lithium",
      "Olanzapine",
      "LAMOTRIGINE"
    ],
    "correctAnswer": 3,
    "rationale": "Weight-neutral mood stabilizer: LAMICTAL (lamotrigine). May cause slight weight LOSS. Lithium, Depakote, Zyprexa cause significant weight gain. For weight-concerned patients, lamotrigine is good choice. Monitor for SJS rash.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 415,
    "question": "A patient with PTSD asks about evidence-based psychotherapy options. Which therapies are first-line for PTSD?",
    "options": [
      "Psychodynamic therapy only",
      "Supportive therapy only",
      "Medication is the only option",
      "EMDR, Prolonged Exposure (PE), Cognitive Processing Therapy (CPT)"
    ],
    "correctAnswer": 3,
    "rationale": "PTSD evidence-based therapies: EMDR (Eye Movement Desensitization Reprocessing), PE (Prolonged Exposure), CPT (Cognitive Processing Therapy). Image rehearsal for nightmares. All trauma-focused CBT variants. First-line per VA/DoD guidelines.",
    "category": "Therapy Approaches",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 416,
    "question": "A patient with alcohol use disorder AND hepatic impairment presents in withdrawal. Which benzodiazepine is preferred?",
    "options": [
      "Diazepam",
      "LORAZEPAM",
      "Chlordiazepoxide",
      "Alprazolam"
    ],
    "correctAnswer": 1,
    "rationale": "LORAZEPAM (Ativan) is preferred for alcohol withdrawal in patients with HEPATIC IMPAIRMENT. Reason: Lorazepam is metabolized by glucuronidation (Phase II) - NOT affected by liver disease. Other benzos (diazepam, chlordiazepoxide) use oxidative (Phase I) metabolism which is impaired in liver disease. Also prefer oxazepam. Avoid long-acting benzos in liver failure due to accumulation risk.",
    "category": "Substance Use",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 417,
    "question": "A patient in alcohol withdrawal has a CIWA-Ar score of 18. What treatment protocol should the PMHNP follow?",
    "options": [
      "No treatment at this score",
      "PRN benzodiazepines only",
      "SCHEDULED benzodiazepines with frequent reassessment (score ≥16)",
      "Antipsychotics only"
    ],
    "correctAnswer": 2,
    "rationale": "ALCOHOL WITHDRAWAL TIMELINE: 6-12h: tremor, anxiety, headache, GI upset, palpitations. 12-24h: withdrawal seizures (peak 24h, usually generalized tonic-clonic). 24-48h: alcoholic hallucinosis (visual hallucinations with clear sensorium). 48-96h: DELIRIUM TREMENS (DTs) - confusion, agitation, fever, autonomic instability, hallucinations, mortality 5-15% untreated. CIWA-Ar score guides treatment: <10 (may not need meds), 10-15 (PRN benzos), >15 (scheduled benzos). Benzodiazepines are first-line for all stages.",
    "category": "Substance Use",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 418,
    "question": "A 20-year-old says 'I cannot make friends, nobody likes me.' According to Erikson, which developmental stage is this patient in?",
    "options": [
      "IDENTITY vs. ROLE CONFUSION (12-20 years)",
      "Intimacy vs. Isolation (20-40 years)",
      "Generativity vs. Stagnation",
      "Industry vs. Inferiority"
    ],
    "correctAnswer": 0,
    "rationale": "20-year-old with social difficulties: Still in IDENTITY VS ROLE CONFUSION stage (12-20 years per Erikson). Forming identity. Next stage (20-40) is Intimacy vs Isolation. Difficulty relates to identity formation challenges.",
    "category": "Developmental Psychology",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 419,
    "question": "An 8-year-old is observed having dolls engage in explicit sexual activity during play therapy. What should the PMHNP do?",
    "options": [
      "REPORT to CPS - age-inappropriate sexual knowledge warrants investigation",
      "Ignore as normal play",
      "Continue observing",
      "Talk to parents only"
    ],
    "correctAnswer": 0,
    "rationale": "8-year-old sexualized play: age-inappropriate sexual knowledge WARRANTS INVESTIGATION. Report to CPS. Sexual behavior in young children may indicate abuse exposure. Not normal developmental play. Mandatory reporting.",
    "category": "Child Protection",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 420,
    "question": "A patient concerned about weight gain asks which mood stabilizer is least likely to cause weight gain. Which is TRUE about lamotrigine?",
    "options": [
      "TRUE - Lamotrigine is WEIGHT-NEUTRAL",
      "False - causes significant weight gain",
      "Only weight neutral short-term",
      "Weight effect depends on dose"
    ],
    "correctAnswer": 0,
    "rationale": "Lamictal weight-neutral: TRUE. One of few mood stabilizers without weight gain. May cause slight weight loss. Good for bipolar depression. Main concern: rash (Stevens-Johnson syndrome)—start low, go slow titration.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 421,
    "question": "A patient on carbamazepine (Tegretol) is prescribed erythromycin. What dose adjustment is needed?",
    "options": [
      "Increase Tegretol dose",
      "DECREASE Tegretol dose",
      "No adjustment needed",
      "Discontinue erythromycin"
    ],
    "correctAnswer": 1,
    "rationale": "Tegretol + erythromycin: DECREASE Tegretol dose (or avoid combo). Erythromycin INHIBITS CYP3A4 → Tegretol accumulates. PHARMACOKINETICS summary: INHIBITORS = ↑ drug levels = toxicity. INDUCERS = ↓ drug levels = failure. 'I for Inhibitor = Increase.'",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 422,
    "question": "During medication reconciliation, the PMHNP notes a patient is on lisinopril. ACE inhibitors are primarily used for:",
    "options": [
      "Diabetes management",
      "HEART FAILURE",
      "Depression",
      "Anxiety"
    ],
    "correctAnswer": 1,
    "rationale": "ACE inhibitors indication: HEART FAILURE (HFrEF) primary indication. Also: hypertension, post-MI, diabetic nephropathy, chronic kidney disease. Reduce mortality in HF. PMHNP needs to know for medication reconciliation.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 423,
    "question": "A mother asks how desmopressin (DDAVP) works for her child's bedwetting. Which statement indicates correct understanding?",
    "options": [
      "It increases urination during the day",
      "It helps the child sleep deeper",
      "It increases bladder capacity",
      "It DECREASES urine production at night"
    ],
    "correctAnswer": 3,
    "rationale": "DDAVP (desmopressin) teaching: mother should understand it DECREASES urine production. Used for enuresis (bedwetting). Synthetic ADH. Give before bed. Monitor for water retention, hyponatremia. Restrict fluids at night.",
    "category": "Patient Education",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 424,
    "question": "A PMHNP is teaching a mother about desmopressin (DDAVP) administration for her child's enuresis. Which response indicates understanding?",
    "options": [
      "Give with plenty of fluids at bedtime",
      "RESTRICT fluids in evening and give medication before bed",
      "Give in the morning with breakfast",
      "Give only after accidents occur"
    ],
    "correctAnswer": 1,
    "rationale": "DDAVP (desmopressin) ADMINISTRATION: Give before bedtime AND RESTRICT fluids in evening/overnight to prevent water intoxication and hyponatremia. Don't drink excessive fluids at bedtime. Monitor for: headache, nausea (hyponatremia signs). Nasal spray or oral forms available.",
    "category": "Professional Practice",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 425,
    "question": "A patient's family asks about the recovery model in mental health treatment. Which statement BEST describes this approach?",
    "options": [
      "TRUE - Recovery model promotes HOPE, empowerment, and meaningful life",
      "False - focuses only on symptom cure",
      "Medical model is the same",
      "Only for mild mental illness"
    ],
    "correctAnswer": 0,
    "rationale": "Recovery model: TRUE—gives HOPE, promotes patient empowerment, self-determination, meaningful life beyond illness. Not cure-focused. Person-centered. Beyond symptom reduction. SAMHSA guiding principle.",
    "category": "Treatment Philosophy",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 426,
    "question": "A PMHNP is using Bowen family systems therapy. Which concepts are central to this approach?",
    "options": [
      "TRIANGULATION and SELF-DIFFERENTIATION",
      "Individual pathology focus",
      "Behavioral modification only",
      "Medication management"
    ],
    "correctAnswer": 0,
    "rationale": "Bowen Family Systems: TRIANGULATION = involving third party to reduce anxiety between two. SELF-DIFFERENTIATION = maintaining sense of self while in relationship. Key concepts for family therapy. Reduces emotional reactivity.",
    "category": "Therapy Approaches",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 427,
    "question": "During a neuropsychological consultation, the PMHNP explains that a patient's difficulty with planning, decision-making, and working memory is related to dysfunction in which brain structure?",
    "options": [
      "Hippocampus",
      "Amygdala",
      "Cerebellum",
      "Dorsolateral prefrontal cortex"
    ],
    "correctAnswer": 3,
    "rationale": "EXECUTIVE FUNCTION: DORSOLATERAL PREFRONTAL CORTEX. Planning, decision-making, working memory, cognitive flexibility, impulse control. AFFECTED IN: ADHD (underactive), schizophrenia (hypofrontality), depression, dementia, TBI. Fully matures around age 25. Tests: Trails B, WCST, clock drawing.",
    "category": "Neurobiology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 428,
    "question": "A PMHNP is educating staff about the neurobiology of aggression. Which brain structure is the primary center for processing fear and threat responses that can lead to aggressive behavior?",
    "options": [
      "Frontal lobe",
      "Parietal lobe",
      "Amygdala",
      "Occipital lobe"
    ],
    "correctAnswer": 2,
    "rationale": "AGGRESSION BRAIN CIRCUITS: AMYGDALA=threat detection, fear/anger. LIMBIC SYSTEM (primitive brain)=emotional responses. PREFRONTAL CORTEX=regulates amygdala ('top-down control'). When PFC fails to regulate amygdala→impulsive aggression. Seen in: TBI, antisocial PD, intoxication (alcohol disinhibits PFC).",
    "category": "Neurobiology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 429,
    "question": "A patient on haloperidol develops acute dystonia with neck stiffness and torticollis. What is the IMMEDIATE treatment?",
    "options": [
      "Benzodiazepines only",
      "Antipsychotic dose increase",
      "ANTICHOLINERGICS IM/IV",
      "Supportive care only"
    ],
    "correctAnswer": 2,
    "rationale": "ACUTE DYSTONIA EMERGENCY: Give ANTICHOLINERGICS immediately - benztropine (Cogentin) 1-2mg IM/IV or diphenhydramine (Benadryl) 25-50mg IM/IV. Response within minutes. Dystonia is painful muscle spasm from D2 blockade. Can affect airway (laryngeal dystonia). Prevention: prophylactic benztropine with high-potency FGAs.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 430,
    "question": "A patient taking kava kava for anxiety asks about drug interactions. What should the PMHNP advise?",
    "options": [
      "AVOID benzodiazepines",
      "Safe with all medications",
      "Only avoid antidepressants",
      "Only avoid antibiotics"
    ],
    "correctAnswer": 0,
    "rationale": "Kava + benzodiazepines: AVOID combination. Both are CNS depressants. Additive sedation, respiratory depression risk. Kava also hepatotoxic. Teach patient: no mixing with alcohol, benzos, sedatives.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 431,
    "question": "A patient is using kava kava supplements for anxiety. What PRIMARY safety concern should the PMHNP discuss?",
    "options": [
      "HEPATOTOXICITY - FDA warning issued",
      "Weight gain",
      "Renal impairment",
      "Cardiac effects"
    ],
    "correctAnswer": 0,
    "rationale": "Kava education: HEPATOTOXICITY main concern. FDA warning for liver damage. Can cause fulminant liver failure. Monitor LFTs. Avoid with liver disease, alcohol, hepatotoxic drugs. Report jaundice, dark urine.",
    "category": "Patient Education",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 432,
    "question": "A patient with fibromyalgia and depression asks about medication options that could help both conditions. Which medication classes are evidence-based for fibromyalgia?",
    "options": [
      "NSAIDs only",
      "Benzodiazepines",
      "TCAs, SNRIs, or pregabalin",
      "Steroids"
    ],
    "correctAnswer": 2,
    "rationale": "Fibromyalgia treatment: TCAs (amitriptyline), SNRIs (duloxetine, milnacipran). Also: pregabalin (Lyrica). NOT NSAIDs (don't help), NOT benzos (worsen fatigue). Exercise, CBT also helpful. Multimodal approach.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 433,
    "question": "A widower speaks only positively about his deceased wife, describing her as 'perfect in every way.' Which defense mechanism is this patient using?",
    "options": [
      "Idealization",
      "Denial",
      "Projection",
      "Regression"
    ],
    "correctAnswer": 0,
    "rationale": "Idealization: defense mechanism where deceased person viewed as perfect, all-good. Common in grief. Protects from ambivalent feelings. Eventually integrate realistic view of person. Different from denial.",
    "category": "Psychology",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 434,
    "question": "A patient on risperidone requires metabolic syndrome screening. What is the BEST initial assessment for central adiposity?",
    "options": [
      "Weight only",
      "Waist-to-hip circumference ratio measurement",
      "Blood pressure only",
      "Fasting glucose only"
    ],
    "correctAnswer": 1,
    "rationale": "Metabolic syndrome assessment: HIP-TO-WAIST ratio or waist circumference (central adiposity key marker). Also: fasting glucose, lipid panel, blood pressure. Atypical antipsychotics increase metabolic syndrome risk.",
    "category": "Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 435,
    "question": "A patient on lithium reports taking indomethacin (Indocin) for back pain. What should the PMHNP do?",
    "options": [
      "No adjustment needed",
      "Increase lithium dose",
      "Continue current regimen",
      "DECREASE lithium dose"
    ],
    "correctAnswer": 3,
    "rationale": "Lithium + NSAIDs (Indocin/Meloxicam): NSAIDs INCREASE lithium levels by decreasing renal clearance. DECREASE lithium dose or use Tylenol instead. All NSAIDs interact: ibuprofen, naproxen, indomethacin, meloxicam.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 436,
    "question": "A nursing student asks about the difference between thought process and thought content in the mental status exam. What is the correct distinction?",
    "options": [
      "PROCESS = HOW thoughts flow; CONTENT = WHAT thoughts are about",
      "They are identical concepts",
      "No clinical relevance",
      "Only content is documented"
    ],
    "correctAnswer": 0,
    "rationale": "Thought PROCESS vs CONTENT: PROCESS = how thoughts flow (logical, tangential, loose associations, circumstantial). CONTENT = what thoughts are about (delusions, suicidal ideation, obsessions). Both documented in MSE.",
    "category": "Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 437,
    "question": "A patient reports thoughts of wanting to die. In which section of the mental status examination should this be documented?",
    "options": [
      "Mood and affect",
      "Thought process",
      "Behavior",
      "THOUGHT CONTENT"
    ],
    "correctAnswer": 3,
    "rationale": "Suicidal ideation documented in THOUGHT CONTENT. Content includes: SI/HI, delusions, obsessions, phobias, ideas of reference, overvalued ideas. Process describes the organization/flow of thinking.",
    "category": "Documentation",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 438,
    "question": "A patient on metoclopramide (Reglan) for nausea develops involuntary facial movements. What adverse effect has occurred?",
    "options": [
      "TARDIVE DYSKINESIA",
      "Weight loss",
      "Hyperglycemia",
      "Hypertension"
    ],
    "correctAnswer": 0,
    "rationale": "Reglan (metoclopramide): causes TARDIVE DYSKINESIA. Dopamine antagonist (like antipsychotics). FDA Black Box Warning for TD with prolonged use (>12 weeks). Also causes EPS, akathisia. Use alternative antiemetics when possible.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 439,
    "question": "A PMHNP asks a patient to subtract 7 from 100 and continue subtracting. What cognitive function is being assessed?",
    "options": [
      "Memory",
      "Language",
      "Mood",
      "CONCENTRATION AND ATTENTION"
    ],
    "correctAnswer": 3,
    "rationale": "Serial 7s (100-7=93-7=86...): tests CONCENTRATION AND ATTENTION. Part of MMSE. Also tests calculation. Alternative: spell WORLD backwards. Affected in delirium, dementia, anxiety, ADHD.",
    "category": "Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 440,
    "question": "A child presents with weight loss, irritability, and increased energy. Before assuming a psychiatric diagnosis, what should the PMHNP order?",
    "options": [
      "Depression screening only",
      "ADHD assessment",
      "Anxiety screening",
      "LEAD LEVEL"
    ],
    "correctAnswer": 3,
    "rationale": "Child with weight loss, irritability, increased energy: check LEAD LEVEL. Lead toxicity symptoms mimic psychiatric conditions. Also causes developmental delays, behavioral changes. Screen high-risk children.",
    "category": "Pediatric Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 441,
    "question": "A PMHNP wants to assess for formal thought disorder in a patient with schizophrenia. What is the BEST assessment technique?",
    "options": [
      "Yes/no questions only",
      "PROVERB INTERPRETATION",
      "Memory testing",
      "Depression scale"
    ],
    "correctAnswer": 1,
    "rationale": "Thought disorder assessment: PROVERB INTERPRETATION tests abstract thinking. Concrete interpretation suggests schizophrenia, cognitive impairment. Example: 'Don't cry over spilled milk' → literal vs. figurative interpretation.",
    "category": "Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 442,
    "question": "A 7-year-old with ODD is at risk for developing conduct disorder. What intervention is MOST effective for prevention?",
    "options": [
      "Medication alone",
      "Punishment-based approaches",
      "Ignoring behaviors",
      "PARENT MANAGEMENT TRAINING and behavioral therapy"
    ],
    "correctAnswer": 3,
    "rationale": "PREVENTING ODD→CD: PARENT TRAINING (PMT) is GOLD STANDARD. Teaches: consistent discipline, positive reinforcement, ignoring minor behaviors, time-out technique. DIFFERENTIAL: ODD (defiant)→CD (aggressive/destructive)→Antisocial PD (≥18 yrs). DMDD is NOT on this pathway—it's mood disorder, not conduct problem. DMDD=chronic irritability; ODD=defiance.",
    "category": "Prevention",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 443,
    "question": "A patient on haloperidol develops acute neck stiffness and torticollis. What is the immediate treatment?",
    "options": [
      "Increase antipsychotic",
      "SSRI",
      "BENZTROPINE (Cogentin) IM - anticholinergic for acute dystonia",
      "Mood stabilizer"
    ],
    "correctAnswer": 2,
    "rationale": "Acute dystonia: BENZTROPINE (Cogentin) IM/IV for rapid relief. Anticholinergic blocks acetylcholine, restores dopamine-acetylcholine balance. Also: diphenhydramine 50mg IM. Prevention: start with anticholinergic in high-risk patients.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 444,
    "question": "A patient using kava kava for anxiety asks what side effects to watch for. What is the PRIMARY education point?",
    "options": [
      "Weight changes",
      "Renal effects",
      "Cardiac effects",
      "HEPATOTOXICITY"
    ],
    "correctAnswer": 3,
    "rationale": "Kava HEPATOTOXICITY: primary education point. FDA warning for liver damage. Can be fatal. Teach patient: monitor for jaundice, abdominal pain, dark urine. Avoid alcohol. Check LFTs periodically.",
    "category": "Patient Education",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 445,
    "question": "A patient taking kava kava is prescribed medication for anxiety. Which medication should be AVOIDED?",
    "options": [
      "BENZODIAZEPINES",
      "Antibiotics",
      "Antihypertensives",
      "Antihistamines"
    ],
    "correctAnswer": 0,
    "rationale": "Kava + benzodiazepines: AVOID. Additive CNS depression, sedation, respiratory depression. Both affect GABA system. Also avoid with alcohol, other sedatives. Hepatotoxicity risk increases with polypharmacy.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 446,
    "question": "A child is admitted to the inpatient unit. Parents express concerns about managing behavior after discharge. When should parent training BEGIN?",
    "options": [
      "At discharge",
      "START ON ADMISSION",
      "After discharge",
      "Only if requested"
    ],
    "correctAnswer": 1,
    "rationale": "Inpatient child discharge planning: START PARENT TRAINING ON ADMISSION. Don't wait until discharge. Allows practice, questions, adjustment. Part of comprehensive discharge planning. Ensures continuity of care.",
    "category": "Professional Practice",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 447,
    "question": "A PMHNP is evaluating risk factors for a patient with antisocial personality disorder. What is this population at increased risk for?",
    "options": [
      "Anxiety disorders",
      "HIGH RISK for violence and homicide",
      "Psychosis",
      "Depression primarily"
    ],
    "correctAnswer": 1,
    "rationale": "ANTISOCIAL PD RISK: Significantly increased risk for VIOLENCE and HOMICIDE. High rates of criminality, substance abuse, premature death. Poor treatment prognosis. Cannot diagnose before age 18 (use Conduct Disorder). Comorbid substance use worsens outcomes.",
    "category": "Risk Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 448,
    "question": "A PMHNP asks a patient to subtract 7 from 100 repeatedly. This tests which cognitive function?",
    "options": [
      "CONCENTRATION and attention",
      "Memory recall",
      "Language comprehension",
      "Judgment"
    ],
    "correctAnswer": 0,
    "rationale": "Serial 7s: tests CONCENTRATION and attention (also calculation). Part of cognitive assessment. Affected by delirium, anxiety, ADHD, dementia. Alternative: spell WORLD backwards. Document number of errors.",
    "category": "Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 449,
    "question": "A patient with HIV and CD4 count of 180 presents with slowed thinking and memory problems. What are the EARLY signs of HIV-associated dementia?",
    "options": [
      "Memory loss only",
      "CONCENTRATION problems and slowed processing",
      "Hallucinations",
      "Delusions"
    ],
    "correctAnswer": 1,
    "rationale": "HIV-associated dementia early signs: CONCENTRATION problems, slowed processing, memory impairment. Subcortical dementia pattern. Motor slowing common. Screen when CD4 <200. Antiretroviral therapy may improve cognition.",
    "category": "Medical Conditions",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 450,
    "question": "An elderly patient with depression performs poorly on cognitive testing but frequently says 'I don't know.' What distinguishes pseudodementia from true dementia?",
    "options": [
      "Progressive, irreversible decline",
      "REVERSIBLE with treatment of underlying depression",
      "Consistent cognitive deficits",
      "No treatment response"
    ],
    "correctAnswer": 1,
    "rationale": "Pseudodementia: REVERSIBLE with depression treatment. Depressed patients appear cognitively impaired but improve when depression treated. Key differentiator: effort on testing (say 'I don't know' vs trying). Treatable.",
    "category": "Diagnosis",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 451,
    "question": "A PMHNP is assessing suicide risk. Which demographic profile has the HIGHEST risk for completed suicide?",
    "options": [
      "Young female",
      "Married middle-aged man",
      "65+ year-old WHITE MALE, single or widowed",
      "Adolescent female"
    ],
    "correctAnswer": 2,
    "rationale": "Highest suicide risk: 65+ YEAR-OLD WHITE MALE, single/widowed. Risk factors: male, elderly, Caucasian, living alone, chronic illness, access to firearms. Men complete suicide 4x more than women. Always assess lethality.",
    "category": "Risk Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 452,
    "question": "An adolescent is newly diagnosed with bipolar disorder. What is the FIRST intervention priority?",
    "options": [
      "Start medication immediately",
      "Immediate hospitalization",
      "Psychotherapy only",
      "EDUCATE patient and parents about illness, medications, warning signs"
    ],
    "correctAnswer": 3,
    "rationale": "New adolescent bipolar: EDUCATE patient and parents first. Explain illness course, medication, warning signs, importance of sleep/routine. Psychoeducation improves adherence, reduces relapse. Don't just start meds without education.",
    "category": "Patient Education",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 453,
    "question": "A patient in the office suddenly discloses being raped. What is the FIRST response the PMHNP should provide?",
    "options": [
      "Call police immediately",
      "REASSURE safety",
      "Continue routine appointment",
      "Immediate ER referral"
    ],
    "correctAnswer": 1,
    "rationale": "Trauma disclosure: First REASSURE safety—'You are in a safe place.' Establish trust before gathering details. Trauma-informed approach. Then assess current safety, offer resources (SANE exam, advocacy). Don't force disclosure.",
    "category": "Crisis Intervention",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 454,
    "question": "A researcher is reviewing pediatric antidepressant trials. What accounts for the discrepancy between child and adult response rates?",
    "options": [
      "Children respond better than adults",
      "Children have HIGHER PLACEBO RESPONSE rates (up to 50%)",
      "Same response rates",
      "Children respond worse due to metabolism"
    ],
    "correctAnswer": 1,
    "rationale": "Pediatric antidepressant trials: children have HIGHER placebo response than adults (up to 50%). Makes demonstrating drug efficacy harder. Contributes to fewer FDA-approved antidepressants for children. Study design challenges.",
    "category": "Research/Pharmacology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 455,
    "question": "A PMHNP is teaching about the neurobiological basis of EPS. Which dopamine pathway is involved?",
    "options": [
      "Mesocortical pathway",
      "NIGROSTRIATAL pathway",
      "Mesolimbic pathway",
      "Tuberoinfundibular pathway"
    ],
    "correctAnswer": 1,
    "rationale": "EPS mechanism: NIGROSTRIATAL PATHWAY dopamine blockade. Movement disorders result from dopamine reduction in substantia nigra → basal ganglia. Both typical and atypical antipsychotics can cause EPS (atypicals less so).",
    "category": "Neurobiology",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 456,
    "question": "A PMHNP suspects thought disorder in a patient with schizophrenia. What assessment technique should be used?",
    "options": [
      "PROVERB INTERPRETATION to assess abstract thinking",
      "Increase medication first",
      "Hospitalization",
      "Change medication"
    ],
    "correctAnswer": 0,
    "rationale": "Assess thought disorder: PROVERB INTERPRETATION tests abstract thinking. Concrete responses suggest thought disorder/cognitive impairment. Example: 'People in glass houses shouldn't throw stones' → literal vs abstract interpretation.",
    "category": "Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 457,
    "question": "A child becomes fearful and worried about dying 2 weeks after a shooting incident near their home. What is the MOST likely diagnosis?",
    "options": [
      "ACUTE STRESS DISORDER",
      "PTSD",
      "Generalized anxiety disorder",
      "Specific phobia"
    ],
    "correctAnswer": 0,
    "rationale": "Child fear after shooting: ACUTE STRESS DISORDER if <1 month since trauma (3 days to 1 month). PTSD diagnosis requires >1 month duration. GAD is chronic worry not linked to specific trauma. Distinguish timeline carefully.",
    "category": "Diagnosis",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 458,
    "question": "A 4-year-old child reports seeing monsters in dreams and wakes up frightened. How should the PMHNP interpret this?",
    "options": [
      "NORMAL developmental phenomenon",
      "Psychotic symptoms requiring evaluation",
      "PTSD symptoms",
      "Anxiety disorder"
    ],
    "correctAnswer": 0,
    "rationale": "NIGHTMARES (4-year-old): NORMAL developmental. SLEEP NEUROBIOLOGY: REM sleep=brainstem activation, prefrontal deactivation (dreams). NIGHT TERRORS=NREM (no recall). CIRCADIAN RHYTHM development: infants=polyphasic, children=consolidated. PINEAL GLAND matures; melatonin rhythm develops by 3-6 months. Screen time=blue light suppresses melatonin.",
    "category": "Development",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 459,
    "question": "A child wakes up screaming at night but cannot be consoled and has no memory of the event. The PMHNP asks about family history. What is the rationale?",
    "options": [
      "Assess for nightmares",
      "Rule out seizures",
      "PARASOMNIAS run in families",
      "Screen for trauma"
    ],
    "correctAnswer": 2,
    "rationale": "SLEEP DISORDERS: Ask FAMILY HISTORY. PARASOMNIAS (sleepwalking, night terrors)=Stage 3/NREM, runs in families, no dream recall. NIGHTMARES=REM sleep, dream recall. SLEEP REGULATION: PINEAL GLAND→melatonin (darkness). HYPOTHALAMUS (SCN)=circadian pacemaker. BRAINSTEM (reticular activating system)=arousal. GABA/adenosine=sleep-promoting.",
    "category": "Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 460,
    "question": "A veteran returns from Afghanistan after losing a close friend. He feels sad when remembering but functions well. What is the appropriate approach?",
    "options": [
      "Diagnose PTSD",
      "Diagnose major depression",
      "SUPPORTIVE THERAPY and encourage return to normal activities",
      "Start antidepressants"
    ],
    "correctAnswer": 2,
    "rationale": "Veteran grief without PTSD: SUPPORTIVE THERAPY and resuming normal activities. Normal grief response if not meeting PTSD criteria (no re-experiencing, avoidance, hyperarousal). Don't over-pathologize normal grief.",
    "category": "Treatment",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 461,
    "question": "A patient presents 3 weeks after receiving a herpes diagnosis, reporting significant distress about the diagnosis. What is the MOST likely diagnosis?",
    "options": [
      "PTSD",
      "ADJUSTMENT DISORDER",
      "Acute stress disorder",
      "GAD"
    ],
    "correctAnswer": 1,
    "rationale": "Distress 3 weeks after herpes diagnosis: ADJUSTMENT DISORDER. Stressor identifiable, symptoms within 3 months, marked distress out of proportion. Not PTSD (not life-threatening). Time-limited once stressor resolves.",
    "category": "Diagnosis",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 462,
    "question": "A nurse was attacked by a patient 3 weeks ago and is now fearful of returning to work. What is the diagnosis?",
    "options": [
      "ACUTE STRESS DISORDER",
      "PTSD",
      "GAD",
      "Specific phobia"
    ],
    "correctAnswer": 0,
    "rationale": "Symptoms 3 weeks after attack: ACUTE STRESS DISORDER (3 days to 1 month duration). Features: intrusion, negative mood, dissociation, avoidance, arousal. After 1 month → reassess for PTSD. Treat with trauma-focused CBT.",
    "category": "Diagnosis",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 463,
    "question": "A patient with anorexia nervosa has a BMI of 14.5 and bradycardia. What level of care is indicated?",
    "options": [
      "INPATIENT hospitalization",
      "Outpatient treatment",
      "Partial hospitalization",
      "Weekly therapy"
    ],
    "correctAnswer": 0,
    "rationale": "Anorexia hospitalization: BMI <15 generally requires inpatient. Also hospitalize for: medical instability, <75% ideal body weight, acute food refusal, cardiac compromise, electrolyte imbalance, suicidal ideation.",
    "category": "Treatment",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 464,
    "question": "An elderly patient with cognitive complaints frequently responds 'I don't know' during testing and shows inconsistent deficits. What should the PMHNP suspect?",
    "options": [
      "Alzheimer's dementia",
      "Vascular dementia",
      "PSEUDODEMENTIA",
      "Lewy body dementia"
    ],
    "correctAnswer": 2,
    "rationale": "PSEUDODEMENTIA: Depression-related cognitive impairment that mimics dementia. Key features: 'I don't know' responses, inconsistent deficits, acute onset, prominent depressive symptoms. REVERSIBLE with depression treatment. Always screen for depression in elderly with cognitive complaints.",
    "category": "Professional Practice",
    "domain": 5,
    "domainName": "Ethical and Legal Principles"
  },
  {
    "id": 465,
    "question": "A patient develops acute dystonia with neck stiffness after starting an antipsychotic. What medication provides rapid relief?",
    "options": [
      "Diphenhydramine or Benztropine (anticholinergics)",
      "Lorazepam",
      "Another antipsychotic",
      "Haloperidol"
    ],
    "correctAnswer": 0,
    "rationale": "ACUTE DYSTONIA TREATMENT: ANTICHOLINERGICS are first-line - diphenhydramine (Benadryl) 25-50mg IM/IV or benztropine (Cogentin) 1-2mg IM/IV. Rapid relief within minutes. Lorazepam is benzodiazepine, not first-line for dystonia. Prevention: prophylactic anticholinergics with high-potency FGAs.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 466,
    "question": "A patient using kava kava asks about drug interactions. Which medication is CONTRAINDICATED with kava?",
    "options": [
      "SSRIs",
      "Antipsychotics",
      "Mood stabilizers",
      "BENZODIAZEPINES"
    ],
    "correctAnswer": 3,
    "rationale": "Kava Kava—avoid: BENZODIAZEPINES. Additive CNS depression, sedation. Both affect GABA. Also hepatotoxicity risk. Avoid alcohol and other sedatives. SSRIs and antipsychotics less concerning.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 467,
    "question": "A patient taking kava kava asks what to monitor. What is the PRIMARY concern?",
    "options": [
      "Weight changes",
      "HEPATOTOXICITY",
      "Cardiac effects",
      "Renal function"
    ],
    "correctAnswer": 1,
    "rationale": "Kava education: HEPATOTOXICITY. FDA warning for liver damage. Monitor LFTs. Report jaundice, abdominal pain, dark urine. Can cause liver failure. Avoid with alcohol, other hepatotoxic substances.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 468,
    "question": "A patient with fibromyalgia asks why benzodiazepines are not recommended. What should the PMHNP explain?",
    "options": [
      "Effective but expensive",
      "Effective short-term only",
      "AVOID benzodiazepines - worsen fatigue, cause dependence; use SNRIs/TCAs",
      "Only effective with other medications"
    ],
    "correctAnswer": 2,
    "rationale": "Fibromyalgia treatment: DO NOT give benzos (worsen fatigue, dependence risk). Use: TCAs (amitriptyline), SNRIs (duloxetine, milnacipran), pregabalin. Exercise, sleep hygiene, CBT also evidence-based.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 469,
    "question": "A man describes his deceased wife as 'perfect' and 'an angel.' Which defense mechanism is operating?",
    "options": [
      "Projection",
      "IDEALIZATION",
      "Displacement",
      "Denial"
    ],
    "correctAnswer": 1,
    "rationale": "Idealization: defense mechanism making deceased seem perfect. Common in grief. Protects from mixed feelings about relationship. Healthy initially; problematic if prevents moving through grief. Different from denial.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 470,
    "question": "A patient on risperidone requires metabolic monitoring. What measurement specifically assesses for central obesity?",
    "options": [
      "Blood glucose alone",
      "BMI calculation",
      "WAIST-TO-HIP circumference ratio",
      "Lipid panel"
    ],
    "correctAnswer": 2,
    "rationale": "Metabolic syndrome—Risperdal: measure HIP-TO-WAIST circumference (central adiposity key marker). Also: weight, BMI, fasting glucose, lipid panel, blood pressure. All atypicals require metabolic monitoring.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 471,
    "question": "A patient on lithium is taking meloxicam (Mobic) for arthritis. What intervention is needed?",
    "options": [
      "Switch mood stabilizer",
      "DECREASE lithium dose",
      "Increase lithium dose",
      "No change needed"
    ],
    "correctAnswer": 1,
    "rationale": "Lithium + NSAIDs: DECREASE LITHIUM dose. NSAIDs (Indocin, Mobic, ibuprofen) reduce renal clearance → increased lithium levels → toxicity risk. Use Tylenol for pain. Monitor lithium levels closely.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 472,
    "question": "A patient on long-term metoclopramide (Reglan) develops involuntary facial movements. What complication has occurred?",
    "options": [
      "NMS",
      "Akathisia only",
      "TARDIVE DYSKINESIA",
      "Serotonin syndrome"
    ],
    "correctAnswer": 2,
    "rationale": "Reglan (metoclopramide): causes TARDIVE DYSKINESIA. Dopamine blocker like antipsychotics. FDA Black Box Warning for TD. Limit use to <12 weeks. Also causes EPS, akathisia. Use alternative antiemetics.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 473,
    "question": "A PMHNP asks a patient to perform serial 7s (100-7=93-7=86...). What cognitive domain is being assessed?",
    "options": [
      "Memory",
      "CONCENTRATION AND ATTENTION",
      "Orientation",
      "Language"
    ],
    "correctAnswer": 1,
    "rationale": "Serial 7s: tests CONCENTRATION AND ATTENTION. Patient subtracts 7 from 100 repeatedly (100, 93, 86, 79...). Part of MMSE. Also tests calculation. Alternative: spell WORLD backwards.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 474,
    "question": "A PMHNP suspects thought disorder and wants to assess abstract thinking. What assessment technique is appropriate?",
    "options": [
      "Memory testing",
      "Calculation tasks",
      "PROVERB INTERPRETATION",
      "Orientation questions"
    ],
    "correctAnswer": 2,
    "rationale": "Thought disorder assessment: PROVERB INTERPRETATION. Tests abstract thinking. Concrete interpretation suggests schizophrenia, cognitive impairment. 'A stitch in time saves nine' → patient explains abstract meaning.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 475,
    "question": "Parents of a child with ODD ask how to prevent progression to conduct disorder. What is the evidence-based intervention?",
    "options": [
      "Medication alone",
      "Strict punishment",
      "PARENT MANAGEMENT TRAINING and behavioral therapy",
      "Ignoring all behaviors"
    ],
    "correctAnswer": 2,
    "rationale": "ODD prevention: PARENT TRAINING and BEHAVIOR THERAPY. Evidence-based. PMT (Parent Management Training) teaches consistent discipline, positive reinforcement. Without intervention, ~30% develop Conduct Disorder.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 476,
    "question": "A veteran with combat-related PTSD asks about evidence-based therapy options. Which therapeutic modalities are recommended as first-line treatments per VA/DoD clinical practice guidelines?",
    "options": [
      "Supportive therapy only",
      "EMDR, Prolonged Exposure (PE), and Cognitive Processing Therapy (CPT)",
      "Psychodynamic therapy only",
      "Medication management without therapy"
    ],
    "correctAnswer": 1,
    "rationale": "PTSD therapy: EMDR, Prolonged Exposure (PE), CPT (Cognitive Processing Therapy) are evidence-based. CBT with trauma focus effective. Image rehearsal for nightmares. APA/VA guidelines support trauma-focused approaches.",
    "category": "Psychotherapy & Treatment",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 477,
    "question": "A patient with alcohol use disorder AND liver disease is in withdrawal. Which benzodiazepine is preferred?",
    "options": [
      "Diazepam",
      "Chlordiazepoxide",
      "Alprazolam",
      "LORAZEPAM"
    ],
    "correctAnswer": 3,
    "rationale": "ALCOHOL + LIVER: LORAZEPAM for withdrawal (glucuronidation metabolism). HEPATIC ENCEPHALOPATHY vs ALCOHOL WITHDRAWAL: Hepatic=ammonia toxicity (asterixis, confusion, reversed sleep cycle, lactulose treatment). Alcohol withdrawal=GABA underactivity (tremors, seizures, DTs, benzo treatment). WERNICKE'S=thiamine deficiency (confusion, ataxia, eye signs).",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 478,
    "question": "A 20-year-old patient tells the PMHNP, 'I cannot make friends. Nobody likes me.' According to Erikson's psychosocial stages, which developmental stage is this patient navigating?",
    "options": [
      "Intimacy vs. Isolation (20-40 years)",
      "Identity vs. Role Confusion (12-20 years)",
      "Trust vs. Mistrust",
      "Generativity vs. Stagnation"
    ],
    "correctAnswer": 0,
    "rationale": "ERIKSON'S STAGES: At 20 years old, patient is entering INTIMACY VS ISOLATION stage (20-40 years). Struggle to form close relationships ('I cannot make friends') is hallmark of this stage. Success = intimate relationships. Failure = isolation and loneliness.",
    "category": "Developmental Theory & Lifespan",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 479,
    "question": "An 8-year-old child in play therapy has dolls engage in explicit sexual activity. When asked, the child states 'This is how daddy plays with me.' What is the PMHNP's IMMEDIATE obligation?",
    "options": [
      "CALL CPS immediately - mandatory reporting of suspected abuse",
      "Consult with supervisor first",
      "Refer to individual therapy",
      "Schedule follow-up appointment"
    ],
    "correctAnswer": 0,
    "rationale": "8-year-old sexualized play: CALL CPS immediately. Age-inappropriate sexual knowledge suggests exposure to sexual activity. Mandatory reporting. Document objectively. Child protection takes priority over other considerations.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 480,
    "question": "A nursing student asks the PMHNP to explain the difference between thought process and thought content. Which description is accurate?",
    "options": [
      "They are interchangeable terms",
      "Process refers to speech rate only",
      "Content includes only mood assessment",
      "PROCESS = organization/flow of thinking; CONTENT = themes/subjects of thoughts"
    ],
    "correctAnswer": 3,
    "rationale": "Thought PROCESS vs CONTENT: PROCESS = how thoughts organized (logical, tangential, loose associations). CONTENT = what thoughts are about (delusions, SI, obsessions). Both documented in Mental Status Exam.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 481,
    "question": "A patient stabilized on carbamazepine (Tegretol) is prescribed erythromycin for a respiratory infection. Which action should the PMHNP take?",
    "options": [
      "Decrease the carbamazepine dose due to CYP3A4 inhibition by erythromycin",
      "Monitor carbamazepine levels only without dose adjustment",
      "Increase carbamazepine due to expected decreased levels",
      "Discontinue carbamazepine during antibiotic treatment"
    ],
    "correctAnswer": 0,
    "rationale": "Tegretol + erythromycin = DECREASE Tegretol. High-yield CYP facts: (1) 3A4 = most common CYP, (2) 2D6 = psych meds, (3) 1A2 = smoking induces, (4) Inhibitors → toxicity, (5) Inducers → failure. Mnemonic: 'SICK FACES inhibit, PC BRAS induce.'",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 482,
    "question": "A healthcare organization is implementing quality improvement using appreciative inquiry. Which statement BEST describes this methodology?",
    "options": [
      "Emphasizes medication compliance tracking",
      "Targets symptom reduction as primary goal",
      "Focuses on identifying deficits to fix",
      "Focuses on STRENGTHS and HOPE, building on successes without blame"
    ],
    "correctAnswer": 3,
    "rationale": "Appreciative inquiry: focuses on STRENGTHS AND HOPE, doesn't blame. Positive change methodology. Identifies what works, builds on successes. Solution-focused. 4-D cycle: Discover, Dream, Design, Destiny.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 483,
    "question": "A PMHNP is explaining the recovery model to a patient with schizophrenia. Which principle is CENTRAL to recovery-oriented care?",
    "options": [
      "Primary focus on symptom elimination",
      "Strict medication compliance emphasis",
      "Providing HOPE and supporting self-determination for a meaningful life",
      "Focus on patient deficits"
    ],
    "correctAnswer": 2,
    "rationale": "Recovery model: gives HOPE to patient. Person-centered, empowerment-focused. Beyond symptom reduction—meaningful life despite illness. Self-determination. SAMHSA guiding principle. Not cure-focused.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 484,
    "question": "A PMHNP is explaining neuroanatomy to a student. Which brain region is correctly paired with its PRIMARY function?",
    "options": [
      "Dorsolateral prefrontal cortex - executive function and working memory",
      "Anterior cingulate cortex - visual processing",
      "Posterior parietal cortex - emotional regulation",
      "Ventromedial prefrontal cortex - motor coordination"
    ],
    "correctAnswer": 0,
    "rationale": "BRAIN REGIONS HIGH-YIELD: DORSOLATERAL PFC=executive function/working memory. ORBITOFRONTAL=impulse control/social. VENTROMEDIAL PFC=emotion/decision-making. ANTERIOR CINGULATE=error detection/motivation. AMYGDALA=fear/emotion. HIPPOCAMPUS=memory. BASAL GANGLIA=movement/habits. SUBSTANTIA NIGRA=dopamine (Parkinson's).",
    "category": "Neuroscience & Neuroanatomy",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 485,
    "question": "A patient with PTSD asks about a therapy that uses bilateral stimulation, including eye movements, to process traumatic memories. Which therapy is the patient describing?",
    "options": [
      "Cognitive Behavioral Therapy (CBT)",
      "Dialectical Behavior Therapy (DBT)",
      "Eye Movement Desensitization and Reprocessing (EMDR)",
      "Psychodynamic therapy"
    ],
    "correctAnswer": 2,
    "rationale": "EMDR: therapy using EYE MOVEMENTS (or bilateral stimulation) to process trauma. Evidence-based for PTSD. 8-phase protocol. Desensitizes traumatic memories. Reduces intrusive symptoms.",
    "category": "Psychotherapy & Treatment",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 486,
    "question": "A patient with bipolar disorder expresses concern about weight gain from mood stabilizers. Which mood stabilizer is considered weight-neutral and may be the BEST option for this patient?",
    "options": [
      "Lithium",
      "Valproate (Depakote)",
      "Lamotrigine (Lamictal)",
      "Olanzapine"
    ],
    "correctAnswer": 2,
    "rationale": "Weight-neutral mood stabilizer: LAMICTAL (lamotrigine). Doesn't cause weight gain, may cause slight loss. Good for bipolar depression. Other options (lithium, Depakote, atypicals) cause weight gain.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 487,
    "question": "A PMHNP is using Bowen family systems therapy. Which concepts are CENTRAL to this therapeutic approach?",
    "options": [
      "Behavioral reinforcement and extinction",
      "Dream interpretation and free association",
      "Exposure and response prevention",
      "Triangulation and self-differentiation"
    ],
    "correctAnswer": 3,
    "rationale": "Bowen family therapy: TRIANGULATION (involving third person to reduce dyad tension) and SELF-DIFFERENTIATION (maintaining self in relationships). Key concepts. Reduces emotional reactivity in family system.",
    "category": "Psychotherapy & Treatment",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 488,
    "question": "A PMHNP is providing health promotion counseling to a patient on long-term antipsychotic therapy. Which interventions are MOST important for osteoporosis prevention?",
    "options": [
      "Bed rest to prevent falls",
      "Calcium intake only",
      "Avoiding all physical activity",
      "Weight-bearing exercise and smoking cessation"
    ],
    "correctAnswer": 3,
    "rationale": "Osteoporosis prevention: WEIGHT-BEARING EXERCISE + STOP SMOKING. Also: calcium 1200mg, vitamin D 800-1000 IU daily. Limit alcohol and caffeine. Relevant for patients on SSRIs, steroids, antipsychotics.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 489,
    "question": "A PMHNP is teaching about the clock drawing test. Which brain regions are assessed by this screening tool?",
    "options": [
      "Temporal lobe only",
      "Occipital lobe only",
      "Frontal motor cortex",
      "DORSOLATERAL PFC and RIGHT HEMISPHERE"
    ],
    "correctAnswer": 3,
    "rationale": "CLOCK DRAWING TEST: RIGHT HEMISPHERE for visuospatial processing + DORSOLATERAL PREFRONTAL for executive planning. Tests: planning, organization, visuospatial, abstract thinking. Sensitive for dementia screening. MoCA includes clock drawing. Abnormal patterns indicate specific lesion locations.",
    "category": "Neuroscience & Neuroanatomy",
    "domain": 1,
    "domainName": "Scientific Foundation"
  },
  {
    "id": 490,
    "question": "A PMHNP has completed a research study and wants maximum scientific credibility for dissemination. What is the BEST method?",
    "options": [
      "Press release",
      "Personal blog",
      "Social media campaign",
      "PEER-REVIEWED JOURNAL publication"
    ],
    "correctAnswer": 3,
    "rationale": "Research dissemination: PEER-REVIEWED JOURNALS highest credibility. Expert review ensures quality. Conferences, newspapers reach broader audience but less rigorous. EBP relies on peer-reviewed evidence.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 491,
    "question": "A PMHNP is conducting a medication reconciliation for a patient who just learned she is pregnant. Which medication poses the HIGHEST teratogenic risk and requires immediate discontinuation?",
    "options": [
      "Prenatal vitamins",
      "Low-dose aspirin",
      "Isotretinoin (Accutane)",
      "Acetaminophen"
    ],
    "correctAnswer": 2,
    "rationale": "Pregnancy teratogen: ACCUTANE (isotretinoin) Category X. Causes severe birth defects: craniofacial, cardiac, CNS abnormalities. iPLEDGE program mandates contraception + pregnancy tests. Absolute contraindication.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 492,
    "question": "A 9-year-old patient with ADHD on amphetamine salts develops motor tics. Which medication should the PMHNP consider switching to?",
    "options": [
      "Methylphenidate (Ritalin)",
      "Higher dose amphetamine",
      "Lisdexamfetamine (Vyvanse)",
      "Guanfacine (Intuniv)"
    ],
    "correctAnswer": 3,
    "rationale": "Stimulant-induced tics: switch to GUANFACINE (alpha-2 agonist). Non-stimulant option that doesn't worsen tics. May actually improve tics. Once-daily dosing. Methamphetamine is a stimulant—would worsen tics.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 493,
    "question": "A 35-year-old woman presents with depression related to marital conflicts and requests time-limited therapy (3-6 months). Which therapeutic approach is MOST appropriate?",
    "options": [
      "Interpersonal therapy (IPT)",
      "Long-term psychoanalysis",
      "Prolonged exposure therapy",
      "Medication management only"
    ],
    "correctAnswer": 0,
    "rationale": "Depression with marital issues (4-6 months): INTERPERSONAL THERAPY (IPT) ideal. Focuses on relationships, role transitions. Time-limited (12-16 sessions). Also consider psychodynamic for deeper exploration.",
    "category": "Psychotherapy & Treatment",
    "domain": 4,
    "domainName": "Psychotherapy and Related Theories"
  },
  {
    "id": 494,
    "question": "A child with enuresis is prescribed desmopressin (DDAVP). Which parent statement indicates correct understanding of administration?",
    "options": [
      "I will give extra fluids at bedtime",
      "I will give it in the morning",
      "This medication permanently cures bedwetting",
      "RESTRICT fluids 1 hour before and 8 hours after medication"
    ],
    "correctAnswer": 3,
    "rationale": "DDAVP (desmopressin) ADMINISTRATION: RESTRICT fluids 1 hour before and 8 hours after medication. Give before bedtime. Prevents water intoxication and hyponatremia. Does NOT permanently cure bedwetting - works while taking medication. Monitor for headache, nausea (hyponatremia signs).",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 495,
    "question": "After prescribing desmopressin for a child's enuresis, which statement by the mother demonstrates correct understanding of the medication's therapeutic effect?",
    "options": [
      "\"It decreases urine production at night\"",
      "\"It increases bladder capacity\"",
      "\"It helps my child wake up when needing to urinate\"",
      "\"It improves my child's deep sleep\""
    ],
    "correctAnswer": 0,
    "rationale": "DDAVP teaching: mother should say it 'DECREASES URINE PRODUCTION.' Synthetic ADH for enuresis. Give before bed. Watch for hyponatremia. Restrict evening fluids. Confirms understanding of mechanism.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 496,
    "question": "A patient taking an MAOI presents with severe headache, hypertension, and diaphoresis after eating aged cheese. What is the priority intervention?",
    "options": [
      "Administer IV phentolamine or nifedipine",
      "Give activated charcoal",
      "Discontinue the MAOI immediately",
      "Provide supportive care only"
    ],
    "correctAnswer": 0,
    "rationale": "MAOI + tyramine crisis: HYPERTENSIVE EMERGENCY. Priority: IV PHENTOLAMINE (alpha-blocker) or nifedipine (calcium channel blocker). Reduces blood pressure. Supportive care. Avoid tyramine-containing foods on MAOIs.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 497,
    "question": "What is the first-line pharmacological treatment for social anxiety disorder according to evidence-based guidelines?",
    "options": [
      "SSRIs or SNRIs",
      "Benzodiazepines",
      "Beta-blockers",
      "Buspirone"
    ],
    "correctAnswer": 0,
    "rationale": "Social anxiety first-line: SSRIs or SNRIs. Paroxetine, sertraline FDA-approved. Beta-blockers for performance anxiety only (not generalized SAD). Benzos not first-line (dependence risk). CBT also effective.",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 498,
    "question": "A patient reports their antidepressant is no longer working after 2 years of effective treatment. What phenomenon is this called?",
    "options": [
      "Tachyphylaxis",
      "Tolerance",
      "Pseudodementia",
      "Treatment-resistant depression"
    ],
    "correctAnswer": 0,
    "rationale": "Antidepressant poop-out: TACHYPHYLAXIS. Loss of response after initial efficacy. Options: dose increase, augmentation, switch medications. Not same as treatment-resistant (which implies multiple failures).",
    "category": "Pharmacology",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  },
  {
    "id": 499,
    "question": "During a mental status exam, a patient states: 'I went to the store, the door, the floor, explore.' This is an example of which thought process disturbance?",
    "options": [
      "Clanging",
      "Flight of ideas",
      "Tangentiality",
      "Perseveration"
    ],
    "correctAnswer": 0,
    "rationale": "Clanging: speech based on SOUND rather than meaning. 'Store, door, floor, explore'—words connected by rhyme. Seen in mania, psychosis. Different from flight of ideas (loosely connected but meaningful).",
    "category": "Assessment",
    "domain": 2,
    "domainName": "Advanced Practice Skills"
  },
  {
    "id": 500,
    "question": "What is the minimum duration of symptoms required to diagnose Persistent Depressive Disorder (Dysthymia) in adults?",
    "options": [
      "6 months",
      "1 year",
      "2 years",
      "5 years"
    ],
    "correctAnswer": 2,
    "rationale": "Persistent Depressive Disorder (Dysthymia): 2 YEARS minimum duration in adults (1 year in children/adolescents). Chronic depressed mood most days. Less severe than MDD but longer duration. May have double depression.",
    "category": "Diagnostic Criteria (DSM-5)",
    "domain": 3,
    "domainName": "Diagnosis and Treatment"
  }
]